syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
CHILDHOOD ABSENCE EPILEPSY	1.521265784	57.072035697967515
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.72054212187669
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687592
OBESITY	1.00390625	37.662697695574224
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.516150233723735
PLUMMER-VINSON SYNDROME	1.0	37.516150233723735
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.516150233723735
DIABETES MELLITUS, NONINSULIN-DEPENDENT	1.0	37.516150233723735
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.9144307499999997	34.30592139533666
LAFORA DISEASE	0.7715289599999999	28.94479637302863
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
EARLY MYOCLONIC ENCEPHALOPATHY	0.70941035	26.61434526795854
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6945606699999999	26.057242442155808
ROLANDIC EPILEPSY	0.6461768999999999	24.242069657961878
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684000000001	22.283407728484516
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.5833333	21.88441971913384
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.008600952602585
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517787982	19.425411721928644
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.515429128	19.33691660088522
XQ12-Q13.3 DUPLICATION SYNDROME	0.511011184	19.171172350057045
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50969036	19.121620118440735
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50969036	19.121620118440735
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50390625	18.904622578712353
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5030581	18.87280325589162
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.501811934	18.82605190501946
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.500961538	18.794148320925302
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.778387073405263
CREST SYNDROME	0.5	18.758075116861868
PAROXYSMAL HEMICRANIA	0.5	18.758075116861868
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.5	18.758075116861868
RESTRICTIVE DERMOPATHY	0.5	18.758075116861868
RHYNS SYNDROME	0.5	18.758075116861868
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.758075116861868
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	18.758075116861868
INHALATIONAL ANTHRAX	0.5	18.758075116861868
CITRULLINEMIA TYPE II	0.476731419	17.8851275363403
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.44703715000000005	16.771112879455696
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.43717484000000006	16.40111697584414
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.4242421	15.91593035907045
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42357368999999995	15.890854189092723
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42126578400000003	15.804270440871415
SPINOCEREBELLAR ATAXIA TYPE 10	0.409852838	15.376100644126037
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38965681	14.618423423553548
PLACENTAL INSUFFICIENCY	0.38310061	14.372460039391207
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.38140101	14.30869759045397
PERIORAL MYOCLONIA WITH ABSENCES	0.36508484399999996	13.69657785555959
CHROMOSOME 17Q12 DELETION SYNDROME	0.36241398399999997	13.59637747054635
CHROMOSOME 5Q12 DELETION SYNDROME	0.35808819099999994	13.434090370478359
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
MENTAL RETARDATION, X-LINKED 12; MRX12	0.353337972	13.255880440831271
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.348302828	13.066981222078839
COG4-CDG	0.3480389	13.057079659579951
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.347540762	13.038391439534823
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34552988399999995	12.962951038385134
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.343806829	12.898308648144166
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34326541	12.877996691600774
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.34268041	12.856049743714046
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34037525	12.769569014841275
PREECLAMPSIA	0.33962231	12.741321604684295
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.3369133429999999	12.639691591734092
OROFACIODIGITAL SYNDROME TYPE 3	0.33643859	12.621880686862182
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.33462	12.553654191208635
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.33385793399999997	12.525064408664624
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.333333	12.505370905857834
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31619084399999997	11.862263206031905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.301697398	11.318524908491543
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.2760734	10.357211149934907
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.2760734	10.357211149934907
PALLISTER-HALL SYNDROME	0.274334434	10.29197184022757
ESOPHAGEAL ATRESIA	0.2722222	10.21272895215479
DISTAL MONOSOMY 12Q	0.268661872	10.079159152025458
BETA-KETOTHIOLASE DEFICIENCY	0.26314042899999995	9.872015866930512
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.256097019	9.607774239212802
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255609334	9.58947817548607
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	9.477765059386002
LYSINURIC PROTEIN INTOLERANCE	0.251811934	9.447014346588526
DYSTONIA 6, TORSION	0.25	9.379037558430934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430934
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.25	9.379037558430934
HEMOPHILIA B	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
SEVERE HEMOPHILIA A	0.25	9.379037558430934
HYPERPARATHYROIDISM 2	0.25	9.379037558430934
TRICHOTHIODYSTROPHY	0.244895088	9.187520912908996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24302453400000001	9.117344928024702
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23852347200000001	8.948482409821398
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.23628216900000001	8.864397349754102
LENNOX-GASTAUT SYNDROME	0.23309624399999998	8.744873708820725
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.22440085	8.418656001175306
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.22433443400000003	8.416164328541383
GITELMAN SYNDROME	0.22350960000000003	8.3852197322795
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.307456256075035
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.220732694	8.281040909598572
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.2192308	8.224695628659443
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21831974400000004	8.190516314892108
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.216493709	8.122010511500068
COHEN SYNDROME	0.215213751	8.073991414879213
KEPPEN-LUBINSKY SYNDROME	0.21485176900000003	8.060411243785309
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.21344093000000003	8.007481995905714
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.212989481	7.990545367398847
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2117647	7.944596299399437
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.20520833000000002	7.698626537491558
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002376
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.20478393100000003	7.682704720848517
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.20218852800000003	7.58533519198346
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.20152905000000002	7.560594116259624
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20128700000000002	7.551513332095551
ROMANO-WARD SYNDROME	0.200541419	7.52354200328814
PITUITARY GIGANTISM	0.2	7.503230046744748
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.503230046744748
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	7.503230046744748
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	7.503230046744748
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.503230046744748
X-LINKED ACROGIGANTISM	0.2	7.503230046744748
MYOCLONIC EPILEPSY OF INFANCY	0.18379836	6.89540688647204
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18379836	6.89540688647204
PFAPA SYNDROME	0.18064726000000003	6.777189745470554
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17994293	6.750765995376434
EHLERS-DANLOS SYNDROME, TYPE VI	0.179537528	6.735556873039382
ACUTE ADRENAL INSUFFICIENCY	0.17493073900000003	6.562727884820317
ADDISON DISEASE	0.17370374900000002	6.51669594364504
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.172902528	6.486637216238625
GRANULOMATOSIS WITH POLYANGIITIS	0.172416749	6.468412658294237
PEMPHIGUS VULGARIS	0.17187533000000002	6.448100701750844
UNILATERAL POLYMICROGYRIA	0.17105979999999998	6.417505155750735
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.16992188100000002	6.374814815592927
GITELMAN SYNDROME	0.168495419	6.32129945289823
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.168478934	6.320680999161627
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004034
PITYRIASIS RUBRA PILARIS	0.166667	6.252704211004034
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	6.252704211004034
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16599404999999998	6.227457717704249
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.164135494	6.157731851590461
PRADER-WILLI SYNDROME	0.162478369	6.095562901134402
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.161279934	6.05060223362905
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
ACROOTOOCULAR SYNDROME	0.15732986	5.902410664010723
WRINKLY SKIN SYNDROME	0.15716734999999998	5.89631391443624
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.155893848	5.848537022081293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.155312838	5.826739763633997
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.70681646315218
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	5.6747063901671355
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.15056904899999995	5.6487710628329095
1P21.3 MICRODELETION SYNDROME	0.14982135	5.6207202748193055
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14975354999999999	5.618176679833459
DE BARSY SYNDROME	0.14973809	5.617596680150846
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14925097800000003	5.599322113178197
CHRONIC HICCUP	0.14806533	5.554841164685882
BRAIN-LUNG-THYROID SYNDROME	0.1472021	5.522456098319625
CONGENITAL MYASTHENIC SYNDROME	0.14545240299999998	5.456814202804129
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.14545240299999998	5.456814202804129
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14495823800000002	5.4382750344238815
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.144144	5.407727959289875
COMBINED SAPOSIN DEFICIENCY	0.143818538	5.395517878002506
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.143381934	5.379138176745861
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	5.3594446739390715
CHOANAL ATRESIA	0.14285699999999998	5.3594446739390715
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	5.3594446739390715
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.3594446739390715
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.3594446739390715
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.3594446739390715
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.133003634	4.989784314775206
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.12221906400000002	4.585188766449097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12133179799999999	4.551901961895821
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.12115313	4.545199026365862
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12106874000000001	4.542033038447638
PRADER-WILLI SYNDROME; PWS	0.120299267	4.513165373778844
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11867818399999999	4.452348580409509
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
AICARDI SYNDROME; AIC	0.117369528	4.403252845309245
TEMPLE SYNDROME	0.11668989800000001	4.377755744125899
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.114847224	4.308625709510122
15Q OVERGROWTH SYNDROME	0.113099869	4.243071676818475
BILATERAL POLYMICROGYRIA	0.11305566	4.241413125332792
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.11120909100000001	4.1721369653118545
INSULINOMA	0.11068131900000001	4.152336991670702
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.10995650000000001	4.1251445731744445
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.10881664	4.082381414169032
PRADER-WILLI-LIKE SYNDROME	0.107972813	4.050724273665759
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.106776594	4.005846741949324
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10673824400000001	4.004407997587862
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.105269784	3.9493170316156476
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.10507549000000001	3.9420278687221364
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10479347400000001	3.931447714097823
MODY	0.10463885	3.9256468168840835
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.104084838	3.9048624194607973
AROMATASE DEFICIENCY	0.09900425000000002	3.7142583167771437
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.09876743	3.705373742078793
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755	3.6918724299326797
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810905
WILSON DISEASE	0.097929364	3.673932732117017
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.0978836	3.672215843017721
LEPRECHAUNISM	0.09770855	3.665648640919308
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.09653641400000001	3.621674610648952
INSULIN-RESISTANCE SYNDROME TYPE B	0.09611743	3.6059559439594246
ADRENOCORTICAL CARCINOMA	0.09611743	3.6059559439594246
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.096089589	3.6049114568207683
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09596549999999998	3.600256115254415
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0956507	3.588446031160839
SCHINZEL-GIEDION SYNDROME	0.09560006000000001	3.5865462133130035
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.09545965000000001	3.5812785706586867
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.09544160000000002	3.580601404146968
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.09544160000000002	3.580601404146968
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09445900900000001	3.5437383725726628
SMITH-MAGENIS SYNDROME; SMS	0.09293699100000001	3.486638116626231
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.09197545300000001	3.4505649125627973
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0909091	3.4105594532126147
HEPATIC VENO-OCCLUSIVE DISEASE	0.0909091	3.4105594532126147
HELLP SYNDROME	0.0909091	3.4105594532126147
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.09032868399999999	3.388784479358557
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.09032868399999999	3.388784479358557
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.09003566900000003	3.3777916845978235
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.08994645000000001	3.374444531190121
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.08975706900000001	3.3673396851427078
49,XXXYY SYNDROME	0.08792327400000001	3.2985427564248564
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.08711866000000001	3.268356736720699
YUNIS-VARON SYNDROME	0.086287998	3.2371934963352533
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.08627051000000001	3.236537413899966
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0861345	3.2314348423066774
49,XYYYY SYNDROME	0.08508522400000001	3.1920700462540372
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.08486235000000002	3.183708671786846
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.08486235000000002	3.183708671786846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.083884438	3.1470211782794846
YUNIS-VARON SYNDROME	0.08381965000000001	3.144590581938142
ISOLATED BILIARY ATRESIA	0.08375382900000002	3.142121231413608
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.083693588	3.1398612210073784
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08337539000000001	3.127923657035308
OVARIAN DYSGENESIS 8; ODG8	0.08333330000000001	3.126344602271971
PRIMARY DYSTONIA, DYT4 TYPE	0.08333330000000001	3.126344602271971
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.08280545	3.1065417023710995
RAMOS-ARROYO SYNDROME	0.081513074	3.05805673019664
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.081000237	3.038817060259228
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.08082935000000001	3.032406037894238
BARDET-BIEDL SYNDROME 21; BBS21	0.08082935000000001	3.032406037894238
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.08082935000000001	3.032406037894238
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.08057010900000001	3.0226803135914975
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0799812	3.000586715073505
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0797842	2.9931960334774614
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.07941368800000001	2.9792958496220643
16P13.2 MICRODELETION SYNDROME	0.07927645300000001	2.9741473207447395
KENNERKNECHT SYNDROME	0.07897708400000002	2.96291614836542
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07869265	2.95224527968984
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.078484788	2.9444470976699577
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.077884638	2.921931780107189
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.07692310000000001	2.8858585760437547
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.07692310000000001	2.8858585760437547
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07692310000000001	2.8858585760437547
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.07692310000000001	2.8858585760437547
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437547
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.07692310000000001	2.8858585760437547
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437547
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.07692310000000001	2.8858585760437547
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.074340564	2.7889717674837544
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.7809878054879147
MARFAN SYNDROME	0.07331114	2.750351742045553
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07291507200000001	2.7354927954547836
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.07247295	2.7189060800811484
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.072286361	2.7119059791251883
KEUTEL SYNDROME; KTLS	0.072077819	2.7040822861231475
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0720664	2.7036538892036286
TUBEROUS SCLEROSIS COMPLEX	0.07205513399999999	2.703231232255095
WERNER SYNDROME	0.07204970000000001	2.703027369494725
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.07179809300000001	2.693588043482869
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845593
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.6535825841326863
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.070481	2.6441757846230827
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07014222799999999	2.631466363376103
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07014222799999999	2.631466363376103
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06891523799999999	2.5854344222008265
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.068249338	2.5604524177601906
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067628238	2.5371511368500244
CITRULLINEMIA TYPE I	0.067551459	2.5342706843512293
WHITE-SUTTON SYNDROME; WHSUS	0.06734305200000001	2.5264520560294703
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.066868353	2.5086431770296715
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06684269100000001	2.5076804375823736
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.50107793278659
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
STICKLER SYNDROME	0.06641459	2.491619736151166
EMANUEL SYNDROME	0.065878901	2.471522747148613
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.06533973400000001	2.4512952769755474
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0653291	2.4508963302339613
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
CHROMOSOME 1P36 DELETION SYNDROME	0.064244121	2.410192095069526
KAGAMI-OGATA SYNDROME	0.063582213	2.3853598551006225
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.06259785000000001	2.348430344908104
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.348430344908104
CHRISTIANSON SYNDROME	0.0624202	2.3417656008190826
MEIER-GORLIN SYNDROME 1; MGORS1	0.062261894	2.3358265691401825
CONGENITAL ANALBUMINEMIA	0.06207722	2.32889831161192
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.061971169000000006	2.3249196863634833
KNIEST-LIKE DYSPLASIA, LETHAL	0.06103496	2.289796728869319
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.289796728869319
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.289796728869319
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2779693873466353
MOMO SYNDROME	0.060614153	2.2740096702379162
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.252315843816815
LUSCAN-LUMISH SYNDROME; LLS	0.05953298099999999	2.2334482590574205
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.059461850000000004	2.2307796977751457
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.059461850000000004	2.2307796977751457
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.05915399	2.219229975764191
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.058613700000000005	2.1989603749544133
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.1676047517505688
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.057609584	2.161289808246327
DISTAL MONOSOMY 7Q36	0.057324009	2.1505761336433316
THAUVIN-ROBINET-FAIVRE SYNDROME	0.057170599999999995	2.1448208185521263
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.057170599999999995	2.1448208185521263
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05684260000000001	2.132515521275465
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.056517138	2.1203054399880967
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.056386034	2.1153869226278545
ZUNICH NEUROECTODERMAL SYNDROME	0.056129421	2.105759790767928
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.056080534	2.103925738731452
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.056080534	2.103925738731452
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.056080534	2.103925738731452
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.056080534	2.103925738731452
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.055555600000000004	2.0842322359246626
GRANGE SYNDROME	0.055555600000000004	2.0842322359246626
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.055555600000000004	2.0842322359246626
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.055555600000000004	2.0842322359246626
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246626
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.054820127999999996	2.056640157879965
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.054712549	2.0526042079539715
SHPRINTZEN OMPHALOCELE SYNDROME	0.053807928	2.01866631061339
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.053593138	2.0106082167046884
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.05282775	1.9818938055095991
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.052704438	1.977267613991978
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.052645449999999996	1.975054611321991
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412542
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412542
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9745350126412542
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.05232459	1.9630171793579985
PEHO SYNDROME	0.05231289	1.962578240400264
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052222132	1.9591733496373518
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.05188166	1.9464001509349755
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051482088	1.9314097477537862
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.0512802	1.9238356872154
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MAN1B1-CDG	0.050336759	1.8884414129227454
SLC35A2-CDG	0.05006959	1.8784182605809516
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04984661	1.8700529094018359
ERYTHERMALGIA, PRIMARY	0.0494995	1.857030678494208
FAMILIAL THROMBOCYTOSIS	0.049228049	1.8468468819971138
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.048809500000000006	1.831144534832939
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.048568964	1.8221205501203197
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8207075418379168
PELIZAEUS-MERZBACHER DISEASE	0.048063433	1.8031549731765153
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.04804732799999999	1.802550775577001
SILVER-RUSSELL SYNDROME	0.04802755	1.8018087811576786
BECKWITH-WIEDEMANN SYNDROME	0.04788381	1.796416209723083
3P25.3 MICRODELETION SYNDROME	0.047286959999999996	1.7740246954560848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.047238867	1.7722204312428946
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047187734	1.7703021179329936
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.04714633299999999	1.7687489117971669
GANGLIOCYTOMA	0.0470086	1.7635816998770255
248100 MACROSOMIA ADIPOSA CONGENITA	0.046946550000000004	1.7612538227550232
SCHAAF-YANG SYNDROME; SHFYNG	0.046845813	1.7574745583289284
ALG13-CDG	0.046377537999999996	1.7399066830782313
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04611104	1.7299087040732446
MENTAL RETARDATION, X-LINKED 98; MRX98	0.045968823	1.7245732697354548
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.04586214	1.7205709342800708
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.045685279999999995	1.7139358279497343
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.045657097	1.7128785102876976
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.045434671999999995	1.7045339805719613
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.045322580999999994	1.7003287577761126
ZIMMERMANN-LABAND SYNDROME 1	0.045185087	1.6951705122158773
FG SYNDROME TYPE 1	0.044927578999999995	1.6855098034014915
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.04473844	1.6784140362624353
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503036
LASSA FEVER	0.044019719000000006	1.6514503912503036
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.044003234	1.6508319375137006
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.043963257000000006	1.6493321543758068
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.641421611485974
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043664738	1.638132870724186
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04359198	1.6354032706654804
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.631138434706911
YELLOW FEVER	0.043478300000000004	1.631138434706911
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.631138434706911
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.631138434706911
ASHERMAN SYNDROME	0.043478300000000004	1.631138434706911
HYDATIDIFORM MOLE	0.043478300000000004	1.631138434706911
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.631138434706911
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.631138434706911
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.631138434706911
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.042782089999999995	1.6050193157526897
AICARDI SYNDROME	0.042473029999999995	1.5934245743614552
CAMURATI-ENGELMANN DISEASE	0.0424603	1.59294699376898
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0424603	1.59294699376898
COSTELLO SYNDROME; CSTLO	0.04204734399999999	1.5774544744330619
COG2-CDG	0.041666699999999994	1.5631741769434964
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.041477021999999995	1.5560581885994644
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.041467509	1.5557012974622912
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.041316007	1.5500175256695816
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.041052274	1.540123278819991
TEMPLE SYNDROME	0.04088782	1.533953597849454
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.040377984	1.5148265138788932
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.040229641	1.5092612556047718
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.04014259	1.5059954372107762
16P13.11 MICRODELETION SYNDROME	0.04014259	1.5059954372107762
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0400951	1.5042137952361767
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.040016822	1.501277106028181
JOUBERT SYNDROME 32; JBTS32	0.039593838	1.4854083747377198
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4743978348379245
NOONAN SYNDROME 7; NS7	0.039065931	1.4656033364162853
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.038986434	1.462620915021155
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.038705173999999995	1.4520691226064177
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143656
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143656
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.4429274122143656
MAL DE MELEDA	0.0384615	1.4429274122143656
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143656
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143656
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143656
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143656
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143656
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143656
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.4429274122143656
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143656
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143656
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143656
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143656
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143656
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143656
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.038375788	1.4397118279455325
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038371772	1.4395611630861938
FRYNS-SMEETS-THIRY SYNDROME	0.038368124	1.4394243041701413
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.038319663999999996	1.4376062715298148
ADNP SYNDROME	0.038290719	1.4365203665612998
CANAVAN DISEASE	0.03826399	1.4355175973817027
LISSENCEPHALY 2; LIS2	0.03826399	1.4355175973817027
7Q11.23 MICRODUPLICATION SYNDROME	0.038215096999999996	1.433683320248325
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.038182437	1.432458042781692
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03814045	1.4308828521818284
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037998538	1.4255588602698603
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
MONOSOMY 9Q22.3	0.037867543000000004	1.4206444321699938
PROTEUS SYNDROME	0.037682553	1.413704319538257
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.037495841	1.4066996040958182
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.037466429999999995	1.4055962166012939
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.037284677999999995	1.398777581264014
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.037214063000000006	1.39612837831526
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.03685862799999999	1.3827938254569359
17Q24.2 MICRODELETION SYNDROME	0.036823919	1.3814916773984738
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.036672644	1.3758164217718674
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03654973	1.3712051616820395
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.036263234	1.3604569347046787
CUTIS LAXA	0.036130129999999996	1.355463385043969
ALPERS-HUTTENLOCHER SYNDROME	0.03604704	1.352346168121049
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.03602274900000001	1.3514348633157218
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.03585674	1.3452068447315713
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
DOORS SYNDROME	0.03559829999999999	1.3355111708651675
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.035428074000000004	1.329124946675482
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.035302951	1.3244308134097877
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.035026984	1.3140775939782376
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.034995169	1.3128840176585517
MONOSOMY 18Q	0.034986969	1.3125763852266352
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.03490175	1.3093792964198676
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.034778017	1.304737310602998
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03477209	1.3045149523805628
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03467435	1.3008481238567187
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.03464369900000001	1.299698216335905
CORNELIA DE LANGE SYNDROME	0.034611909	1.2985055779199748
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034594184	1.297840604157082
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034594184	1.297840604157082
22Q11.2 DISTAL DELETION SYNDROME	0.034592044	1.2977603195955818
15Q24 RECURRENT MICRODELETION SYNDROME	0.034592044	1.2977603195955818
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.034587397	1.2975859820454456
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.034557738	1.2964732905456637
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.034518359000000005	1.29499594206561
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.034444590000000004	1.2922284131790185
KOSAKI OVERGROWTH SYNDROME; KOGS	0.034368039999999996	1.2893565518786265
CENTRAL PRECOCIOUS PUBERTY	0.03420925	1.2833993623830138
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034070034	1.2781765140120755
DWARFISM, LEVI TYPE	0.034067110000000005	1.2780668167887925
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0340536	1.2775599735991348
CHROMOSOME 19P13.13 DELETION SYNDROME	0.033950008999999996	1.273673638080273
NEUROFIBROMATOSIS, TYPE I	0.033902519	1.2718919961056734
PITT-HOPKINS SYNDROME	0.033823468999999995	1.2689263444296974
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.033730384	1.2654341535851914
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.033594764	1.260346213290494
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.03355788099999999	1.2589625051214228
NETHERTON SYNDROME; NETH	0.033545099999999994	1.2584830112052858
MARFANOID HYPERMOBILITY SYNDROME	0.0334256	1.2539998312523561
TUBEROUS SCLEROSIS 2; TSC2	0.033324453	1.2502051852046656
TUBEROUS SCLEROSIS-1	0.033324453	1.2502051852046656
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03331631	1.2498996911933125
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.03321795	1.2462096026563234
MARSHALL-SMITH SYNDROME; MRSHSS	0.032988102	1.2375865905574024
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978761
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978761
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.032783033999999996	1.229893228661273
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032783033999999996	1.229893228661273
HYDROXYKYNURENINURIA	0.032783033999999996	1.229893228661273
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.032743343	1.2284041751423467
COCKAYNE SYNDROME	0.032721453000000005	1.2275829466137305
15Q26 OVERGROWTH SYNDROME	0.032356984	1.2139094728541953
SOTOS SYNDROME	0.032330313	1.2129088796113117
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.03231701	1.2124098022647525
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544837
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544837
INFANTILE MYOFIBROMATOSIS	0.0322581	1.2101997258544837
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544837
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544837
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544837
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544837
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544837
DESMOID TUMOR	0.0322581	1.2101997258544837
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544837
WEST SYNDROME	0.0322581	1.2101997258544837
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	1.2101997258544837
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544837
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544837
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2101997258544837
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544837
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544837
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544837
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544837
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.032193547	1.207777945808446
CK SYNDROME	0.032128341	1.2053316677163057
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03204225	1.2021018648265345
PERLMAN SYNDROME	0.031907474000000005	1.1970455881626343
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.031813218000000004	1.1935094659062042
SOTOS SYNDROME 2	0.03178947199999999	1.1926186074027538
MENINGIOMA	0.031684050000000005	1.188663579812815
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.031677834	1.1884303794229618
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031636281	1.1868714708322998
CLAPO SYNDROME	0.03158999999999999	1.1851351858833326
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.03138745	1.177536289653492
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.031369352999999996	1.1768573598827123
MCDONOUGH SYNDROME	0.031363034	1.1766202953293854
AMISH INFANTILE EPILEPSY SYNDROME	0.031317849999999994	1.1749251655972248
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.0311529	1.1687368766161723
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.031129650000000002	1.1678646261232382
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.030995500000000002	1.1628318345693842
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.030995500000000002	1.1628318345693842
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.03093264	1.1604735693656922
PEHO-LIKE SYNDROME; PEHOL	0.03092511	1.1601910727544322
FAMILIAL MULTIPLE LIPOMATOSIS	0.030844418999999998	1.1571638570759228
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030835900000000003	1.1568442569920818
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.030680119000000002	1.1509999535925222
PETERS-PLUS SYNDROME; PTRPLS	0.030584859000000002	1.1474261651212576
EPILEPSY, PYRIDOXINE-DEPENDENT	0.030509271999999997	1.144590431873541
OSTEOPENIA AND SPARSE HAIR	0.030491262	1.1439147660078317
CLASSICAL EHLERS-DANLOS SYNDROME	0.030415800000000003	1.1410837222788945
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.030302999999999997	1.1368519005325304
BECKWITH-WIEDEMANN SYNDROME	0.030302999999999997	1.1368519005325304
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.030302999999999997	1.1368519005325304
SCLEROSTEOSIS 1; SOST1	0.030302999999999997	1.1368519005325304
ESTROGEN RESISTANCE SYNDROME	0.030302999999999997	1.1368519005325304
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.030302999999999997	1.1368519005325304
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.030302999999999997	1.1368519005325304
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.030302999999999997	1.1368519005325304
NIEVERGELT SYNDROME	0.030302999999999997	1.1368519005325304
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.030302999999999997	1.1368519005325304
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.03021912	1.1337050458509257
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.030138699999999997	1.1306879970491295
NEMALINE MYOPATHY 2; NEM2	0.03010045	1.1292530043026896
DISTAL NEBULIN MYOPATHY	0.03010045	1.1292530043026896
NEMALINE MYOPATHY 3; NEM3	0.03010045	1.1292530043026896
15Q13.3 MICRODELETION SYNDROME	0.030071143	1.12815351848779
20Q13.33 MICRODELETION SYNDROME	0.029998073	1.1254122133902116
MALAN OVERGROWTH SYNDROME	0.029946249000000005	1.1234679764204993
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.029886519000000004	1.121227136767039
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.029839319000000003	1.1194563744760073
MENKES DISEASE	0.029805691000000002	1.1181947813759476
NORRIE DISEASE	0.029764809000000003	1.1166610461220925
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029690353	1.1138677436402904
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.029625409000000005	1.1114312947795115
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.029624690000000002	1.1114043206674933
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.02962385	1.111372807101297
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.029589734000000003	1.1100929061199234
EDINBURGH MALFORMATION SYNDROME	0.029589734000000003	1.1100929061199234
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.029532938	1.1079621388512488
2P15P16.1 MICRODELETION SYNDROME	0.029361148000000004	1.1015172394025974
WILLIAMS-BEUREN SYNDROME; WBS	0.029262122000000005	1.0978021651095526
TRISOMY 18P	0.02918545	1.0949257268388324
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.02906504	1.0904084071891897
PEDIATRIC-ONSET GRAVES DISEASE	0.02892116	1.0850105834935615
WOLF-HIRSCHHORN SYNDROME	0.028888299	1.0837777652807312
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.028853559000000004	1.0824744542216118
MCCUNE-ALBRIGHT SYNDROME	0.0287139	1.0772349861961201
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0285948	1.0727668127032834
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0285714	1.0718889347878144
SILLENCE SYNDROME	0.0285714	1.0718889347878144
CAMURATI-ENGELMANN DISEASE	0.0285714	1.0718889347878144
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0285714	1.0718889347878144
THORACOLARYNGOPELVIC DYSPLASIA	0.0285714	1.0718889347878144
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.028529957	1.0703341529736783
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.028513472	1.0697156992370753
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.028410660000000004	1.0658585887992458
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.028302734000000003	1.0618096207691208
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.028302734000000003	1.0618096207691208
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028302734000000003	1.0618096207691208
MAPLE SYRUP URINE DISEASE; MSUD	0.028254881000000003	1.0600143604319865
MENKES DISEASE	0.028014473000000005	1.0509951777865976
FUMARASE DEFICIENCY; FMRD	0.027993177999999997	1.05019627136737
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.027952124	1.0486560833356748
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.027946943000000005	1.0484617121613142
COHEN SYNDROME	0.027802043000000002	1.0430256219924474
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623313
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	1.0421161179623313
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623313
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623313
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623313
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623313
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623313
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623313
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623313
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623313
CLEFT CHIN	0.027777800000000002	1.0421161179623313
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623313
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623313
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623313
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623313
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623313
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623313
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.0421161179623313
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623313
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623313
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.027759599000000003	1.0414332865119273
XP22.13P22.2 DUPLICATION SYNDROME	0.027698308999999997	1.0391339216641022
MGAT2-CDG	0.027690790000000003	1.038851837730495
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027551934	1.0336424951736412
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027551934	1.0336424951736412
BOHRING-OPITZ SYNDROME	0.027512797	1.0321742256019437
PERMANENT NEONATAL DIABETES MELLITUS	0.02712942	1.0177913964737895
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.02697144	1.0118645950598657
SLC39A8-CDG	0.026741619	1.0032425958970013
1P36 DELETION SYNDROME	0.026717393000000002	1.002333729641439
PITT-HOPKINS SYNDROME	0.026592547	0.9976499883493596
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.026549693000000003	0.9960422712472435
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.026529050000000002	0.9952678253579688
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.026475841	0.9932716285201825
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.026471319	0.9931019804888256
L-2-HYDROXYGLUTARIC ACIDURIA	0.026466429000000007	0.9929185265141829
ANGELMAN SYNDROME	0.026466429000000007	0.9929185265141829
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.026430930000000002	0.9915867406970359
JACOBSEN SYNDROME	0.026418913000000002	0.9911359091196772
CARDIOFACIOCUTANEOUS SYNDROME	0.026390234	0.990059983447124
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.026066353	0.9779092151932754
RETT SYNDROME; RTT	0.025924619000000003	0.972591901156049
6Q16 MICRODELETION SYNDROME	0.02589309	0.9714090544553298
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.025885880000000003	0.9711385630121447
SMITH-KINGSMORE SYNDROME; SKS	0.025837391	0.9693194424034617
3Q27.3 MICRODELETION SYNDROME	0.025832889999999997	0.9691505822112595
HYPOTONIA-CYSTINURIA SYNDROME	0.025811918	0.9683637935085578
SECONDARY SHORT BOWEL SYNDROME	0.02572613	0.9651453580123072
8Q24.3 MICRODELETION SYNDROME	0.025676167000000003	0.9632709385981798
HOOFT DISEASE	0.025524934000000003	0.9575972586498831
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.025517257	0.9573092471645388
TURNER SYNDROME	0.025508700000000002	0.9569882214669888
MOSAIC MONOSOMY X	0.025508700000000002	0.9569882214669888
MONOSOMY X	0.025508700000000002	0.9569882214669888
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.025508700000000002	0.9569882214669888
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.0254346	0.9542082747346698
CLASSIC HOMOCYSTINURIA	0.025322703000000002	0.9500103300719669
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.025193619	0.9451675953351968
MICROHYDRANENCEPHALY; MHAC	0.025185350000000002	0.9448573742889143
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.025185350000000002	0.9448573742889143
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.9379037558430935
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.9379037558430935
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.9379037558430935
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.9379037558430935
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.9379037558430935
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.9379037558430935
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.9379037558430935
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.9379037558430935
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	0.9379037558430935
ALKAPTONURIA	0.025	0.9379037558430935
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.9379037558430935
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.9379037558430935
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.9379037558430935
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.9379037558430935
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.9379037558430935
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	0.9379037558430935
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.9379037558430935
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.9379037558430935
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.024987739999999998	0.9374438078412279
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.024942269000000003	0.9357379109739504
WITTEVEEN-KOLK SYNDROME	0.024934141	0.9354329797048507
CONGENITAL TOXOPLASMOSIS	0.024877669	0.9333143676688518
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.024875853000000003	0.9332462383400275
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.024875853000000003	0.9332462383400275
FRYNS SYNDROME; FRNS	0.024875853000000003	0.9332462383400275
JUVENILE POLYPOSIS OF INFANCY	0.024805088000000003	0.9305914079687381
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.024718093	0.9273276904791551
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.024589431000000005	0.922500787557784
TRANSIENT NEONATAL DIABETES MELLITUS	0.024548764	0.9209751182762288
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02443913	0.9168620726615049
XYLT1-CDG	0.02440085	0.915425954430558
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024350919000000002	0.9135527355332379
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024350919000000002	0.9135527355332379
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024350919000000002	0.9135527355332379
FACIOCARDIOMELIC SYNDROME	0.024334434000000002	0.9129342817966349
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.02425635	0.9100048707217848
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.02425635	0.9100048707217848
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.02425635	0.9100048707217848
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02425635	0.9100048707217848
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.02425635	0.9100048707217848
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.02425635	0.9100048707217848
CRANIOPHARYNGIOMA	0.024203403000000002	0.9080185031153598
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.024203403000000002	0.9080185031153598
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.907315337911529
2Q23.1 MICRODELETION SYNDROME	0.024104799	0.9043192606377136
XQ27.3Q28 DUPLICATION SYNDROME	0.024090590000000002	0.9037861936590428
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.024081759	0.9034548885363288
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.023950137999999996	0.8985169753264155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.023950137999999996	0.8985169753264155
SALT-AND-PEPPER SYNDROME	0.023890678	0.8962862650335185
ALLAN-HERNDON-DUDLEY SYNDROME	0.023862600000000005	0.8952328865672562
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.023850450000000002	0.8947770653419164
ABCD SYNDROME	0.0238095	0.8932407789898453
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0238095	0.8932407789898453
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0238095	0.8932407789898453
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.0238095	0.8932407789898453
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0238095	0.8932407789898453
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.02372683	0.8901393188500233
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.023678469	0.8883250003085702
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.023584998	0.8848183282300739
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.023549918000000003	0.8835022616798749
CARTILAGE-HAIR HYPOPLASIA	0.02352823	0.8826886114136059
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.023447043999999997	0.8796428252407306
ATKIN-FLAITZ SYNDROME	0.023335509000000004	0.8754584614244125
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.023252234	0.872334304013699
SCLERODERMA	0.023202249	0.8704590592442665
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02313705	0.8680130437651777
OBESITY DUE TO SIM1 DEFICIENCY	0.02313705	0.8680130437651777
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.02313705	0.8680130437651777
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.02313705	0.8680130437651777
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.02313705	0.8680130437651777
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02311827	0.8673084904637884
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.023108474	0.866940982256099
PIERPONT SYNDROME	0.023027553	0.8639051378630356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.022995464	0.8627012821181859
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.022968340000000004	0.8616836940592464
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022929188	0.8602148617452956
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.022801371	0.8554196599708717
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.022756819000000005	0.8537482404456589
BRITTLE CORNEA SYNDROME	0.0227273	0.8526408012069095
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.0227273	0.8526408012069095
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0227273	0.8526408012069095
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0227273	0.8526408012069095
MARFANOID HABITUS WITH SITUS INVERSUS	0.0227273	0.8526408012069095
STICKLER SYNDROME, TYPE I	0.0227273	0.8526408012069095
19P13.3 MICRODUPLICATION SYNDROME	0.022686539999999998	0.8511116429233828
DIENCEPHALIC SYNDROME	0.02266083	0.8501471027008739
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.022586379000000004	0.847353987799823
ANGELMAN SYNDROME	0.022562287	0.8464501487083921
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.8430077793113963
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.022462817000000003	0.8427184172446436
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02244973	0.8422274433865349
11Q22.2Q22.3 MICRODELETION SYNDROME	0.022338829000000004	0.8380668648094648
TETRASOMY 12P	0.02228652	0.8361044325068888
HALLERMANN-STREIFF SYNDROME; HSS	0.022282094000000002	0.8359383860259544
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.02224123	0.8344053260628034
PALLISTER-KILLIAN SYNDROME	0.022195536999999998	0.8326911006101738
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.022178639	0.8320571527035244
MELAS	0.02215814	0.8312881091398833
WEAVER-WILLIAMS SYNDROME	0.02214584	0.8308266604920085
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.022118019000000003	0.8297829236763562
GAUCHER DISEASE, PERINATAL LETHAL	0.022102679	0.8292074259317708
AL KAISSI SYNDROME; ALKAS	0.022082341000000002	0.8284444224683173
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.022075441	0.8281855610317046
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.022072257	0.8280661096093606
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022012077999999997	0.825808425204445
LYSINURIC PROTEIN INTOLERANCE; LPI	0.021994028	0.8251312586927264
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818612
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.021916131000000002	0.82220886313797
RENPENNING SYNDROME	0.021851803000000003	0.8197955242257351
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.02174815	0.815906862705559
HYPOTONIA-CYSTINURIA SYNDROME	0.02174479	0.8157808084407735
6P22 MICRODELETION SYNDROME	0.021234290000000003	0.7966288137464577
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02118466	0.794766887210358
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.021111063	0.7920058111016065
SIMPSON-GOLABI-BEHMEL SYNDROME	0.020954593000000004	0.7861356590745359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.020940518	0.7856076192599962
PEHO SYNDROME; PEHO	0.020933767	0.7853543477297682
SMITH-MAGENIS SYNDROME	0.020905493	0.78429361609806
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.020861110000000002	0.7826285368022367
CHUDLEY-LOWRY-HOAR SYNDROME	0.0208307	0.7814876706736291
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.020811843	0.7807802286286717
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.02080775	0.780626675025765
CLARK-BARAITSER SYNDROME	0.020802343	0.7804238252014514
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.020753559999999997	0.7785936748445995
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.020753559999999997	0.7785936748445995
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
PHELAN-MCDERMID SYNDROME	0.020679057000000004	0.7757986091037367
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.020596209000000004	0.7726904710891731
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020582497	0.7721760496371682
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.020558749	0.7712851161014177
48,XXXY SYNDROME	0.020497459000000003	0.7689857512535928
HIRSCHSPRUNG DISEASE	0.020439164	0.7667987472757177
HEART AND BRAIN MALFORMATION SYNDROME	0.020401057000000004	0.7653691193387614
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.020392347999999998	0.7650423911863757
WILLIAMS SYNDROME	0.020364074000000003	0.7639816595546676
GROWTH HORMONE INSENSITIVITY SYNDROME	0.020330434	0.7627196162608051
PRADER-WILLI SYNDROME (TYPE 1)	0.020270424000000002	0.7604682720852793
PRADER-WILLI SYNDROME (TYPE 2)	0.020270424000000002	0.7604682720852793
DISTAL MONOSOMY 10Q	0.020222273000000002	0.7586618319353753
OLIVER SYNDROME	0.0200656	0.752784064129807
OROFACIODIGITAL SYNDROME XVII	0.02005445	0.752365759054701
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.02004755	0.7521068976180884
MYHRE SYNDROME	0.020033843	0.7515926637468346
PRIMROSE SYNDROME; PRIMS	0.020004972	0.7505095349734368
DESBUQUOIS DYSPLASIA 2; DBQD2	0.020004972	0.7505095349734368
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.019954369000000003	0.7486111052231598
GABRIELE-DE VRIES SYNDROME	0.0198644	0.7452358147027818
20P13 MICRODELETION SYNDROME	0.019837293	0.7442188644183962
CUSHING DISEASE	0.0198055	0.7430261134540155
ACTH-INDEPENDENT CUSHING SYNDROME	0.0198055	0.7430261134540155
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0198055	0.7430261134540155
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.019772219	0.7417775384580869
6Q TERMINAL DELETION SYNDROME	0.019754359000000003	0.7411075000149127
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.019651229000000003	0.7372384594413087
WILSON-TURNER SYNDROME	0.019584853	0.734748287453395
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.019584853	0.734748287453395
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.019584853	0.734748287453395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.019584853	0.734748287453395
ALSTRÖM SYNDROME	0.019584853	0.734748287453395
LOEYS-DIETZ SYNDROME 5	0.019583060000000003	0.7346810209960261
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.019581669000000003	0.734628836031051
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.019560039999999997	0.7338173992176455
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.019386681000000003	0.7273136369292776
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.01935961	0.7262980372263004
KLEINE-LEVIN HIBERNATION SYNDROME	0.0192308	0.7214655819146945
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0192308	0.7214655819146945
FRONTOTEMPORAL DEMENTIA; FTD	0.0192308	0.7214655819146945
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.0192308	0.7214655819146945
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0192308	0.7214655819146945
EARLY-ONSET SCHIZOPHRENIA	0.0192308	0.7214655819146945
MOSAIC TRISOMY 8	0.0191761	0.7194134484969098
MEGALENCEPHALY	0.019043434	0.7144363309100026
LARON SYNDROME	0.019043434	0.7144363309100026
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.019043434	0.7144363309100026
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.019043434	0.7144363309100026
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.019022779	0.713661434826925
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.019009751000000002	0.7131726744216801
TEEBI-SHALTOUT SYNDROME; TBSH	0.0188981	0.7089839587319345
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018845438	0.7070082832283262
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.018717609000000003	0.7022126312600996
NEONATAL ADRENOLEUKODYSTROPHY	0.018717609000000003	0.7022126312600996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.018716047	0.7021540310334344
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.018701124000000003	0.7015941775234967
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.018701124000000003	0.7015941775234967
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.018701124000000003	0.7015941775234967
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.01866125	0.7000982585490771
TEMPLE-BARAITSER SYNDROME; TMBTS	0.018656037	0.6999026868579087
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
C SYNDROME	0.018528293	0.6951102237624519
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0185185	0.694742828103213
ALSTROM SYNDROME; ALMS	0.0185185	0.694742828103213
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0185185	0.694742828103213
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0185185	0.694742828103213
CUSHING SYNDROME	0.0185185	0.694742828103213
BARATELA-SCOTT SYNDROME	0.0185185	0.694742828103213
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0185185	0.694742828103213
SHORT STATURE DUE TO PRIMARY ACID-LABILE SUBUNIT DEFICIENCY	0.0185185	0.694742828103213
MOSAIC TRISOMY 15	0.01846839	0.6928628938150012
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01845865	0.6924974865117246
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.01839085	0.6899538915258783
TYSHCHENKO SYNDROME	0.01835801	0.6887218611522027
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018333239999999997	0.6877925861109133
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.018289287	0.6861436387596905
CORNELIA DE LANGE SYNDROME 1	0.018263883	0.6851905784791531
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.01820002	0.6827946845767767
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.018184478	0.6822116085698442
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.018184478	0.6822116085698442
TRISOMY 20P	0.018176190000000002	0.6819006747167071
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.018176190000000002	0.6819006747167071
TRISOMY 4P	0.018176190000000002	0.6819006747167071
GRANT SYNDROME	0.018176190000000002	0.6819006747167071
ARIMA SYNDROME	0.018114618000000002	0.6795907303145163
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.018114618000000002	0.6795907303145163
MYOTONIC DYSTROPHY 1	0.018114618000000002	0.6795907303145163
KOOLEN-DE VRIES SYNDROME; KDVS	0.018029801	0.6764087230001425
FOUNTAIN SYNDROME	0.018015553000000004	0.6758741928916125
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.018015553000000004	0.6758741928916125
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.0179835	0.6746716877281708
48,XXYY SYNDROME	0.017964293000000003	0.6739511150306318
CHROMOSOME 18Q DELETION SYNDROME	0.017960781000000002	0.6738193583110109
COFFIN-LOWRY SYNDROME; CLS	0.017941831	0.6731084272640817
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.017910738000000002	0.6719419376048646
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.017879489	0.670769595426211
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.017872829	0.6705197378656544
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.017848582	0.6696100837709373
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.017766447	0.6665286947714905
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.017764	0.6664368927518683
LESCH-NYHAN SYNDROME	0.01771238	0.6645003090768037
8P INVERTED DUPLICATION/DELETION SYNDROME	0.017666699	0.6627865338179769
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01755924	0.6587550858300112
GAUCHER DISEASE	0.0175285	0.6576018393718265
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.017490619000000002	0.6561806900848229
ENDOCARDIAL FIBROELASTOSIS	0.017490619000000002	0.6561806900848229
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.017482627	0.6558808610121549
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.017474134000000002	0.65556223634822
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.017474134000000002	0.65556223634822
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.017474134000000002	0.65556223634822
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.017474134000000002	0.65556223634822
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.017474134000000002	0.65556223634822
RING CHROMOSOME 8 SYNDROME	0.017474134000000002	0.65556223634822
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.017474134000000002	0.65556223634822
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.017474134000000002	0.65556223634822
TEMTAMY SYNDROME	0.017474134000000002	0.65556223634822
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.017474134000000002	0.65556223634822
HEART-HAND SYNDROME TYPE 2	0.017474134000000002	0.65556223634822
20Q11.2 MICRODUPLICATION SYNDROME	0.017465869000000002	0.6552521653665383
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.01746194	0.6551047644122698
MARTSOLF SYNDROME	0.017455140000000004	0.6548496545906807
DESMOSTEROLOSIS	0.017371274	0.651703325135179
RUBINSTEIN-TAYBI SYNDROME	0.017301303	0.6490782825871751
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.017264744000000002	0.6477067296507806
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.017263048	0.6476431022599841
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397245
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
FG SYNDROME 2; FGS2	0.01722294	0.6461384045064099
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.01722294	0.6461384045064099
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01721309	0.6457688704266077
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.017203791000000003	0.6454200077455844
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.017173907000000002	0.6442988751119998
STEINERT MYOTONIC DYSTROPHY	0.01715308	0.6435175262510819
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.017046023	0.6395011597555101
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.016999292	0.637747992538938
FREE SIALIC ACID STORAGE DISEASE	0.016999243	0.6377461542475766
GALACTOSEMIA	0.016999243	0.6377461542475766
MULTIPLE MYELOMA	0.01697303	0.6367627434015
JACKSON-WEISS SYNDROME	0.0169492	0.6358687335414304
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0169492	0.6358687335414304
WHITE FORELOCK WITH MALFORMATIONS	0.0169492	0.6358687335414304
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0169492	0.6358687335414304
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0169492	0.6358687335414304
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.0169492	0.6358687335414304
GAPO SYNDROME	0.0169492	0.6358687335414304
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0169492	0.6358687335414304
DEAFNESS-CRANIOFACIAL SYNDROME	0.0169492	0.6358687335414304
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.0169492	0.6358687335414304
GAMMA-HEAVY CHAIN DISEASE	0.0169492	0.6358687335414304
MUCKLE-WELLS SYNDROME	0.0169492	0.6358687335414304
DYSOSTOSIS, STANESCU TYPE	0.0169492	0.6358687335414304
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
FAMILIAL TUMORAL CALCINOSIS	0.0169492	0.6358687335414304
XFE PROGEROID SYNDROME; XFEPS	0.016947	0.6357861980109162
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.016837447000000005	0.6316761912043612
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.016837447000000002	0.6316761912043611
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016826444	0.6312634010033393
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.016821223	0.631067529182969
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.016804909	0.6304554907080562
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.016759884	0.6287663260437827
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.016757419000000003	0.6286738487334567
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.0165749	0.6218264385089476
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.016493709	0.6187804647553212
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.016474309	0.618052651440787
HYPOPHOSPHATASIA	0.016474309	0.618052651440787
HOLOPROSENCEPHALY	0.016474309	0.618052651440787
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.016474309	0.618052651440787
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.016467509000000005	0.6177975416191979
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.016467509000000005	0.6177975416191979
MUCOPOLYSACCHARIDOSIS TYPE 3	0.016467509	0.6177975416191978
KAPUR-TORIELLO SYNDROME	0.016467509	0.6177975416191978
LAMBERT SYNDROME	0.016457824	0.6174341977041842
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.016428309000000002	0.6163269085300359
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.016420391	0.6160298556524851
MENTAL RETARDATION, X-LINKED 41	0.016411872	0.6157102555686441
HAREL-YOON SYNDROME; HAYOS	0.016411871999999997	0.615710255568644
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.016368299	0.6140755643545099
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.016366263	0.6139991814726341
48,XYYY SYNDROME	0.01635185	0.6134584611993155
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
DUPLICATION OF THE PITUITARY GLAND	0.01626349	0.6101435341646636
ALAZAMI SYNDROME; ALAZS	0.01626349	0.6101435341646636
BALLER-GEROLD SYNDROME	0.016234949999999998	0.6090728232369931
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.016216	0.6083618921900642
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0162124	0.6082268340492226
SUMMITT SYNDROME	0.016195884000000004	0.6076072173119628
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.016182243	0.6070954595066242
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.016182243	0.6070954595066242
RING CHROMOSOME 10 SYNDROME	0.016182243	0.6070954595066242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.016173422	0.6067645295454126
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.016102847	0.6041168272426676
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.016102847	0.6041168272426676
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.016084987	0.6034467887994932
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016055357	0.6023351852680681
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.016036180999999997	0.6016157755711861
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.016023697	0.6011474239516683
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.015992784	0.5999876871994932
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01597967	0.5994957004053283
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015959369	0.5987340850394334
SCHWARTZ-JAMPEL SYNDROME	0.015942884	0.5981156313028304
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.015932889999999998	0.5977406948973945
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.015932889999999998	0.5977406948973945
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.015926090000000004	0.5974855850758054
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.015926090000000004	0.5974855850758054
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.015926090000000004	0.5974855850758054
%203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1;;AMR SYNDROME	0.015926090000000004	0.5974855850758054
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.015926090000000004	0.5974855850758054
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.015926090000000004	0.5974855850758054
FACIOCARDIORENAL SYNDROME	0.015926090000000004	0.5974855850758054
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.015926090000000004	0.5974855850758054
ALLAN-HERNDON-DUDLEY SYNDROME	0.015926090000000004	0.5974855850758054
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.015926090000000004	0.5974855850758054
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.015926090000000004	0.5974855850758054
260150 PALANT CLEFT PALATE SYNDROME	0.015926090000000004	0.5974855850758054
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.015926090000000004	0.5974855850758054
MACS SYNDROME	0.01591394	0.5970297638504656
EPILEPSY, HOT WATER, 1	0.015887128	0.5960238808303989
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015886938	0.5960167527618545
MICROPHTHALMIA WITH LIMB ANOMALIES	0.01586903	0.595344913543469
CRANIOFACIOFRONTODIGITAL SYNDROME	0.015829740000000002	0.593870904000786
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.015794598	0.5925525114492725
OGDEN SYNDROME	0.015794598	0.5925525114492725
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.015772253	0.5917142130723
21Q22.11Q22.12 MICRODELETION SYNDROME	0.015772253	0.5917142130723
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.015717319	0.5896533008753605
19Q13.11 MICRODELETION SYNDROME	0.015700834	0.5890348471387575
INFANTILE NEUROAXONAL DYSTROPHY	0.015657309	0.5874019566998347
DISTAL TRISOMY 15Q	0.015587093000000002	0.5847677226950238
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015561427999999999	0.583804870699275
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.015550447000000002	0.5833929058535586
SIALURIA	0.015522647	0.582349956877061
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015510533999999998	0.5818955237492799
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015450523999999998	0.5796441795737541
MYOCLONIC-ATONIC EPILEPSY	0.015450333999999998	0.5796370515052097
NIEMANN-PICK DISEASE TYPE B	0.015450333999999998	0.5796370515052097
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.015374479000000002	0.5767912639292307
NEUROFIBROMATOSIS TYPE 1	0.015364219	0.5764063482278327
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.015346428	0.5757388983990245
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015313617	0.5745079559937057
VELO-FACIAL-SKELETAL SYNDROME	0.01529991	0.5739937221224521
INTERMEDIATE NEMALINE MYOPATHY	0.01529991	0.5739937221224521
VASCULAR EHLERS-DANLOS SYNDROME	0.01529991	0.5739937221224521
OSTEOGLOSPHONIC DYSPLASIA	0.015230833999999999	0.5714022565289074
COSTELLO SYNDROME	0.015230833999999999	0.5714022565289074
MENTAL RETARDATION, X-LINKED 102	0.015185790999999999	0.5697124165739298
MAJEED SYNDROME	0.0151759	0.5693413443319681
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0151759	0.5693413443319681
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.015141308999999999	0.5680436231792332
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.015115890000000002	0.5670900001564424
TRISOMY 18	0.015115890000000002	0.5670900001564424
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.015115890000000002	0.5670900001564424
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.015079591	0.5657282014191084
GENITOPATELLAR SYNDROME; GTPTS	0.015009028000000002	0.5630809493101662
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014985599999999998	0.5622020209424904
MOYNAHAN SYNDROME	0.014955253	0.5610635183313476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984202
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.014890969000000002	0.558651830129723
ACROCALLOSAL SYNDROME	0.014870290000000001	0.5578760336590398
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014851768999999999	0.5571811970405609
HYPERPROLINEMIA, TYPE I	0.014749180999999998	0.5533324902203836
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.014732164000000002	0.5526940778918565
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.014714910000000001	0.5520467742357238
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.0147059	0.5517087537221178
CONGENITAL ADRENAL HYPERPLASIA	0.0147059	0.5517087537221178
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.0147059	0.5517087537221178
GLYCOGEN STORAGE DISEASE VI	0.0147059	0.5517087537221178
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0147059	0.5517087537221178
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0147059	0.5517087537221178
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.0147059	0.5517087537221178
COMMON VARIABLE IMMUNODEFICIENCY	0.0147059	0.5517087537221178
CYSTINOSIS, NEPHROPATHIC; CTNS	0.0147059	0.5517087537221178
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0147059	0.5517087537221178
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0147059	0.5517087537221178
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.014692670000000001	0.5512124150545258
SCHISIS ASSOCIATION	0.014692670000000001	0.5512124150545258
DIETHYLSTILBESTROL SYNDROME	0.014692670000000001	0.5512124150545258
BRONCHOPULMONARY DYSPLASIA	0.014692670000000001	0.5512124150545258
RETINOPATHY OF PREMATURITY	0.014692670000000001	0.5512124150545258
MEIER-GORLIN SYNDROME 7	0.01468695	0.5509978226751888
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.01468695	0.5509978226751888
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.014660857	0.5500189137671403
N-ACETYLASPARTATE DEFICIENCY; NACED	0.014660857	0.5500189137671403
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.014660857	0.5500189137671403
XERODERMA PIGMENTOSUM	0.014648919000000002	0.5495710459656501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.014644372	0.5494004600305373
TAY-SACHS DISEASE	0.014588909000000002	0.5473197017901243
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014547309	0.5457590299404014
17P13.3 MICRODUPLICATION SYNDROME	0.014520740000000002	0.5447622633448417
RING CHROMOSOME 14 SYNDROME	0.014509821999999999	0.5443526620165897
KRABBE DISEASE	0.014467589999999999	0.5427682799599192
MICROSPORIDIOSIS	0.014430319	0.5413700155245581
WHIPPLE DISEASE	0.014430319	0.5413700155245581
CRONKHITE-CANADA SYNDROME	0.014430319	0.5413700155245581
SYSTEMIC SCLEROSIS	0.014430319	0.5413700155245581
FLYNN-AIRD SYNDROME	0.014430319	0.5413700155245581
SECKEL SYNDROME	0.014413834	0.5407515617879551
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.014413834	0.5407515617879551
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.014413834	0.5407515617879551
NEONATAL MARFAN SYNDROME	0.014412850000000001	0.5407146458961253
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014267771999999998	0.535271877852517
8P23.1 MICRODELETION SYNDROME	0.014243149	0.5343481176853121
SECKEL SYNDROME 2; SCKL2	0.01422582	0.5336980003179118
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.01422582	0.5336980003179118
RAMON SYNDROME	0.014224253	0.5336392125104955
FILIPPI SYNDROME; FLPIS	0.014224253	0.5336392125104955
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.014224246999999999	0.5336389874135941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014223533999999998	0.5336122383984774
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014223533999999998	0.5336122383984774
MENTAL RETARDATION, X-LINKED 77	0.014223533999999998	0.5336122383984774
AYMÉ-GRIPP SYNDROME	0.014223533999999998	0.5336122383984774
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.014223533999999998	0.5336122383984774
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.014119438	0.5297069572237477
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.014117691	0.5296414165092895
COG5-CDG	0.014116509	0.5295970724197132
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.014029440999999998	0.5263306162511633
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014029440999999998	0.5263306162511633
INFANTILE SIALIC ACID STORAGE DISEASE	0.013949357000000003	0.5233261728758459
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.013947852	0.5232697110697442
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.013896744000000003	0.5213523356635991
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.013888900000000001	0.5210580589811656
NIJMEGEN BREAKAGE SYNDROME	0.013888900000000001	0.5210580589811656
IDIOPATHIC BRONCHIECTASIS	0.013888900000000001	0.5210580589811656
BETHLEM MYOPATHY	0.013888900000000001	0.5210580589811656
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.013888900000000001	0.5210580589811656
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.013888900000000001	0.5210580589811656
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.013888900000000001	0.5210580589811656
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.013888900000000001	0.5210580589811656
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.013888900000000001	0.5210580589811656
WOLMAN DISEASE	0.013888900000000001	0.5210580589811656
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.013888900000000001	0.5210580589811656
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.013888900000000001	0.5210580589811656
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.013888900000000001	0.5210580589811656
PRIMARY MYELOFIBROSIS	0.013888900000000001	0.5210580589811656
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.013888900000000001	0.5210580589811656
AREDYLD SYNDROME	0.013888900000000001	0.5210580589811656
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.013888900000000001	0.5210580589811656
MULIBREY NANISM	0.013888900000000001	0.5210580589811656
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.013860899999999999	0.5200076067746213
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.013818684000000001	0.5184238249763545
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.013792591	0.5174449160683059
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.013744533	0.5156419649203736
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013742837999999999	0.5155783750457275
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.013742837999999999	0.5155783750457275
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013742837999999999	0.5155783750457275
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013699319	0.513945709703706
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013699319	0.513945709703706
MIRAGE SYNDROME; MIRAGE	0.013699319	0.513945709703706
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.013699319	0.513945709703706
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5139187355916879
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.013682834	0.513327255967103
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.013682834	0.513327255967103
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.013682834	0.513327255967103
GRANGE SYNDROME; GRNG	0.013682834	0.513327255967103
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.013682828	0.5133270308702017
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.013682828	0.5133270308702017
POTOCKI-LUPSKI SYNDROME	0.013666417	0.5127113533287161
ROIFMAN SYNDROME; RFMN	0.013649988	0.5120950004965261
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.013556993	0.5086061861055411
TRISOMY X	0.013533109000000001	0.5077101503733589
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0135306	0.5076160223524224
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.013516624000000001	0.5070916966367559
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.013516624000000001	0.5070916966367559
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013435609	0.5040523257255707
SYNDROMIC DIARRHEA	0.01341245	0.5031834892023079
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.013361919000000002	0.5012877606148477
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.013345434000000002	0.5006693068782447
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013332987	0.5002023433562856
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01333156	0.500148807809902
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.013306233999999998	0.49919867378908267
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.013306233999999998	0.49919867378908267
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.013293750000000002	0.498730322169565
LOEYS-DIETZ SYNDROME	0.013293750000000002	0.498730322169565
MARFAN SYNDROME; MFS	0.013293750000000002	0.498730322169565
THANATOPHORIC DYSPLASIA TYPE 1	0.013262709	0.4975657833501599
THANATOPHORIC DYSPLASIA	0.013262709	0.4975657833501599
COHEN-GIBSON SYNDROME; COGIS	0.013251172	0.4971329595249135
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.013246224	0.4969473296135569
PYRIDOXINE-DEPENDENT EPILEPSY	0.013246224	0.4969473296135569
RING CHROMOSOME 12 SYNDROME	0.01318586	0.4946827047208485
SPONDYLOOCULAR SYNDROME; SOS	0.0131579	0.49363375316031355
SHORT STATURE DUE TO GHSR DEFICIENCY	0.0131579	0.49363375316031355
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.0131579	0.49363375316031355
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0131579	0.49363375316031355
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0131579	0.49363375316031355
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0131579	0.49363375316031355
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.0131579	0.49363375316031355
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0131579	0.49363375316031355
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0131579	0.49363375316031355
SECKEL SYNDROME 4	0.0131579	0.49363375316031355
FORSYTHE-WAKELING SYNDROME; FWS	0.0131579	0.49363375316031355
OVARIAN DYSGENESIS 4; ODG4	0.0131579	0.49363375316031355
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0131579	0.49363375316031355
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.49363375316031355
MEIER-GORLIN SYNDROME 8; MGORS8	0.0131579	0.49363375316031355
RUIJS-AALFS SYNDROME; RJALS	0.0131579	0.49363375316031355
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.013112569000000001	0.49193310855406863
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.013067903	0.4902574121877291
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.013052979999999999	0.48969755867779124
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.012997256999999998	0.4876070462383174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.012997256999999998	0.4876070462383174
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.012997256999999998	0.4876070462383174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.012997256999999998	0.4876070462383174
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.012989480999999999	0.48731532065410005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012980771999999998	0.48698859250171445
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012980771999999998	0.48698859250171445
OSTEOGENESIS IMPERFECTA, TYPE X	0.012963088000000001	0.4863251569009814
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.012963088000000001	0.4863251569009814
PELGER-HUET ANOMALY; PHA	0.012919224	0.48467954848712935
1Q44 MICRODELETION SYNDROME	0.012903880000000001	0.4841039006779431
DIGEORGE SYNDROME; DGS	0.012873269000000001	0.48295549380313857
BARDET-BIEDL SYNDROME 1; BBS1	0.012856784000000001	0.48233704006653566
AUTISM, SUSCEPTIBILITY TO, 18	0.012831053	0.4813717120048717
47,XYY SYNDROME	0.012831053	0.4813717120048717
CHIME SYNDROME	0.012831053	0.4813717120048717
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012820607	0.4809798182995302
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.012820500000000002	0.48097580407145524
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.012820500000000002	0.48097580407145524
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012781299999999999	0.4795051709822931
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012781299999999999	0.4795051709822931
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.012780451	0.47947331977074475
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012780451	0.47947331977074475
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.012772392	0.4791709771160112
THANATOPHORIC DYSPLASIA, TYPE I	0.01272129	0.4772538268067675
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.01272129	0.4772538268067675
LATHOSTEROLOSIS	0.012720441	0.477221975595219
COG1-CDG	0.012718038	0.4771318242862073
LATHOSTEROLOSIS	0.012520969000000002	0.46973855407579773
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012455837999999999	0.46729508969492495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.012455837999999999	0.46729508969492495
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.012455837999999999	0.46729508969492495
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.012455837999999999	0.46729508969492495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012455837999999999	0.46729508969492495
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.012455837999999999	0.46729508969492495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012455837999999999	0.46729508969492495
9Q33.3Q34.11 MICRODELETION SYNDROME	0.012418939	0.46591078126745084
ARGININEMIA	0.012418939	0.46591078126745084
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.012403822000000002	0.4653436496243677
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.012403822000000002	0.4653436496243677
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.01236485	0.46388157021745896
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.012352273	0.46340972959596943
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012328871000000002	0.4625317766481999
MENTAL RETARDATION, X-LINKED 90	0.012328871	0.4625317766481998
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.012306119	0.4616782091980821
GABA-TRANSAMINASE DEFICIENCY	0.012306119	0.4616782091980821
KLIPPEL-TRÉNAUNAY SYNDROME	0.012289634	0.46105975546147915
WEAVER SYNDROME	0.012289634	0.46105975546147915
MEHMO SYNDROME; MEHMO	0.012223451	0.45857682409056066
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.012179022000000001	0.45691001905182654
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01217166	0.4566338251538059
OCULOPHARYNGODISTAL MYOPATHY	0.01210488	0.4541284966411978
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.012050369	0.4520834537758073
MUCOPOLYSACCHARIDOSIS, TYPE II	0.012035718999999999	0.4515338421748832
AICARDI-GOUTIÈRES SYNDROME	0.012035718999999999	0.4515338421748832
LISSENCEPHALY 4	0.012035718999999999	0.4515338421748832
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.012035718999999999	0.4515338421748832
WARBURG MICRO SYNDROME 3; WARBM3	0.012035718999999999	0.4515338421748832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.012035718999999999	0.4515338421748832
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.012035718999999999	0.4515338421748832
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.012035718999999999	0.4515338421748832
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012035718999999999	0.4515338421748832
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.012035718999999999	0.4515338421748832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.012035718999999999	0.4515338421748832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.012035718999999999	0.4515338421748832
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012032732	0.45142178143413514
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012032732	0.45142178143413514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012032732	0.45142178143413514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.012026811000000002	0.45119964830860126
WEAVER SYNDROME	0.012026811000000002	0.45119964830860126
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012019233999999998	0.4509153884382802
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012019233999999998	0.4509153884382802
BETA-UREIDOPROPIONASE DEFICIENCY	0.012019233999999998	0.4509153884382802
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.012019233999999998	0.4509153884382802
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012019233999999998	0.4509153884382802
JOUBERT SYNDROME 10	0.012019233999999998	0.4509153884382802
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.012019233999999998	0.4509153884382802
ACROCALLOSAL SYNDROME; ACLS	0.012014571	0.45074045062974044
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.011923128000000002	0.4473098613039181
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01184276	0.44429476334193413
MENTAL RETARDATION, X-LINKED 19	0.011840821999999999	0.4442220570427811
INFANTILE REFSUM DISEASE	0.011827339000000001	0.4437162267891799
TRISOMY 13	0.011770549	0.44158568461740666
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.011764700000000001	0.4413662526546897
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.011764700000000001	0.4413662526546897
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.011764700000000001	0.4413662526546897
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.011764700000000001	0.4413662526546897
SOMATOMAMMOTROPINOMA	0.011764700000000001	0.4413662526546897
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.011764700000000001	0.4413662526546897
SCLEROSTEOSIS	0.011764700000000001	0.4413662526546897
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.011764700000000001	0.4413662526546897
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.011764700000000001	0.4413662526546897
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.011764700000000001	0.4413662526546897
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.011764700000000001	0.4413662526546897
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.011764700000000001	0.4413662526546897
46,XY SEX REVERSAL 1; SRXY1	0.011764700000000001	0.4413662526546897
46,XX SEX REVERSAL 1; SRXX1	0.011764700000000001	0.4413662526546897
PREMATURE OVARIAN FAILURE 2B	0.011764700000000001	0.4413662526546897
ACROMEGALY	0.011764700000000001	0.4413662526546897
DIABETIC EMBRYOPATHY	0.011764700000000001	0.4413662526546897
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.011764700000000001	0.4413662526546897
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.011764700000000001	0.4413662526546897
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.011764338	0.44135267180830495
ZELLWEGER SYNDROME	0.011760829	0.4412210276371349
DIAMOND-BLACKFAN ANEMIA 1	0.011744344	0.440602573900532
MARDEN-WALKER SYNDROME	0.011680481000000001	0.4382066799981557
TRICHOHEPATOENTERIC SYNDROME 2	0.01164135	0.43673863552335984
TRICHOHEPATOENTERIC SYNDROME 1	0.01164135	0.43673863552335984
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.011583519	0.4345690390391933
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.011561887	0.43375748967733746
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.01149764	0.4313471895732714
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.011494299999999999	0.4312218856314908
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.011494299999999999	0.4312218856314908
DPM3-CDG	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.011494299999999999	0.4312218856314908
RICHIERI COSTA-DA SILVA SYNDROME	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.011494299999999999	0.4312218856314908
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.011494299999999999	0.4312218856314908
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.011494299999999999	0.4312218856314908
SPINOCEREBELLAR ATAXIA 47; SCA47	0.011493451	0.4311900344199423
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011493451	0.4311900344199423
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.011486524000000001	0.43093016004727336
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.011486524000000001	0.43093016004727336
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.011486524000000001	0.43093016004727336
2Q33.1 DELETION SYNDROME	0.011367333	0.4264585725847656
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.011315888	0.4245285542359916
17Q23.1Q23.2 MICRODELETION SYNDROME	0.011285920000000001	0.4234042702457874
JABERI-ELAHI SYNDROME; JABELS	0.011251401	0.42210925025586943
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.011125283	0.41737778842069273
W SYNDROME	0.011107289999999999	0.4167027603295373
13Q12.3 MICRODELETION SYNDROME	0.0110756	0.41551387352863056
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.011073241000000001	0.4154253729302293
NEURONAL CEROID LIPOFUSCINOSIS	0.011065273	0.415126444245167
METACHROMATIC LEUKODYSTROPHY	0.011065273	0.415126444245167
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.011042100000000001	0.4142570824958009
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.010968517	0.4114965316131528
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.010968517	0.4114965316131528
VAN MALDERGEM SYNDROME 2; VMLDS2	0.010952032	0.41087807787654984
VAN MALDERGEM SYNDROME 1; VMLDS1	0.010952032	0.41087807787654984
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010913497000000001	0.4094323930272934
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.010895769	0.40876730671594985
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010893948	0.40869898980637426
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.010893948	0.40869898980637426
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.010799821	0.4051677071333245
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01078831	0.4047358587279841
ADAMS-OLIVER SYNDROME	0.010756713000000001	0.40355046092904917
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.010745732000000001	0.4031384960833327
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.010745732000000001	0.4031384960833327
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010726467	0.40241574744907993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.010726467	0.40241574744907993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010651898	0.3996182056423014
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.010651898	0.3996182056423014
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.01063441	0.3989621232070141
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.010600349	0.3976842856139032
HEREDITARY FOLATE MALABSORPTION	0.010600349	0.3976842856139032
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.010540339000000001	0.3954329414383774
FAMILIAL DYSAUTONOMIA	0.010540339000000001	0.3954329414383774
ISOLATED CEREBELLAR AGENESIS	0.010540339000000001	0.3954329414383774
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010531913	0.3951168303565081
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.010523854000000001	0.3948144877017746
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.010523854000000001	0.3948144877017746
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.010523854000000001	0.3948144877017746
MONOSOMY 18P	0.010523854000000001	0.3948144877017746
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.010517778	0.39458653957295436
BIOTINIDASE DEFICIENCY	0.01048625	0.3934037303883856
ROBERTS SYNDROME	0.010457344	0.39231928854972953
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010431251	0.391340379641681
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010425511	0.3911250369393394
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.01035435	0.3884553501725574
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01035435	0.3884553501725574
SHORT SYNDROME	0.01035435	0.3884553501725574
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.01035435	0.3884553501725574
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.010330019	0.3875425447212206
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010330019	0.3875425447212206
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.010330019	0.3875425447212206
MENTAL RETARDATION, X-LINKED 97; MRX97	0.010313534	0.38692409098461766
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.010308948	0.38675204191964585
JOHANSON-BLIZZARD SYNDROME; JBS	0.010289772	0.38603263222276396
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.010274887	0.38547420432653495
TONNE-KALSCHEUER SYNDROME; TOKAS	0.010258402	0.38485575058993204
601095 HARROD SYNDROME	0.010237534000000001	0.38407286356685477
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.010231779	0.3838569581222596
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.010231779	0.3838569581222596
FUCOSIDOSIS	0.010226039000000001	0.3836416154199181
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.010220798	0.38344499327654313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.010185048	0.38210379090568747
GALLOWAY-MOWAT SYNDROME	0.010171769	0.38160561394673387
X SMALL RINGS	0.01014784	0.3807078899877911
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.010111703000000001	0.37935216886679507
SARCOSINEMIA	0.01010035	0.3789262480131915
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01010035	0.3789262480131915
CHROMOSOME 16Q22 DELETION SYNDROME	0.010066898000000001	0.37767125775557303
22Q11.2 DELETION SYNDROME	0.010019759	0.3759027839497055
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010006979000000001	0.3754233275497185
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.01000214	0.3752417868987375
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009999181	0.37513077661019595
HELSMOORTEL-VAN DER AA SYNDROME	0.009999181	0.37513077661019595
20Q11.2 MICRODELETION SYNDROME	0.009998920000000001	0.37512098489498497
HOLOPROSENCEPHALY 5; HPE5	0.009990494	0.3748048738131156
ELSAHY-WATERS SYNDROME; ESWS	0.009990494	0.3748048738131156
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009964401	0.37382596490506703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.009964401	0.37382596490506703
ACROPECTOROVERTEBRAL DYSPLASIA	0.00995465	0.37346014492413804
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00994739	0.3731877776734412
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00994739	0.3731877776734412
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.009936319	0.37277243637420365
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.009936319	0.37277243637420365
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.009936319	0.37277243637420365
HEREDITARY METHEMOGLOBINEMIA	0.009936319	0.37277243637420365
SHPRINTZEN-GOLDBERG SYNDROME	0.009935474000000001	0.37274073522725615
KAGAMI-OGATA SYNDROME	0.009906317000000001	0.37164687683489145
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.009901987999999999	0.3714844694205296
HADDAD SYNDROME	0.009869652999999999	0.37027138470272214
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009846251	0.3693934317549526
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.009838283	0.3690945030698902
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.009838283	0.3690945030698902
NEUROCUTANEOUS MELANOCYTOSIS	0.009838283	0.3690945030698902
LANDAU-KLEFFNER SYNDROME	0.009838283	0.3690945030698902
1Q41Q42 MICRODELETION SYNDROME	0.009838283	0.3690945030698902
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.009838283	0.3690945030698902
5Q35 MICRODUPLICATION SYNDROME	0.009838283	0.3690945030698902
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.009815721999999999	0.36824810120446716
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565013
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0097886	0.36723058817782817
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.0097886	0.36723058817782817
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.009784194	0.3670652920198984
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.009784194	0.3670652920198984
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.009784194	0.3670652920198984
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009784194	0.3670652920198984
CARNOSINEMIA	0.009784194	0.3670652920198984
HYDROXYLYSINURIA	0.009784194	0.3670652920198984
CARNOSINASE DEFICIENCY	0.009784194	0.3670652920198984
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.009784194	0.3670652920198984
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009764929	0.3663425433856457
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.009764838000000001	0.3663391294159745
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.009741787	0.3654743446369369
PEMPHIGOID GESTATIONIS	0.00969036	0.36354500157886716
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00969036	0.36354500157886716
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009630350000000001	0.3612936574033414
CHROMOSOME 9P DELETION SYNDROME	0.009610012000000001	0.360530653939888
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009586769000000002	0.3596586660600055
CHROMOSOME 10Q26 DELETION SYNDROME	0.009544191	0.358061303415354
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.009544191	0.358061303415354
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.009529359	0.3575048638750874
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009529359	0.3575048638750874
MUENKE SYNDROME	0.009491953000000001	0.3561015347594447
PARTINGTON SYNDROME	0.009481868999999999	0.35572322190048783
MICROFORM HOLOPROSENCEPHALY	0.009469713000000001	0.3552671755782467
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.009465560000000001	0.3551113710063261
DISTAL 17P13.1 MICRODELETION SYNDROME	0.009465560000000001	0.3551113710063261
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.009465560000000001	0.3551113710063261
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.009465560000000001	0.3551113710063261
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.009465560000000001	0.3551113710063261
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.009465560000000001	0.3551113710063261
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.009457762	0.35481882006680343
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.009439467	0.3541324620982775
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.009439467	0.3541324620982775
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.009422982	0.35351400836167457
LEGIUS SYNDROME	0.009387138000000001	0.35216927947269705
ADDUCTED THUMBS SYNDROME	0.009387138	0.35216927947269694
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009364898	0.351334920291499
NEMALINE MYOPATHY 10	0.009364898	0.351334920291499
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.351334920291499
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00934741	0.35067883785621157
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00934741	0.35067883785621157
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00934741	0.35067883785621157
DYSTONIA, JUVENILE-ONSET	0.00934741	0.35067883785621157
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.3494010002631007
SNEDDON SYNDROME	0.009313349	0.3494010002631007
PINEOBLASTOMA	0.009313349	0.3494010002631007
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.009313349	0.3494010002631007
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.3494010002631007
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.3494010002631007
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.3494010002631007
CRYPTOCOCCOSIS	0.009313349	0.3494010002631007
MENTAL RETARDATION, X-LINKED 93	0.009311668	0.3493379356145579
HSD10 DISEASE, ATYPICAL TYPE	0.009296864	0.3487825465264978
NANCE-HORAN SYNDROME	0.009296864	0.3487825465264978
FAMILIAL PAROXYSMAL ATAXIA	0.009296864	0.3487825465264978
FETAL ALCOHOL SYNDROME	0.009296864	0.3487825465264978
ADULT POLYGLUCOSAN BODY DISEASE	0.009296864	0.3487825465264978
MENTAL RETARDATION, X-LINKED 105; MRX105	0.009296864	0.3487825465264978
ABETAL34V AMYLOIDOSIS	0.009296864	0.3487825465264978
NEUROFERRITINOPATHY	0.009296864	0.3487825465264978
HISTIDINEMIA	0.009296864	0.3487825465264978
SPINOCEREBELLAR ATAXIA TYPE 21	0.009296864	0.3487825465264978
SHORT SYNDROME	0.00927337	0.3479011420929067
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
GAUCHER DISEASE TYPE 3	0.00925926	0.34737178921310885
GAUCHER DISEASE TYPE 2	0.00925926	0.34737178921310885
MERRF	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.34737178921310885
PAINE SYNDROME	0.00925926	0.34737178921310885
PGM3-CDG	0.009239819	0.346642437736415
LIG4 SYNDROME	0.00922351	0.34603058684225324
KOOLEN-DE VRIES SYNDROME	0.009189893000000001	0.3447694064198462
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.009163500000000002	0.3437792426667275
FONTAINE PROGEROID SYNDROME; FPS	0.009145088000000001	0.3430884953086242
THYROTOXIC PERIODIC PARALYSIS	0.00911458	0.3419439525972937
CARCINOMA OF ESOPHAGUS	0.00911458	0.3419439525972937
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009079267	0.3406191447840902
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.009079267	0.3406191447840902
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.009079267	0.3406191447840902
MENTAL RETARDATION, X-LINKED 91; MRX91	0.009034819	0.33895162693850167
CHROMOSOME 16P13.3 DELETION SYNDROME	0.009015643	0.3382322172416198
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.009002863	0.33775276084163275
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009002863	0.33775276084163275
15Q14 MICRODELETION SYNDROME	0.009002863	0.33775276084163275
CEREBROFACIOARTICULAR SYNDROME	0.00898794	0.33719290733169494
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00898794	0.33719290733169494
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00898794	0.33719290733169494
ISOLATED OXYCEPHALY	0.00898794	0.33719290733169494
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00898794	0.33719290733169494
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.33557367277145717
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.33557367277145717
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33557367277145717
SCARF SYNDROME	0.008940449999999999	0.33541126535709537
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.008940449999999999	0.33541126535709537
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.008940449999999999	0.33541126535709537
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.008940449999999999	0.33541126535709537
2P21 MICRODELETION SYNDROME	0.008937758999999998	0.3353103093968164
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008932828	0.335125317260014
GMS SYNDROME	0.008928294	0.33495521903485426
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008928294	0.33495521903485426
CINCA SYNDROME	0.008928294	0.33495521903485426
MICROPHTHALMIA, SYNDROMIC 1	0.008924441	0.3348106693080037
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008898048	0.33382050555488507
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008898048	0.33382050555488507
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.008884712999999999	0.3333202276915183
MEHMO SYNDROME	0.008780249	0.3294011405735026
KLEEFSTRA SYNDROME	0.008780249	0.3294011405735026
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.008780248999999999	0.32940114057350256
HUNTINGTON DISEASE	0.00877193	0.32908904371970826
HISTIDINEMIA	0.00877193	0.32908904371970826
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.32908904371970826
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.32908904371970826
KEIPERT SYNDROME	0.00877193	0.32908904371970826
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.32908904371970826
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.32908904371970826
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.32908904371970826
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.32908904371970826
RHEUMATIC FEVER	0.00877193	0.32908904371970826
CORTICOBASAL SYNDROME	0.00877193	0.32908904371970826
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.32908904371970826
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.32908904371970826
BREATH-HOLDING SPELLS	0.00877193	0.32908904371970826
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.32908904371970826
LOCKED-IN SYNDROME	0.00877193	0.32908904371970826
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.32908904371970826
CAFFEY DISEASE	0.00877193	0.32908904371970826
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.32908904371970826
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.32908904371970826
MILROY DISEASE	0.00877193	0.32908904371970826
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.32908904371970826
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.32908904371970826
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.32908904371970826
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.32908904371970826
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.008708484	0.32670879405197945
EAR-PATELLA-SHORT STATURE SYNDROME	0.008708484	0.32670879405197945
OROFACIODIGITAL SYNDROME TYPE 4	0.008708484	0.32670879405197945
PETTIGREW SYNDROME	0.008673586999999998	0.3253995929572731
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.008648474000000001	0.3244574498764537
3C SYNDROME	0.008648474000000001	0.3244574498764537
OCCIPITAL HORN SYNDROME	0.008648474000000001	0.3244574498764537
DISTAL MONOSOMY 9P	0.008648474000000001	0.3244574498764537
2Q24 MICRODELETION SYNDROME	0.008642663	0.3242394435274455
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008642663	0.3242394435274455
FRIED SYNDROME	0.00863839	0.3240791370174968
COACH SYNDROME	0.008612297	0.3231002281094482
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.008606921	0.3228985412857917
WOLF-HIRSCHHORN SYNDROME	0.008582652999999999	0.3219880993519197
OROFACIODIGITAL SYNDROME TYPE 2	0.0085713	0.32156217849831625
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.008537848	0.32030718824069776
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008528721999999999	0.3199648158536647
KLEEFSTRA SYNDROME	0.008514797	0.31944240346166014
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.008496224	0.31874561600336926
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.008496223999999998	0.31874561600336915
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0084934	0.31863967039510915
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.0084934	0.31863967039510915
KABUKI SYNDROME	0.008490708999999999	0.3185387144348302
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.008477929	0.31805925803484325
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008477929	0.31805925803484325
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.008477929	0.31805925803484325
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.008477838000000001	0.31805584406517207
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.008461444	0.31744080429824034
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.008461444	0.31744080429824034
CRANIOECTODERMAL DYSPLASIA 1	0.0084256	0.3160960754092627
RAPADILINO SYNDROME	0.0084256	0.3160960754092627
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0084256	0.3160960754092627
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.0084256	0.3160960754092627
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0084256	0.3160960754092627
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.0084256	0.3160960754092627
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.0084256	0.3160960754092627
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.3152617162280647
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3152617162280647
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3152617162280647
DISTAL MONOSOMY 17Q	0.00840336	0.3152617162280647
HEC SYNDROME	0.00840336	0.3152617162280647
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.3152617162280647
VACTERL/VATER ASSOCIATION	0.00840336	0.3152617162280647
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
HYDROLETHALUS	0.00840336	0.3152617162280647
RENAL TUBULAR DYSGENESIS	0.00840336	0.3152617162280647
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.3152617162280647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.3152617162280647
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3152617162280647
OMPHALOCELE	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3152617162280647
EBSTEIN MALFORMATION	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3152617162280647
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.3152617162280647
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3152617162280647
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3152617162280647
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.3152617162280647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.3152617162280647
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3152617162280647
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3152617162280647
FATCO SYNDROME	0.00840336	0.3152617162280647
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3152617162280647
COFFIN-SIRIS SYNDROME 6; CSS6	0.008383022	0.3144987127646113
CHROMOSOME 18P DELETION SYNDROME	0.008343294000000001	0.3130082711481259
CRI-DU-CHAT SYNDROME	0.008343294000000001	0.3130082711481259
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.008317201	0.31202936224007727
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.008307552	0.31166736890647206
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008307552	0.31166736890647206
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00826924	0.3102300501587177
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00826924	0.3102300501587177
AMISH LETHAL MICROCEPHALY	0.00826924	0.3102300501587177
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00826924	0.3102300501587177
MYOPATHIC EHLERS-DANLOS SYNDROME	0.008183550000000001	0.30701529124518995
16P12.1P12.3 TRIPLICATION SYNDROME	0.008183550000000001	0.30701529124518995
LATERAL MENINGOCELE SYNDROME	0.00812354	0.30476394706966414
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00812354	0.30476394706966414
DISTAL MONOSOMY 15Q	0.008117729	0.30454594072065594
MEIER-GORLIN SYNDROME 6; MGORS6	0.008101244	0.30392748698405303
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.008081987	0.30320503847900226
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.008081987	0.30320503847900226
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.008041234	0.3016761428085272
HYPERCALCEMIA, INFANTILE, 1	0.007981802	0.29944648296783655
GAPO SYNDROME; GAPOS	0.007962903	0.29873746524456946
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.007962903	0.29873746524456946
16Q24.3 MICRODELETION SYNDROME	0.007952819	0.2983591523856126
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.007947443	0.29815746556195605
PMM2-CDG	0.007947442999999998	0.29815746556195605
HUNTER-MACDONALD SYNDROME	0.00793651	0.2977473014914508
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.00793651	0.2977473014914508
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.007887433	0.2959061213864303
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.007842628	0.29422521027520837
THREE M SYNDROME 2; 3M2	0.00781836	0.2933147683413363
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00781836	0.2933147683413363
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.007792267	0.29233585943328777
3Q29 MICRODUPLICATION SYNDROME	0.007728643	0.28994893189081733
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007728643	0.28994893189081733
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0077223199999999995	0.28971171727288947
AICA-RIBOSIDURIA	0.007712049	0.28932638889383894
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.007712049	0.28932638889383894
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007710768999999999	0.28927836822153974
EAST SYNDROME	0.007710768999999999	0.28927836822153974
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007690048999999999	0.28850103358869694
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.007666646999999999	0.28762308064092734
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.007664559	0.28754474691923937
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007650758999999999	0.28702702404601393
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.007650758999999999	0.28702702404601393
FRAGILE X SYNDROME	0.007650758999999999	0.28702702404601393
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
TRANSALDOLASE DEFICIENCY	0.00757631	0.2842339841772635
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.007567184	0.28389161179023054
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.007567184	0.28389161179023054
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.007567184	0.28389161179023054
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.007567184	0.28389161179023054
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.007553259	0.2833691993982259
XQ21 MICRODELETION SYNDROME	0.007505768999999999	0.28158755742362634
WOLCOTT-RALLISON SYNDROME	0.0075016729999999995	0.28143389127226903
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.007463191	0.2799901947789749
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.007463191	0.2799901947789749
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.007450689999999999	0.27952120538490305
LOWRY-MACLEAN SYNDROME	0.007437969000000001	0.27904396243777996
QAZI-MARKOUIZOS SYNDROME	0.007437969000000001	0.27904396243777996
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007424596999999999	0.2785422964768545
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.007421484000000001	0.278425508701177
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.007421484000000001	0.278425508701177
HALLERMANN-STREIFF SYNDROME	0.007421484000000001	0.278425508701177
OCULO-PALATO-CEREBRAL SYNDROME	0.007421484000000001	0.278425508701177
OROFACIODIGITAL SYNDROME TYPE 5	0.007421484000000001	0.278425508701177
BARBER-SAY SYNDROME; BBRSAY	0.007421484000000001	0.278425508701177
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.007421484000000001	0.278425508701177
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.007411399999999999	0.27804719584222004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.007385306999999999	0.2770682869341715
XQ25 MICRODUPLICATION SYNDROME	0.007385306999999999	0.2770682869341715
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.007385306999999999	0.2770682869341715
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.007379930999999999	0.276866600110515
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.007355663	0.27595615817664304
GLYCEROL KINASE DEFICIENCY; GKD	0.007355663	0.27595615817664304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.007355663	0.27595615817664304
BANGSTAD SYNDROME	0.007355663	0.27595615817664304
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007319920999999999	0.27461525593498926
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.007319920999999999	0.27461525593498926
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.007319920999999999	0.27461525593498926
FANCONI ANEMIA	0.007262314	0.27245406306847514
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.007250848000000001	0.2720239028898953
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.007250848000000001	0.2720239028898953
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00716935	0.2689664116781473
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00714863	0.2681890770453045
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.007125227999999999	0.2673111240975349
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00712314	0.2672327903758469
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00710934	0.26671506750262153
16P11.2P12.2 MICRODELETION SYNDROME	0.00710934	0.26671506750262153
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00710934	0.26671506750262153
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0070970469999999996	0.2662538814677983
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0070970469999999996	0.2662538814677983
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.264198108983441
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.264198108983441
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.007036749	0.2639917326410053
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.007036749	0.2639917326410053
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.007036749	0.2639917326410053
CENTRAL DIABETES INSIPIDUS	0.007036749	0.2639917326410053
CLASSIC GALACTOSEMIA	0.007020264	0.2633732789044023
TRISOMY 5P	0.00701184	0.26305724285483345
CHOREOACANTHOCYTOSIS	0.006976739	0.26174038846547953
LYNCH SYNDROME	0.006976739	0.26174038846547953
FAMILIAL COLORECTAL CANCER TYPE X	0.006976739	0.26174038846547953
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006976739	0.26174038846547953
GM1 GANGLIOSIDOSIS	0.006976739	0.26174038846547953
MULTIPLE CARBOXYLASE DEFICIENCY	0.006976739	0.26174038846547953
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.006964349999999999	0.2612756008802339
MONOSOMY 13Q34	0.006964349999999999	0.2612756008802339
GALACTOSE EPIMERASE DEFICIENCY	0.006960254	0.26112193472887657
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006921772	0.2596782382355824
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00689655	0.2587320058943875
CLEIDOCRANIAL DYSPLASIA; CCD	0.00689655	0.2587320058943875
RADIO-RENAL SYNDROME	0.00689655	0.2587320058943875
600736 VELOFACIOSKELETAL SYNDROME	0.00689655	0.2587320058943875
PHOCOMELIA, SCHINZEL TYPE	0.00689655	0.2587320058943875
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00689655	0.2587320058943875
SIMOSA CRANIOFACIAL SYNDROME	0.00689655	0.2587320058943875
FAMILIAL ANETODERMA	0.00689655	0.2587320058943875
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00689655	0.2587320058943875
STICKLER SYNDROME, TYPE II	0.00689655	0.2587320058943875
CHILDHOOD APRAXIA OF SPEECH	0.00689655	0.2587320058943875
CENANI-LENZ SYNDROME	0.00689655	0.2587320058943875
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00689655	0.2587320058943875
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00689655	0.2587320058943875
MESOMELIA-SYNOSTOSES SYNDROME	0.00689655	0.2587320058943875
CLEIDOCRANIAL DYSPLASIA	0.00689655	0.2587320058943875
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00689655	0.2587320058943875
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00689655	0.2587320058943875
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.006883177999999999	0.25823033993346206
ROIFMAN SYNDROME	0.006843887999999999	0.25675633039077905
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006838512	0.2565546435671226
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.006830729000000001	0.25626265536985354
ROTHMUND-THOMSON SYNDROME	0.0068142440000000006	0.2556442016332506
OLIVER-MCFARLANE SYNDROME	0.0068142440000000006	0.2556442016332506
FANCONI ANEMIA	0.0068142440000000006	0.2556442016332506
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0068142440000000006	0.2556442016332506
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0068142440000000006	0.2556442016332506
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0068142440000000006	0.2556442016332506
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0068142440000000006	0.2556442016332506
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0067785020000000005	0.25430329939159685
JOUBERT SYNDROME 1	0.006778502	0.2543032993915968
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.006737379999999999	0.25276056026168564
HUNTINGTON DISEASE-LIKE 1	0.006711287	0.25178165135363706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006705108999999999	0.2515498765774931
19P13.13 MICRODELETION SYNDROME	0.006660442999999999	0.24987418021115362
DYSOSTEOSCLEROSIS	0.006660442999999999	0.24987418021115362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006660442999999999	0.24987418021115362
DESBUQUOIS DYSPLASIA 1	0.006619712	0.24834610989598382
JOUBERT SYNDROME 8	0.006619712	0.24834610989598382
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0065016530000000005	0.24391699071554065
ACRODERMATITIS ENTEROPATHICA	0.00649533	0.24367977609761277
MUCOLIPIDOSIS TYPE II	0.00649533	0.24367977609761277
RETICULAR DYSGENESIS	0.00649533	0.24367977609761277
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00649533	0.24367977609761277
X-LINKED AGAMMAGLOBULINEMIA	0.00649533	0.24367977609761277
CRYPTOSPORIDIOSIS	0.00649533	0.24367977609761277
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.006463058999999999	0.2424690924134203
JUVENILE DERMATOMYOSITIS	0.00643532	0.24142843192208702
POLYMYOSITIS	0.00643532	0.24142843192208702
DERMATOMYOSITIS	0.00643532	0.24142843192208702
FRAGILE X MENTAL RETARDATION SYNDROME	0.006423768999999999	0.2409950828707373
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.006423768999999999	0.2409950828707373
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006423768999999999	0.2409950828707373
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.006423768999999999	0.2409950828707373
HSD10 DISEASE	0.006423768999999999	0.2409950828707373
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.006423768999999999	0.2409950828707373
BRANCHIOSKELETOGENITAL SYNDROME	0.006423768999999999	0.2409950828707373
MENTAL RETARDATION, X-LINKED 21	0.006423768999999999	0.2409950828707373
SAETHRE-CHOTZEN SYNDROME	0.006423768999999999	0.2409950828707373
PACHYGYRIA, FRONTOTEMPORAL	0.006423768999999999	0.2409950828707373
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006423768999999999	0.2409950828707373
MENTAL RETARDATION, X-LINKED 14	0.006423768999999999	0.2409950828707373
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.006423768999999999	0.2409950828707373
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.006418393	0.2407933960470808
6Q25 MICRODELETION SYNDROME	0.0064155689999999994	0.24068745043882073
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.006407284	0.24037662913413438
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.006407284	0.24037662913413438
MICRO SYNDROME	0.006403049	0.24021774823789455
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.006403049	0.24021774823789455
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006360471	0.23862038559324308
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.006358383	0.23854205187155503
FILIPPI SYNDROME	0.006358383	0.23854205187155503
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.006358383	0.23854205187155503
SILVER-RUSSELL SYNDROME; SRS	0.00628931	0.23595069882646102
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00628931	0.23595069882646102
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00628931	0.23595069882646102
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00628931	0.23595069882646102
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00628931	0.23595069882646102
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00628931	0.23595069882646102
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00628931	0.23595069882646102
PANCREATIC AGENESIS 2; PAGEN2	0.00628931	0.23595069882646102
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00628931	0.23595069882646102
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00628931	0.23595069882646102
BOWEN-CONRADI SYNDROME	0.00628931	0.23595069882646102
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00628931	0.23595069882646102
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00628931	0.23595069882646102
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00628931	0.23595069882646102
SECKEL SYNDROME 9; SCKL9	0.00628931	0.23595069882646102
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00628931	0.23595069882646102
ISOLATED CLEFT LIP	0.00628931	0.23595069882646102
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00628931	0.23595069882646102
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.006253568	0.2346097965848073
LARSEN-LIKE SYNDROME	0.006253568	0.2346097965848073
2Q37 MICRODELETION SYNDROME	0.006199593000000001	0.23258486237594206
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.006199593000000001	0.23258486237594206
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.0061636899999999994	0.23123792003410062
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0061636899999999994	0.23123792003410062
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0061609989999999995	0.2311369640738217
CONO-SPONDYLAR DYSPLASIA	0.0061609989999999995	0.2311369640738217
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0061609989999999995	0.2311369640738217
TEMPLE-BARAITSER SYNDROME	0.006137596999999999	0.23025901112605204
FETAL TRIMETHADIONE SYNDROME	0.006119024	0.22956222366776113
CEREBROOCULONASAL SYNDROME	0.006119024	0.22956222366776113
CEREBROOCULONASAL SYNDROME	0.006119024	0.22956222366776113
12Q14 MICRODELETION SYNDROME	0.0060970239999999995	0.22873686836261922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006092931	0.2285833147597126
WIEACKER-WOLFF SYNDROME	0.006090106999999999	0.22847736915145253
WIEDEMANN-STEINER SYNDROME; WDSTS	0.006070931	0.22775795945457067
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.006070931	0.22775795945457067
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.006070931	0.22775795945457067
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.005895546999999999	0.22117822696197925
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.005895546999999999	0.22117822696197925
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.005895546999999999	0.22117822696197925
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.005895546999999999	0.22117822696197925
GRACILE BONE DYSPLASIA; GCLEB	0.005893459	0.22109989324029128
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00588235	0.2206831263273448
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00588235	0.2206831263273448
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00588235	0.2206831263273448
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00588235	0.2206831263273448
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.2206831263273448
MOSAIC TRISOMY 1	0.00588235	0.2206831263273448
CARPENTER-WAZIRI SYNDROME	0.00588235	0.2206831263273448
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11	0.00588235	0.2206831263273448
PROTEUS SYNDROME	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00588235	0.2206831263273448
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00588235	0.2206831263273448
NANCE-HORAN SYNDROME	0.00588235	0.2206831263273448
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00588235	0.2206831263273448
DISTAL TRISOMY 5Q	0.00588235	0.2206831263273448
X-LINKED INTELLECTUAL DISABILITY-MACROCEPHALY-MACROORCHIDISM SYNDROME	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00588235	0.2206831263273448
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00588235	0.2206831263273448
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.2206831263273448
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00588235	0.2206831263273448
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00588235	0.2206831263273448
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00588235	0.2206831263273448
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.2206831263273448
MYOPATHY AND DIABETES MELLITUS	0.00588235	0.2206831263273448
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00588235	0.2206831263273448
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00588235	0.2206831263273448
SPINOCEREBELLAR ATAXIA TYPE 35	0.00588235	0.2206831263273448
HYPERTRYPTOPHANEMIA; HYPTRP	0.00588235	0.2206831263273448
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.00588235	0.2206831263273448
OTOFACIOCERVICAL SYNDROME 2	0.00588235	0.2206831263273448
GARDNER SYNDROME	0.00588235	0.2206831263273448
MARSHALL-SMITH SYNDROME	0.005876974	0.22048143950368831
2Q32Q33 MICRODELETION SYNDROME	0.00586163	0.21990579169450208
MONOSOMY 5P	0.00586163	0.21990579169450208
SCHINDLER DISEASE, TYPE I	0.005835537	0.2189268827864535
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.005833449	0.21884854906476547
NEUROFACIODIGITORENAL SYNDROME	0.005816964	0.2182300953281626
FAMILIAL LAMBDOID SYNOSTOSIS	0.005816964	0.2182300953281626
NATIVE AMERICAN MYOPATHY	0.00581414	0.2181241497199025
NOCARDIOSIS	0.005749749	0.21570844729020283
MALIGNANT ATROPHIC PAPULOSIS	0.005749749	0.21570844729020283
JUVENILE HUNTINGTON DISEASE	0.005749749	0.21570844729020283
TAKAYASU ARTERITIS	0.005749749	0.21570844729020283
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005749749	0.21570844729020283
ACUTE INTERMITTENT PORPHYRIA	0.005749749	0.21570844729020283
BEHÇET DISEASE	0.005749749	0.21570844729020283
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005749749	0.21570844729020283
TSH-SECRETING PITUITARY ADENOMA	0.005749749	0.21570844729020283
RIFT VALLEY FEVER	0.005749749	0.21570844729020283
ERYTHROKERATODERMIA VARIABILIS	0.005733264	0.2150899935535999
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.005718184	0.21452425000807537
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.005674658999999999	0.21289135956915248
19P13.12 MICRODELETION SYNDROME	0.005674658999999999	0.21289135956915248
KALLMANN SYNDROME	0.005674658999999999	0.21289135956915248
DOWN SYNDROME	0.005658174	0.21227290583254957
COWDEN SYNDROME 6; CWS6	0.005653502999999999	0.2120976678948078
COWDEN SYNDROME 5; CWS5	0.005653502999999999	0.2120976678948078
RING CHROMOSOME 13 SYNDROME	0.005596177999999999	0.2099470545826596
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0055940899999999995	0.2098687208609716
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0055940899999999995	0.2098687208609716
FRANK-TER HAAR SYNDROME; FTHS	0.0055940899999999995	0.2098687208609716
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0055940899999999995	0.2098687208609716
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0055940899999999995	0.2098687208609716
NASODIGITOACOUSTIC SYNDROME	0.0055940899999999995	0.2098687208609716
OGDEN SYNDROME; OGDNS	0.0055940899999999995	0.2098687208609716
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0055940899999999995	0.2098687208609716
17P11.2 MICRODUPLICATION SYNDROME	0.00557209	0.2090433655558297
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00557209	0.2090433655558297
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00557209	0.2090433655558297
DESANTO-SHINAWI SYNDROME	0.005567997	0.20888981195292308
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005567997	0.20888981195292308
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.005567997	0.20888981195292308
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.005567997	0.20888981195292308
MENTAL RETARDATION, X-LINKED 99	0.005551512000000001	0.20827135821632017
COFFIN-SIRIS SYNDROME 7; CSS7	0.005551512	0.20827135821632012
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.005551512	0.20827135821632012
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.005551512	0.20827135821632012
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0055486879999999995	0.2081654126080601
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0055486879999999995	0.2081654126080601
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0055486879999999995	0.2081654126080601
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0055486879999999995	0.2081654126080601
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0055486879999999995	0.2081654126080601
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0055486879999999995	0.2081654126080601
C SYNDROME	0.0055459969999999996	0.20806445664778112
OROFACIODIGITAL SYNDROME VI	0.0055295119999999994	0.20744600291117818
HADZISELIMOVIC SYNDROME	0.0055295119999999994	0.20744600291117818
JOUBERT SYNDROME 2	0.0055295119999999994	0.20744600291117818
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0055295119999999994	0.20744600291117818
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005458942999999999	0.20479852570533452
SHOX-RELATED SHORT STATURE	0.0054353	0.20391153136535858
NON-DISTAL MONOSOMY 20Q	0.005409206999999999	0.20293262245731003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.005409206999999999	0.20293262245731003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005409206999999999	0.20293262245731003
MICROTRIPLICATION 11Q24.1	0.005392722	0.20231416872070712
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.005392722	0.20231416872070712
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005354128	0.20086627041858682
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00535204	0.2007879366968988
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00535204	0.2007879366968988
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00535204	0.2007879366968988
HYPERLYSINEMIA, TYPE I	0.005351442999999999	0.2007655395552092
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00529203	0.198536592521373
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00529203	0.198536592521373
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00529203	0.198536592521373
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.005246628	0.1968332842684615
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.005246628	0.1968332842684615
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.005246628	0.1968332842684615
HEPATOCELLULAR CARCINOMA	0.00520833	0.19539649074681037
MANTLE CELL LYMPHOMA	0.00520833	0.19539649074681037
PERITONEAL CYSTIC MESOTHELIOMA	0.00520833	0.19539649074681037
MALIGNANT PERITONEAL MESOTHELIOMA	0.00520833	0.19539649074681037
GIANT CELL ARTERITIS	0.00520833	0.19539649074681037
MALT LYMPHOMA	0.00520833	0.19539649074681037
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00520833	0.19539649074681037
ACUTE PROMYELOCYTIC LEUKEMIA	0.00520833	0.19539649074681037
EOSINOPHILIC GASTROENTERITIS	0.00520833	0.19539649074681037
NON-FUNCTIONING PARAGANGLIOMA	0.00520833	0.19539649074681037
PSEUDOMYXOMA PERITONEI	0.00520833	0.19539649074681037
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00520833	0.19539649074681037
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00520833	0.19539649074681037
PLEURAL MESOTHELIOMA	0.00520833	0.19539649074681037
FELTY SYNDROME	0.00520833	0.19539649074681037
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00520833	0.19539649074681037
PERRY SYNDROME	0.00520833	0.19539649074681037
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00520833	0.19539649074681037
SYSTEMIC CAPILLARY LEAK SYNDROME	0.00520833	0.19539649074681037
CHRONIC GRAFT VERSUS HOST DISEASE	0.00520833	0.19539649074681037
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.00520833	0.19539649074681037
FOCAL MYOSITIS	0.00520833	0.19539649074681037
GRFOMA	0.00520833	0.19539649074681037
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00520833	0.19539649074681037
CLASSIC HODGKIN LYMPHOMA	0.00520833	0.19539649074681037
THYMIC CARCINOMA	0.00520833	0.19539649074681037
ACUTE MONOBLASTIC LEUKEMIA	0.00520833	0.19539649074681037
LEISHMANIASIS	0.00520833	0.19539649074681037
PRIMARY SCLEROSING CHOLANGITIS	0.00520833	0.19539649074681037
RIDDLE SYNDROME	0.00520833	0.19539649074681037
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00520833	0.19539649074681037
HERMANSKY-PUDLAK SYNDROME	0.00520833	0.19539649074681037
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00520833	0.19539649074681037
MARBURG HEMORRHAGIC FEVER	0.00520833	0.19539649074681037
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00520833	0.19539649074681037
INSULIN AUTOIMMUNE SYNDROME	0.00520833	0.19539649074681037
KIKUCHI-FUJIMOTO DISEASE	0.00520833	0.19539649074681037
BUDD-CHIARI SYNDROME	0.00520833	0.19539649074681037
OROMANDIBULAR DYSTONIA	0.00520833	0.19539649074681037
STEVENS-JOHNSON SYNDROME	0.00520833	0.19539649074681037
YAO SYNDROME	0.00520833	0.19539649074681037
MU-HEAVY CHAIN DISEASE	0.00520833	0.19539649074681037
THYMIC NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00520833	0.19539649074681037
BRONCHIAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00520833	0.19539649074681037
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00520833	0.19539649074681037
NEPHROBLASTOMA	0.00520833	0.19539649074681037
WILD TYPE ATTR AMYLOIDOSIS	0.00520833	0.19539649074681037
MAST CELL SARCOMA	0.00520833	0.19539649074681037
KAPOSI SARCOMA	0.00520833	0.19539649074681037
PULMONARY BLASTOMA	0.00520833	0.19539649074681037
REACTIVE ARTHRITIS	0.00520833	0.19539649074681037
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF STOMACH	0.00520833	0.19539649074681037
JEJUNAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00520833	0.19539649074681037
OSTEOSARCOMA	0.00520833	0.19539649074681037
MEDULLARY THYROID CARCINOMA	0.00520833	0.19539649074681037
BULLOUS PEMPHIGOID	0.00520833	0.19539649074681037
ANAPLASTIC THYROID CARCINOMA	0.00520833	0.19539649074681037
PARATHYROID CARCINOMA	0.00520833	0.19539649074681037
AUTOSOMAL DOMINANT EPIDERMOLYTIC ICHTHYOSIS	0.00520833	0.19539649074681037
RAT-BITE FEVER	0.00520833	0.19539649074681037
VARIANT ABETA2M AMYLOIDOSIS	0.00520833	0.19539649074681037
POLYCYTHEMIA VERA	0.00520833	0.19539649074681037
EOSINOPHILIC FASCIITIS	0.00520833	0.19539649074681037
PANCREATOBLASTOMA	0.00520833	0.19539649074681037
LIPOSARCOMA	0.00520833	0.19539649074681037
ISAAC SYNDROME	0.00520833	0.19539649074681037
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00520833	0.19539649074681037
RHABDOID TUMOR	0.00520833	0.19539649074681037
MÉNÉTRIER DISEASE	0.00520833	0.19539649074681037
HODGKIN LYMPHOMA	0.00520833	0.19539649074681037
CARNEY-STRATAKIS SYNDROME	0.00520833	0.19539649074681037
ILEAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
TUBERCULOSIS	0.00520833	0.19539649074681037
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00520833	0.19539649074681037
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.19539649074681037
VIPOMA	0.00520833	0.19539649074681037
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.00520833	0.19539649074681037
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.00520833	0.19539649074681037
POEMS SYNDROME	0.00520833	0.19539649074681037
FAMILIAL PANCREATIC CARCINOMA	0.00520833	0.19539649074681037
ZOLLINGER-ELLISON SYNDROME	0.00520833	0.19539649074681037
THYMIC EPITHELIAL NEOPLASM	0.00520833	0.19539649074681037
FOLLICULAR LYMPHOMA	0.00520833	0.19539649074681037
GLUCAGONOMA	0.00520833	0.19539649074681037
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00520833	0.19539649074681037
PPOMA	0.00520833	0.19539649074681037
POLYARTERITIS NODOSA	0.00520833	0.19539649074681037
TOXIC EPIDERMAL NECROLYSIS	0.00520833	0.19539649074681037
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00520833	0.19539649074681037
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00520833	0.19539649074681037
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00520833	0.19539649074681037
GALLBLADDER NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00520833	0.19539649074681037
CAP POLYPOSIS	0.00520833	0.19539649074681037
ATTRV30M AMYLOIDOSIS	0.00520833	0.19539649074681037
ERDHEIM-CHESTER DISEASE	0.00520833	0.19539649074681037
LARYNGEAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
CASTLEMAN DISEASE	0.00520833	0.19539649074681037
SARCOIDOSIS	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00520833	0.19539649074681037
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00520833	0.19539649074681037
ALPORT SYNDROME	0.00520833	0.19539649074681037
SOMATOSTATINOMA	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF THE COLON	0.00520833	0.19539649074681037
PYOMYOSITIS	0.00520833	0.19539649074681037
KLATSKIN TUMOR	0.00520833	0.19539649074681037
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00520833	0.19539649074681037
INFLAMMATORY BOWEL DISEASE 11	0.00520833	0.19539649074681037
PERRY SYNDROME	0.00520833	0.19539649074681037
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00520833	0.19539649074681037
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00520833	0.19539649074681037
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00520833	0.19539649074681037
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.19539649074681037
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00520833	0.19539649074681037
DISTAL TRISOMY 17Q	0.005176059	0.19418580706261787
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.005176059	0.19418580706261787
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576002
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576002
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576002
ACHONDROPLASIA	0.00513324	0.19257940302576002
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576002
DISTAL MONOSOMY 1Q	0.005131393000000001	0.19251011069627838
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.005131393	0.19251011069627832
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0051285689999999995	0.1924041650880183
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.005112083999999999	0.19178571135141537
1Q21.1 MICRODELETION SYNDROME	0.005109392999999999	0.19168475539113639
WIEDEMANN-STEINER SYNDROME	0.005109392999999999	0.19168475539113639
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.005109392999999999	0.19168475539113639
HENNEKAM-BEEMER SYNDROME	0.005109392999999999	0.19168475539113639
ALEXANDER DISEASE	0.005109392999999999	0.19168475539113639
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.005026578	0.1885778554095306
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005026578	0.1885778554095306
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.005026578	0.1885778554095306
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.005026578	0.1885778554095306
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.005026578	0.1885778554095306
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005026578	0.1885778554095306
RIGID SPINE MUSCULAR DYSTROPHY 1	0.005004578	0.18775250010438865
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.005004578	0.18775250010438865
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.005004578	0.18775250010438865
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.004972603000000001	0.18655292120066538
11P15.4 MICRODUPLICATION SYNDROME	0.004972603000000001	0.18655292120066538
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.004972603000000001	0.18655292120066538
MONOSOMY 22Q13.3	0.004972603000000001	0.18655292120066538
CHROMOSOME 2Q37 DELETION SYNDROME	0.004972603000000001	0.18655292120066538
DISTAL 16P11.2 MICRODELETION SYNDROME	0.004972603000000001	0.18655292120066538
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004972603000000001	0.18655292120066538
BOHRING-OPITZ SYNDROME	0.004934009	0.185105022898545
XQ28 (MECP2) DUPLICATION	0.004934009	0.185105022898545
RETT SYNDROME	0.004934009	0.185105022898545
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004934009	0.185105022898545
PITT-HOPKINS-LIKE SYNDROME	0.004934009	0.185105022898545
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004934009	0.185105022898545
HALL-RIGGS SYNDROME	0.004934009	0.185105022898545
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004886519	0.18332338092394546
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.004873999	0.18285367872301928
4Q21 MICRODELETION SYNDROME	0.004873999	0.18285367872301928
5Q14.3 MICRODELETION SYNDROME	0.004873999	0.18285367872301928
14Q12 MICRODELETION SYNDROME	0.004873999	0.18285367872301928
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.004873999	0.18285367872301928
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.004873999	0.18285367872301928
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004873999	0.18285367872301928
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004873999	0.18285367872301928
MEND SYNDROME	0.004843941	0.181726018279294
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004843941	0.181726018279294
OROFACIODIGITAL SYNDROME TYPE 6	0.004843941	0.181726018279294
ZTTK SYNDROME; ZTTKS	0.004843941	0.181726018279294
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004783931	0.17947467410376822
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004783931	0.17947467410376822
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004783931	0.17947467410376822
EMANUEL SYNDROME	0.004783931	0.17947467410376822
KABUKI SYNDROME 1	0.004783931	0.17947467410376822
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00463464	0.17387385051922538
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00463464	0.17387385051922538
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004608546999999999	0.1728949416111768
TRISOMY 8P	0.004608546999999999	0.1728949416111768
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004608546999999999	0.1728949416111768
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.004608546999999999	0.1728949416111768
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004608546999999999	0.1728949416111768
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.004608546999999999	0.1728949416111768
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.004608546999999999	0.1728949416111768
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004608546999999999	0.1728949416111768
LISSENCEPHALY 3; LIS3	0.004608546999999999	0.1728949416111768
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.004608546999999999	0.1728949416111768
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.004608546999999999	0.1728949416111768
MOWAT-WILSON SYNDROME; MOWS	0.004608546999999999	0.1728949416111768
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004608546999999999	0.1728949416111768
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004606459	0.17281660788948883
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004606459	0.17281660788948883
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004606459	0.17281660788948883
WEBB-DATTANI SYNDROME; WEDAS	0.004606459	0.17281660788948883
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.1721981541528859
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.004589974	0.1721981541528859
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.1721981541528859
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004589974	0.1721981541528859
PETERS PLUS SYNDROME	0.004589974	0.1721981541528859
ZECHI-CEIDE SYNDROME	0.004589974	0.1721981541528859
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.004589974	0.1721981541528859
ZECHI-CEIDE SYNDROME	0.004589974	0.1721981541528859
KEIPERT SYNDROME; KPTS	0.004589974	0.1721981541528859
LARSEN SYNDROME	0.004589974	0.1721981541528859
NOONAN SYNDROME 5; NS5	0.004589974	0.1721981541528859
OPITZ G/BBB SYNDROME	0.004589974	0.1721981541528859
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00458715	0.17209220854462584
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00458715	0.17209220854462584
FRONTOOCULAR SYNDROME	0.00458715	0.17209220854462584
14Q11.2 MICRODELETION SYNDROME	0.00458715	0.17209220854462584
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00458715	0.17209220854462584
MOEBIUS SYNDROME; MBS	0.00458715	0.17209220854462584
17Q21.31 MICRODUPLICATION SYNDROME	0.004567974	0.17137279884774395
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.004567974	0.17137279884774395
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.004567974	0.17137279884774395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004561057	0.17111329963657732
SPINOCEREBELLAR ATAXIA TYPE 13	0.004561057	0.17111329963657732
TEMTAMY SYNDROME; TEMTYS	0.004561057	0.17111329963657732
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.004541881000000001	0.17039388993969543
PELIZAEUS-MERZBACHER DISEASE	0.004541881	0.17039388993969543
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004541881	0.17039388993969543
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004541881	0.17039388993969543
LEIGH SYNDROME; LS	0.004541881	0.17039388993969543
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004541881	0.17039388993969543
FOLATE MALABSORPTION, HEREDITARY	0.004541881	0.17039388993969543
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004541881	0.17039388993969543
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.004541881	0.17039388993969543
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.004541881	0.17039388993969543
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004541881	0.17039388993969543
ADIPOSIS DOLOROSA	0.004447669	0.1668594183938758
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.004447669	0.1668594183938758
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.004447669	0.1668594183938758
BARDET-BIEDL SYNDROME 14; BBS14	0.004431184	0.1662409646572729
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.004431184	0.1662409646572729
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 13; BBS13	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 9; BBS9	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 8; BBS8	0.004431184	0.1662409646572729
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004431184	0.1662409646572729
URBAN-ROGERS-MEYER SYNDROME	0.004431184	0.1662409646572729
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.004431184	0.1662409646572729
CARPENTER SYNDROME	0.004431184	0.1662409646572729
BIEMOND SYNDROME TYPE 2	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 16; BBS16	0.004431184	0.1662409646572729
LAURENCE-MOON SYNDROME	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 4; BBS4	0.004431184	0.1662409646572729
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.004431184	0.1662409646572729
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.004431184	0.1662409646572729
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.004431184	0.1662409646572729
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 3; BBS3	0.004431184	0.1662409646572729
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME	0.004431184	0.1662409646572729
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.004431184	0.1662409646572729
RETINITIS PIGMENTOSA	0.004431184	0.1662409646572729
WAGR SYNDROME	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 6; BBS6	0.004431184	0.1662409646572729
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.004431184	0.1662409646572729
MACROCEPHALY/AUTISM SYNDROME	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 2	0.004431184	0.1662409646572729
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 19; BBS19	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 7; BBS7	0.004431184	0.1662409646572729
BARDET-BIEDL SYNDROME 20	0.004431184	0.1662409646572729
ATKIN-FLAITZ SYNDROME	0.004431184	0.1662409646572729
CHOPS SYNDROME; CHOPS	0.004431184	0.1662409646572729
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00439259	0.16479306635515256
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.004345099999999999	0.163011424380553
ALAGILLE SYNDROME	0.004345099999999999	0.163011424380553
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.004345099999999999	0.163011424380553
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.004345099999999999	0.163011424380553
DOUBLE OUTLET RIGHT VENTRICLE	0.004345099999999999	0.163011424380553
CYSTINOSIS	0.004345099999999999	0.163011424380553
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.004345099999999999	0.163011424380553
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.004345099999999999	0.163011424380553
AARSKOG-SCOTT SYNDROME	0.004345099999999999	0.163011424380553
ALAGILLE SYNDROME 1; ALGS1	0.004345099999999999	0.163011424380553
JUVENILE POLYPOSIS SYNDROME	0.004345099999999999	0.163011424380553
CONGENITAL HYPOTHYROIDISM	0.00433258	0.16254172217962679
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00433258	0.16254172217962679
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00433258	0.16254172217962679
ATHYREOSIS	0.00433258	0.16254172217962679
THYROID ECTOPIA	0.00433258	0.16254172217962679
THYROID HYPOPLASIA	0.00433258	0.16254172217962679
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00433258	0.16254172217962679
REFSUM DISEASE	0.00433258	0.16254172217962679
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004319007	0.16203251547250444
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.004302522	0.1614140617359015
ERMINE PHENOTYPE	0.00428509	0.16076008020502727
CAT-EYE SYNDROME	0.00428509	0.16076008020502727
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00428509	0.16076008020502727
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00428509	0.16076008020502727
TRANSKETOLASE DEFICIENCY	0.00428509	0.16076008020502727
GERODERMA OSTEODYSPLASTICA	0.00428509	0.16076008020502727
DENT DISEASE	0.00428509	0.16076008020502727
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.004258997	0.15978117129697866
LISSENCEPHALY, X-LINKED, 2	0.004258997	0.15978117129697866
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004258997	0.15978117129697866
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0042425119999999995	0.15916271756037575
ARTERIAL TORTUOSITY SYNDROME	0.0042425119999999995	0.15916271756037575
DUBOWITZ SYNDROME	0.0042425119999999995	0.15916271756037575
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004171943	0.1565152403545321
OROFACIODIGITAL SYNDROME XVI; OFD16	0.004067128	0.15258298506778434
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004067128	0.15258298506778434
SCHOLTE SYNDROME; SHLTS	0.004067128	0.15258298506778434
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.004067128	0.15258298506778434
JOUBERT SYNDROME 14	0.004067128	0.15258298506778434
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.004067128	0.15258298506778434
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.004067128	0.15258298506778434
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004067128	0.15258298506778434
SAUL-WILSON SYNDROME; SWILS	0.00406504	0.15250465134609634
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.15250465134609634
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.15250465134609634
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00406504	0.15250465134609634
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00406504	0.15250465134609634
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.15250465134609634
CRANIOSYNOSTOSIS 4; CRS4	0.00406504	0.15250465134609634
STEEL SYNDROME; STLS	0.00406504	0.15250465134609634
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00406504	0.15250465134609634
HYPERTELORISM, TEEBI TYPE	0.00406504	0.15250465134609634
AXENFELD-RIEGER SYNDROME	0.00406504	0.15250465134609634
268650 RUDIGER SYNDROME	0.00406504	0.15250465134609634
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00406504	0.15250465134609634
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.15250465134609634
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00406504	0.15250465134609634
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00406504	0.15250465134609634
HYPERTELORISM, TEEBI TYPE; TBHS	0.00406504	0.15250465134609634
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00406504	0.15250465134609634
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.15250465134609634
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00406504	0.15250465134609634
ODONTOCHONDRODYSPLASIA; ODCD	0.00406504	0.15250465134609634
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.15250465134609634
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00406504	0.15250465134609634
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.15250465134609634
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00406504	0.15250465134609634
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00406504	0.15250465134609634
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0040430399999999995	0.1516792960409544
NEUTRAL LIPID STORAGE MYOPATHY	0.004019638	0.1508013430931848
NOONAN SYNDROME 6; NS6	0.004019638	0.1508013430931848
VERVERI-BRADY SYNDROME; VERBRAS	0.004019638	0.1508013430931848
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.004019638	0.1508013430931848
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.004019638	0.1508013430931848
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.004019638	0.1508013430931848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.004019638	0.1508013430931848
VICI SYNDROME; VICIS	0.004016947	0.15070038713290587
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.004016947	0.15070038713290587
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004016947	0.15070038713290587
GLUTARIC ACIDEMIA I; GA1	0.004016947	0.15070038713290587
HYPOPHOSPHATASIA, INFANTILE	0.004016947	0.15070038713290587
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.004016947	0.15070038713290587
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004016947	0.15070038713290587
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004016947	0.15070038713290587
GALACTOSE EPIMERASE DEFICIENCY	0.004000462000000001	0.15008193339630296
WARBURG MICRO SYNDROME 1	0.004000462	0.1500819333963029
NIEMANN-PICK DISEASE, TYPE A	0.004000462	0.1500819333963029
PEROXISOME BIOGENESIS DISORDER 3B	0.004000462	0.1500819333963029
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00390625	0.14654746185048334
ACROCEPHALOSYNDACTYLY	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 5; BBS5	0.00390625	0.14654746185048334
ULNAR-MAMMARY SYNDROME	0.00390625	0.14654746185048334
SHEEHAN SYNDROME	0.00390625	0.14654746185048334
HALOTHANE HEPATITIS	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 11; BBS11	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 10; BBS10	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 17; BBS17	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 18; BBS18	0.00390625	0.14654746185048334
SERTOLI CELL-ONLY SYNDROME	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 12; BBS12	0.00390625	0.14654746185048334
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00390625	0.14654746185048334
PERIPARTUM CARDIOMYOPATHY	0.00390625	0.14654746185048334
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00390625	0.14654746185048334
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	0.00390625	0.14654746185048334
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00390625	0.14654746185048334
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00390625	0.14654746185048334
IMMUNODEFICIENCY 61; IMD61	0.00390625	0.14654746185048334
ADENOCARCINOMA OF THE ESOPHAGUS	0.00390625	0.14654746185048334
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00390625	0.14654746185048334
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00390625	0.14654746185048334
POLYCYSTIC OVARY SYNDROME 1	0.00390625	0.14654746185048334
SECONDARY POLYCYTHEMIA	0.00390625	0.14654746185048334
TRIGLYCERIDE STORAGE DISEASE, TYPE II	0.00390625	0.14654746185048334
RING CHROMOSOME Y SYNDROME	0.00390625	0.14654746185048334
NARCOLEPSY 7; NRCLP7	0.00390625	0.14654746185048334
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00390625	0.14654746185048334
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00390625	0.14654746185048334
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.00390625	0.14654746185048334
SUMMITT SYNDROME	0.00390625	0.14654746185048334
RETINITIS PIGMENTOSA 71; RP71	0.00390625	0.14654746185048334
ADIPOSIS DOLOROSA	0.00390625	0.14654746185048334
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00390625	0.14654746185048334
DYSBETALIPOPROTEINEMIA	0.00390625	0.14654746185048334
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00390625	0.14654746185048334
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.00390625	0.14654746185048334
OBESITY-HYPOVENTILATION SYNDROME	0.00390625	0.14654746185048334
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.00390625	0.14654746185048334
SENIOR-LOKEN SYNDROME 9	0.00390625	0.14654746185048334
NARCOLEPSY TYPE 1	0.00390625	0.14654746185048334
ULNAR-MAMMARY SYNDROME; UMS	0.00390625	0.14654746185048334
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0038824029999999995	0.14565281421585974
MOSAIC TRISOMY 14	0.0038824029999999995	0.14565281421585974
HARROD SYNDROME	0.0038824029999999995	0.14565281421585974
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0038824029999999995	0.14565281421585974
COWDEN SYNDROME	0.0038824029999999995	0.14565281421585974
MONOSOMY 9P	0.0038223929999999995	0.14340147004033393
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0038223929999999995	0.14340147004033393
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0038223929999999995	0.14340147004033393
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0038223929999999995	0.14340147004033393
COFFIN-LOWRY SYNDROME	0.0038223929999999995	0.14340147004033393
VICI SYNDROME	0.0038223929999999995	0.14340147004033393
COFFIN-SIRIS SYNDROME 1; CSS1	0.0038223929999999995	0.14340147004033393
TARP SYNDROME; TARPS	0.003777588	0.141720558929112
CLASSIC MULTIMINICORE MYOPATHY	0.003777588	0.141720558929112
NEMALINE MYOPATHY 7; NEM7	0.003717578	0.13946921475358623
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.003717578	0.13946921475358623
NEMALINE MYOPATHY 4	0.003717578	0.13946921475358623
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.003647009	0.13682173754774257
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.003647009	0.13682173754774257
CHILDHOOD DISINTEGRATIVE DISORDER	0.003647009	0.13682173754774257
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.003647009	0.13682173754774257
RENIER-GABREELS-JASPER SYNDROME	0.003647009	0.13682173754774257
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.003647009	0.13682173754774257
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.003647009	0.13682173754774257
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.003647009	0.13682173754774257
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.003647009	0.13682173754774257
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.003647009	0.13682173754774257
INTELLECTUAL DISABILITY, WOLFF TYPE	0.003647009	0.13682173754774257
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.003647009	0.13682173754774257
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003647009	0.13682173754774257
SECKEL SYNDROME 7; SCKL7	0.003647009	0.13682173754774257
RETT SYNDROME, CONGENITAL VARIANT	0.003647009	0.13682173754774257
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.003647009	0.13682173754774257
BAND HETEROTOPIA; BH	0.003647009	0.13682173754774257
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.003647009	0.13682173754774257
CLASSIC PHENYLKETONURIA	0.003647009	0.13682173754774257
NARP SYNDROME	0.003647009	0.13682173754774257
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.003630524	0.13620328381113964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.003630524	0.13620328381113964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.003630524	0.13620328381113964
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.003599519	0.13504009557314303
CENTRAL BILATERAL MACROGYRIA	0.003599519	0.13504009557314303
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.003599519	0.13504009557314303
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.003599519	0.13504009557314303
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.003599519	0.13504009557314303
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003599519	0.13504009557314303
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.003599519	0.13504009557314303
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.003599519	0.13504009557314303
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.003599519	0.13504009557314303
BRANCHIOOCULOFACIAL SYNDROME	0.003599519	0.13504009557314303
KEUTEL SYNDROME	0.003599519	0.13504009557314303
MENTAL RETARDATION, X-LINKED 9	0.003599519	0.13504009557314303
DARIER-WHITE DISEASE; DAR	0.003599519	0.13504009557314303
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.003599519	0.13504009557314303
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.003599519	0.13504009557314303
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0035830339999999997	0.13442164183654007
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0035830339999999997	0.13442164183654007
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.0035830339999999997	0.13442164183654007
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0035803429999999997	0.13432068587626114
1Q21.1 MICRODUPLICATION SYNDROME	0.0035803429999999997	0.13432068587626114
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0035803429999999997	0.13432068587626114
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0035803429999999997	0.13432068587626114
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0035803429999999997	0.13432068587626114
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0035803429999999997	0.13432068587626114
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0035803429999999997	0.13432068587626114
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.003556941	0.13344273292849154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.003556941	0.13344273292849154
MEND SYNDROME; MEND	0.003556941	0.13344273292849154
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.003556941	0.13344273292849154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.003556941	0.13344273292849154
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0034755280000000003	0.1303884305895134
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0034755280000000003	0.1303884305895134
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0034755280000000003	0.1303884305895134
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0034755280000000003	0.1303884305895134
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0034755280000000003	0.1303884305895134
GLYCOGEN STORAGE DISEASE IV	0.0034755280000000003	0.1303884305895134
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0034755280000000003	0.1303884305895134
MEVALONIC ACIDURIA; MEVA	0.0034755280000000003	0.1303884305895134
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0034755280000000003	0.1303884305895134
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0034755280000000003	0.1303884305895134
CAMPOMELIC DYSPLASIA	0.0034755280000000003	0.1303884305895134
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0034755280000000003	0.1303884305895134
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0034755280000000003	0.1303884305895134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0034755280000000003	0.1303884305895134
PORPHYRIA, ACUTE HEPATIC	0.0034755280000000003	0.1303884305895134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.003357469	0.12595931140907018
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.003357469	0.12595931140907018
TETRASOMY 5P	0.003357469	0.12595931140907018
TURNPENNY-FRY SYNDROME; TPFS	0.003340984	0.12534085767246728
MCKUSICK-KAUFMAN SYNDROME	0.003340984	0.12534085767246728
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.003340984	0.12534085767246728
3Q29 MICRODELETION SYNDROME	0.003340984	0.12534085767246728
MENTAL RETARDATION, BUENOS AIRES TYPE	0.003340984	0.12534085767246728
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.003314891	0.12436194876441871
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003314891	0.12436194876441871
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.003314891	0.12436194876441871
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003314891	0.12436194876441871
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003314891	0.12436194876441871
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.003314891	0.12436194876441871
STT3A-CDG	0.003314891	0.12436194876441871
STT3B-CDG	0.003314891	0.12436194876441871
SSR4-CDG	0.003314891	0.12436194876441871
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.003314891	0.12436194876441871
TARP SYNDROME	0.003314891	0.12436194876441871
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.003314891	0.12436194876441871
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003314891	0.12436194876441871
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003314891	0.12436194876441871
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003314891	0.12436194876441871
PONTINE TEGMENTAL CAP DYSPLASIA	0.003314891	0.12436194876441871
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.003314891	0.12436194876441871
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003314891	0.12436194876441871
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.003314891	0.12436194876441871
ETHYLMALONIC ENCEPHALOPATHY	0.003314891	0.12436194876441871
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.003314891	0.12436194876441871
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.003314891	0.12436194876441871
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.003297459	0.12370796723354444
FETAL GAUCHER DISEASE	0.003297459	0.12370796723354444
MOWAT-WILSON SYNDROME	0.003297459	0.12370796723354444
DISTAL MONOSOMY 3P	0.003297459	0.12370796723354444
PYRUVATE DEHYDROGENASE DEFICIENCY	0.003297459	0.12370796723354444
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003280974	0.1230895134969415
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.003280974	0.1230895134969415
8Q21.11 MICRODELETION SYNDROME	0.003280974	0.1230895134969415
CRANIOFRONTONASAL DYSPLASIA	0.003280974	0.1230895134969415
GERMAN SYNDROME	0.003280974	0.1230895134969415
CAREY-FINEMAN-ZITER SYNDROME	0.003280974	0.1230895134969415
TRISOMY 17P	0.003280974	0.1230895134969415
GRISCELLI SYNDROME, TYPE 1	0.0032548810000000003	0.12211060458889296
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0032548810000000003	0.12211060458889296
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0032548810000000003	0.12211060458889296
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0032548810000000003	0.12211060458889296
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0032548810000000003	0.12211060458889296
ADAMS-OLIVER SYNDROME 1; AOS1	0.0032548810000000003	0.12211060458889296
ELEJALDE DISEASE	0.0032548810000000003	0.12211060458889296
KETOADIPICACIDURIA	0.0032548810000000003	0.12211060458889296
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0032548810000000003	0.12211060458889296
NEURAMINIDASE DEFICIENCY	0.0032548810000000003	0.12211060458889296
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0032548810000000003	0.12211060458889296
NIEMANN-PICK DISEASE, TYPE C2	0.0032548810000000003	0.12211060458889296
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0032548810000000003	0.12211060458889296
KLEEFSTRA SYNDROME 2; KLEFS2	0.0032548810000000003	0.12211060458889296
SALLA DISEASE	0.0032548810000000003	0.12211060458889296
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0032548810000000003	0.12211060458889296
HOLOPROSENCEPHALY 2; HPE2	0.0032548810000000003	0.12211060458889296
ASPARTYLGLUCOSAMINURIA; AGU	0.0032548810000000003	0.12211060458889296
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0032548810000000003	0.12211060458889296
PYRUVATE CARBOXYLASE DEFICIENCY	0.0032548810000000003	0.12211060458889296
OHDO SYNDROME	0.0032548810000000003	0.12211060458889296
CYCLIC VOMITING SYNDROME	0.0032548810000000003	0.12211060458889296
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0032548810000000003	0.12211060458889296
METACHROMATIC LEUKODYSTROPHY	0.0032548810000000003	0.12211060458889296
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0032548810000000003	0.12211060458889296
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0032548810000000003	0.12211060458889296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0032548810000000003	0.12211060458889296
GLYCINE ENCEPHALOPATHY; GCE	0.0032548810000000003	0.12211060458889296
CODAS SYNDROME	0.0032548810000000003	0.12211060458889296
STIMMLER SYNDROME	0.00310559	0.1165097810043501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00310559	0.1165097810043501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00310559	0.1165097810043501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00310559	0.1165097810043501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.00310559	0.1165097810043501
BRESEK SYNDROME	0.00310559	0.1165097810043501
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00310559	0.1165097810043501
OKAMOTO SYNDROME	0.00310559	0.1165097810043501
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00310559	0.1165097810043501
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00310559	0.1165097810043501
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00310559	0.1165097810043501
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00310559	0.1165097810043501
PHENYLKETONURIA	0.00310559	0.1165097810043501
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00310559	0.1165097810043501
JUBERG-MARSIDI SYNDROME	0.00310559	0.1165097810043501
TRISOMY XQ28	0.00310559	0.1165097810043501
NEPHROSIALIDOSIS	0.00310559	0.1165097810043501
HOLMES-GANG SYNDROME	0.00310559	0.1165097810043501
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00310559	0.1165097810043501
%613930 ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	0.00310559	0.1165097810043501
WARBURG MICRO SYNDROME 2; WARBM2	0.00310559	0.1165097810043501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00310559	0.1165097810043501
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00310559	0.1165097810043501
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00310559	0.1165097810043501
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00310559	0.1165097810043501
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00310559	0.1165097810043501
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00310559	0.1165097810043501
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00310559	0.1165097810043501
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.0030581	0.11472813902975054
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0030581	0.11472813902975054
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0030581	0.11472813902975054
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0030581	0.11472813902975054
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0030581	0.11472813902975054
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0030581	0.11472813902975054
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.0030581	0.11472813902975054
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0030581	0.11472813902975054
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0030581	0.11472813902975054
MENTAL RETARDATION, X-LINKED 73	0.0030581	0.11472813902975054
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975054
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0030581	0.11472813902975054
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0030581	0.11472813902975054
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0030581	0.11472813902975054
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0030581	0.11472813902975054
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.0030581	0.11472813902975054
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.0030581	0.11472813902975054
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0030581	0.11472813902975054
OTOFACIOCERVICAL SYNDROME	0.0030581	0.11472813902975054
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0030581	0.11472813902975054
CHAR SYNDROME	0.0030581	0.11472813902975054
BLOOM SYNDROME	0.0030581	0.11472813902975054
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.0030581	0.11472813902975054
BONNEMANN-MEINECKE-REICH SYNDROME	0.0030581	0.11472813902975054
PEROXISOME BIOGENESIS DISORDER 14B	0.0030581	0.11472813902975054
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.0030581	0.11472813902975054
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0030581	0.11472813902975054
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0030581	0.11472813902975054
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0030581	0.11472813902975054
BLOOM SYNDROME	0.0030581	0.11472813902975054
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0030581	0.11472813902975054
WOODHOUSE-SAKATI SYNDROME	0.0030581	0.11472813902975054
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0030581	0.11472813902975054
SPINOCEREBELLAR ATAXIA TYPE 27	0.0030581	0.11472813902975054
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0030581	0.11472813902975054
WEILL-MARCHESANI SYNDROME	0.0030581	0.11472813902975054
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0030581	0.11472813902975054
AUROCEPHALOSYNDACTYLY	0.0030581	0.11472813902975054
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0030581	0.11472813902975054
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0030581	0.11472813902975054
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975054
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0030581	0.11472813902975054
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0030581	0.11472813902975054
MUCOLIPIDOSIS III GAMMA	0.0030581	0.11472813902975054
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0030581	0.11472813902975054
MICROPHTHALMIA-ANKYLOBLEPHARON-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975054
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0030581	0.11472813902975054
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0030581	0.11472813902975054
BOUCHER-NEUHAUSER SYNDROME	0.0030581	0.11472813902975054
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0030581	0.11472813902975054
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0030581	0.11472813902975054
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.0030581	0.11472813902975054
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0030581	0.11472813902975054
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0030581	0.11472813902975054
VAN BOGAERT-HOZAY SYNDROME	0.0030581	0.11472813902975054
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.0030581	0.11472813902975054
3MC SYNDROME 1	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.0030581	0.11472813902975054
ISOLATED HEMIHYPERPLASIA	0.0030581	0.11472813902975054
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0030581	0.11472813902975054
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.0030581	0.11472813902975054
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0030581	0.11472813902975054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.0030581	0.11472813902975054
MENTAL RETARDATION, X-LINKED 58	0.0030581	0.11472813902975054
H SYNDROME	0.0030581	0.11472813902975054
%300115 MENTAL RETARDATION, X-LINKED 50; MRX50	0.0030581	0.11472813902975054
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0030581	0.11472813902975054
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.0030581	0.11472813902975054
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0030581	0.11472813902975054
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0030581	0.11472813902975054
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0030581	0.11472813902975054
ERMINE PHENOTYPE	0.0030581	0.11472813902975054
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0030581	0.11472813902975054
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0030581	0.11472813902975054
DISTAL MONOSOMY 6P	0.0030581	0.11472813902975054
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0030581	0.11472813902975054
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0030581	0.11472813902975054
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0030581	0.11472813902975054
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0030581	0.11472813902975054
HEMIHYPERPLASIA, ISOLATED	0.0030581	0.11472813902975054
ALOPECIA-INTELLECTUAL DISABILITY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.0030581	0.11472813902975054
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.0030581	0.11472813902975054
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.0030581	0.11472813902975054
NAKAJO-NISHIMURA SYNDROME	0.0030581	0.11472813902975054
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0030581	0.11472813902975054
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0030581	0.11472813902975054
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.0030581	0.11472813902975054
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0030581	0.11472813902975054
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.0030581	0.11472813902975054
OTOONYCHOPERONEAL SYNDROME	0.0030581	0.11472813902975054
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0030581	0.11472813902975054
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0030581	0.11472813902975054
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0030581	0.11472813902975054
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0030581	0.11472813902975054
MIRROR MOVEMENTS 1; MRMV1	0.0030581	0.11472813902975054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0030581	0.11472813902975054
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.0030581	0.11472813902975054
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.0030581	0.11472813902975054
OTOPALATODIGITAL SYNDROME TYPE 1	0.0030581	0.11472813902975054
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.0030581	0.11472813902975054
RFT1-CDG	0.0030554090000000002	0.11462718306947163
KRABBE DISEASE	0.0030554090000000002	0.11462718306947163
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0030554090000000002	0.11462718306947163
ADRENOMYODYSTROPHY	0.003055409	0.1146271830694716
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.003055409	0.1146271830694716
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.003055409	0.1146271830694716
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003038924	0.11400872933286868
JOHANSON-BLIZZARD SYNDROME	0.003038924	0.11400872933286868
MARDEN-WALKER SYNDROME	0.003038924	0.11400872933286868
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.0030389239999999997	0.11400872933286865
MATTHEW-WOOD SYNDROME	0.0030389239999999997	0.11400872933286865
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.0030389239999999997	0.11400872933286865
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.003032007	0.11374923012170202
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.003032007	0.11374923012170202
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.003032007	0.11374923012170202
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0030320069999999998	0.113749230121702
DUPLICATION/INVERSION 15Q11	0.0030320069999999998	0.113749230121702
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0030320069999999998	0.113749230121702
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0030320069999999998	0.113749230121702
TETRASOMY 9P	0.0030320069999999998	0.113749230121702
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.003015522	0.11313077638509907
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.003015522	0.11313077638509907
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.003015522	0.11313077638509907
IMMUNODEFICIENCY 23; IMD23	0.0030155219999999996	0.11313077638509905
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0030155219999999996	0.11313077638509905
WARSAW BREAKAGE SYNDROME; WABS	0.0030155219999999996	0.11313077638509905
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0030155219999999996	0.11313077638509905
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0030155219999999996	0.11313077638509905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0030155219999999996	0.11313077638509905
AU-KLINE SYNDROME; AUKS	0.0030155219999999996	0.11313077638509905
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0028160499999999996	0.10564735486567772
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0028160499999999996	0.10564735486567772
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0028160499999999996	0.10564735486567772
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0028160499999999996	0.10564735486567772
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0028160499999999996	0.10564735486567772
TREACHER-COLLINS SYNDROME	0.0028160499999999996	0.10564735486567772
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.0028160499999999996	0.10564735486567772
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0028160499999999996	0.10564735486567772
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.002789957	0.10466844595762917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002789957	0.10466844595762917
COFFIN-SIRIS SYNDROME 8; CSS8	0.002789957	0.10466844595762917
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.002789957	0.10466844595762917
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.002789957	0.10466844595762917
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002789957	0.10466844595762917
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002789957	0.10466844595762917
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002789957	0.10466844595762917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002789957	0.10466844595762917
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.002789957	0.10466844595762917
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002789957	0.10466844595762917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002789957	0.10466844595762917
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.002789957	0.10466844595762917
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002789957	0.10466844595762917
INFANTILE LIVER FAILURE SYNDROME 1	0.002789957	0.10466844595762917
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002789957	0.10466844595762917
DDOST-CDG	0.002789957	0.10466844595762917
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.002789957	0.10466844595762917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002789957	0.10466844595762917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002789957	0.10466844595762917
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002789957	0.10466844595762917
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.002789957	0.10466844595762917
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.002789957	0.10466844595762917
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002773472	0.10404999222102625
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.002773472	0.10404999222102625
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002773472	0.10404999222102625
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.002773472	0.10404999222102625
JACOBSEN SYNDROME	0.002773472	0.10404999222102625
XIA-GIBBS SYNDROME	0.002773472	0.10404999222102625
SHWACHMAN-DIAMOND SYNDROME	0.002773472	0.10404999222102625
MARINESCO-SJOGREN SYNDROME; MSS	0.002773472	0.10404999222102625
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00275604	0.10339601069015197
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00275604	0.10339601069015197
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00275604	0.10339601069015197
MOEBIUS SYNDROME	0.00275604	0.10339601069015197
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00275604	0.10339601069015197
NOONAN SYNDROME	0.00275604	0.10339601069015197
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0027299470000000004	0.10241710178210343
VISCERAL STEATOSIS, CONGENITAL	0.0027299470000000004	0.10241710178210343
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0027299470000000004	0.10241710178210343
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0027299470000000004	0.10241710178210343
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0027299470000000004	0.10241710178210343
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0027299470000000004	0.10241710178210343
XYLOSIDASE DEFICIENCY	0.0027299470000000004	0.10241710178210343
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0027299470000000004	0.10241710178210343
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0027299470000000004	0.10241710178210343
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002729947	0.1024171017821034
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002729947	0.1024171017821034
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.002729947	0.1024171017821034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002729947	0.1024171017821034
GM2-GANGLIOSIDOSIS, AB VARIANT	0.002729947	0.1024171017821034
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.002729947	0.1024171017821034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002729947	0.1024171017821034
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0027134620000000003	0.10179864804550048
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0027134620000000003	0.10179864804550048
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0027134620000000003	0.10179864804550048
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0027134620000000003	0.10179864804550048
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0027134620000000003	0.10179864804550048
SPINOCEREBELLAR ATAXIA 13	0.0027134620000000003	0.10179864804550048
MUCOLIPIDOSIS IV; ML4	0.002713462	0.10179864804550048
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.002713462	0.10179864804550048
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.002713462	0.10179864804550048
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002713462	0.10179864804550048
JOUBERT SYNDROME 3; JBTS3	0.002713462	0.10179864804550048
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.002713462	0.10179864804550048
LESCH-NYHAN SYNDROME; LNS	0.002713462	0.10179864804550048
JOUBERT SYNDROME 6	0.002713462	0.10179864804550048
JOUBERT SYNDROME 5	0.002713462	0.10179864804550048
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002713462	0.10179864804550048
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.002713462	0.10179864804550048
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.002713462	0.10179864804550048
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.002595403	0.09736952886505729
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.002595403	0.09736952886505729
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0025954029999999996	0.09736952886505727
MATERNAL PHENYLKETONURIA	0.0025954029999999996	0.09736952886505727
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0025954029999999996	0.09736952886505727
RENPENNING SYNDROME 1; RENS1	0.0025954029999999996	0.09736952886505727
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0025954029999999996	0.09736952886505727
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0025954029999999996	0.09736952886505727
SECKEL SYNDROME 1; SCKL1	0.0025954029999999996	0.09736952886505727
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0025954029999999996	0.09736952886505727
PFEIFFER SYNDROME TYPE 3	0.0025954029999999996	0.09736952886505727
PFEIFFER SYNDROME TYPE 2	0.0025954029999999996	0.09736952886505727
CHROMOSOME 1P35 DELETION SYNDROME	0.0025954029999999996	0.09736952886505727
CORNELIA DE LANGE SYNDROME 3	0.0025954029999999996	0.09736952886505727
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0025954029999999996	0.09736952886505727
OROFACIODIGITAL SYNDROME I; OFD1	0.0025954029999999996	0.09736952886505727
15Q24 MICRODELETION SYNDROME	0.0025954029999999996	0.09736952886505727
8P11.2 DELETION SYNDROME	0.0025954029999999996	0.09736952886505727
ZIMMERMANN-LABAND SYNDROME	0.0025954029999999996	0.09736952886505727
GLASS SYNDROME	0.0025954029999999996	0.09736952886505727
OROFACIODIGITAL SYNDROME TYPE 1	0.0025954029999999996	0.09736952886505727
FRYNS SYNDROME	0.0025954029999999996	0.09736952886505727
DUBOWITZ SYNDROME	0.0025954029999999996	0.09736952886505727
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025954029999999996	0.09736952886505727
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0025954029999999996	0.09736952886505727
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0025954029999999996	0.09736952886505727
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00251399	0.09431522652607913
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00251399	0.09431522652607913
PEARSON SYNDROME	0.00251399	0.09431522652607913
ISOLATED COMPLEX I DEFICIENCY	0.00251399	0.09431522652607913
INFANTILE SYSTEMIC HYALINOSIS	0.00251399	0.09431522652607913
IMMUNODEFICIENCY 9; IMD9	0.00251399	0.09431522652607913
HAWKINSINURIA	0.00251399	0.09431522652607913
HYPERCALCEMIA, INFANTILE 2	0.00251399	0.09431522652607913
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.002490588	0.09343727357830954
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.002490588	0.09343727357830954
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002490588	0.09343727357830954
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.002490588	0.09343727357830954
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.002490588	0.09343727357830954
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.002490588	0.09343727357830954
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002490588	0.09343727357830954
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.002490588	0.09343727357830954
LATERAL MENINGOCELE SYNDROME	0.002490588	0.09343727357830954
CHROMOSOME 17P13.1 DELETION SYNDROME	0.002490588	0.09343727357830954
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.002490588	0.09343727357830954
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002490588	0.09343727357830954
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002490588	0.09343727357830954
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.002490588	0.09343727357830954
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.002490588	0.09343727357830954
MYOPATHY, CENTRONUCLEAR, 5	0.002490588	0.09343727357830954
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.002490588	0.09343727357830954
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.002490588	0.09343727357830954
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.002490588	0.09343727357830954
CAP MYOPATHY	0.002490588	0.09343727357830954
EDINBURGH MALFORMATION SYNDROME	0.002353353	0.08828874470098445
COG8-CDG	0.002353353	0.08828874470098445
OCULOCEREBRORENAL SYNDROME OF LOWE	0.002353353	0.08828874470098445
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.002353353	0.08828874470098445
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.002353353	0.08828874470098445
PITUITARY STALK INTERRUPTION SYNDROME	0.002353353	0.08828874470098445
CITRULLINEMIA, CLASSIC	0.002353353	0.08828874470098445
ARGININOSUCCINIC ACIDURIA	0.002353353	0.08828874470098445
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002353353	0.08828874470098445
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002353353	0.08828874470098445
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002353353	0.08828874470098445
HYPERLEUCINE-ISOLEUCINEMIA	0.002353353	0.08828874470098445
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.002353353	0.08828874470098445
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002353353	0.08828874470098445
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.002353353	0.08828874470098445
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.002353353	0.08828874470098445
RAMON SYNDROME	0.002353353	0.08828874470098445
LOWE OCULOCEREBRORENAL SYNDROME	0.002353353	0.08828874470098445
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.002353353	0.08828874470098445
ALG11-CDG	0.002353353	0.08828874470098445
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002293343	0.0860374005254587
ISOLATED SPINA BIFIDA	0.002293343	0.0860374005254587
LEBER CONGENITAL AMAUROSIS	0.002293343	0.0860374005254587
1P36 MICRODELETION SYNDROME	0.002293343	0.0860374005254587
DPAGT1-CDG	0.002293343	0.0860374005254587
MEVALONIC ACIDURIA	0.002293343	0.0860374005254587
MAPLE SYRUP URINE DISEASE	0.002293343	0.0860374005254587
SEVERE CANAVAN DISEASE	0.002293343	0.0860374005254587
15Q11Q13 MICRODUPLICATION SYNDROME	0.002293343	0.0860374005254587
CAMOS SYNDROME	0.002293343	0.0860374005254587
DYSEQUILIBRIUM SYNDROME	0.002293343	0.0860374005254587
ISOLATED GLYCEROL KINASE DEFICIENCY	0.002293343	0.0860374005254587
ACROCARDIOFACIAL SYNDROME	0.0022933429999999998	0.08603740052545868
CONGENITAL RUBELLA SYNDROME	0.0022933429999999998	0.08603740052545868
HARTNUP DISEASE	0.0022933429999999998	0.08603740052545868
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.08603740052545868
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0022933429999999998	0.08603740052545868
22Q11.2 MICRODUPLICATION SYNDROME	0.0022933429999999998	0.08603740052545868
GRISCELLI SYNDROME	0.0022933429999999998	0.08603740052545868
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.08603740052545868
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.08603740052545868
49,XXXXY SYNDROME	0.0022933429999999998	0.08603740052545868
POTOCKI-SHAFFER SYNDROME	0.0022933429999999998	0.08603740052545868
WALKER-WARBURG SYNDROME	0.0022933429999999998	0.08603740052545868
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0022933429999999998	0.08603740052545868
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0022933429999999998	0.08603740052545868
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0022933429999999998	0.08603740052545868
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0022933429999999998	0.08603740052545868
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0022933429999999998	0.08603740052545868
COFFIN-SIRIS SYNDROME	0.0022933429999999998	0.08603740052545868
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0022933429999999998	0.08603740052545868
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0022933429999999998	0.08603740052545868
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0022933429999999998	0.08603740052545868
2Q31.1 MICRODELETION SYNDROME	0.0022933429999999998	0.08603740052545868
SIALIDOSIS TYPE 1	0.0022933429999999998	0.08603740052545868
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
LINEAR NEVUS SEBACEUS SYNDROME	0.0022933429999999998	0.08603740052545868
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME WITH RENAL DEFECT	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0022933429999999998	0.08603740052545868
INCONTINENTIA PIGMENTI	0.0022933429999999998	0.08603740052545868
DISTAL MONOSOMY 19P13.3	0.0022933429999999998	0.08603740052545868
SJÖGREN-LARSSON SYNDROME	0.0022933429999999998	0.08603740052545868
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.0022933429999999998	0.08603740052545868
SMITH-LEMLI-OPITZ SYNDROME	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME	0.0022933429999999998	0.08603740052545868
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0022933429999999998	0.08603740052545868
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.002248538	0.08435648941423671
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002248538	0.08435648941423671
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.002248538	0.08435648941423671
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.002248538	0.08435648941423671
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002248538	0.08435648941423671
MULTIMINICORE MYOPATHY	0.002248538	0.08435648941423671
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.002248538	0.08435648941423671
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.002248538	0.08435648941423671
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.002248538	0.08435648941423671
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.002248538	0.08435648941423671
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.002248538	0.08435648941423671
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.002248538	0.08435648941423671
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.002248538	0.08435648941423671
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.002248538	0.08435648941423671
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.002248538	0.08435648941423671
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.002248538	0.08435648941423671
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002248538	0.08435648941423671
NAVAJO NEUROHEPATOPATHY	0.002248538	0.08435648941423671
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.002248538	0.08435648941423671
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.002248538	0.08435648941423671
CEREBELLAR HYPOPLASIA	0.0021885280000000003	0.08210514523871096
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0021885280000000003	0.08210514523871096
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0021885280000000003	0.08210514523871096
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0021885280000000003	0.08210514523871096
SENGERS SYNDROME	0.0021885280000000003	0.08210514523871096
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0021885280000000003	0.08210514523871096
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021885280000000003	0.08210514523871096
GLYCOGEN STORAGE DISEASE II	0.0021885280000000003	0.08210514523871096
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0021885280000000003	0.08210514523871096
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0021885280000000003	0.08210514523871096
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0021885280000000003	0.08210514523871096
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0021885280000000003	0.08210514523871096
STUVE-WIEDEMANN SYNDROME	0.0021885280000000003	0.08210514523871096
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0021885280000000003	0.08210514523871096
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0021885280000000003	0.08210514523871096
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0021885280000000003	0.08210514523871096
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0021885280000000003	0.08210514523871096
OPSISMODYSPLASIA; OPSMD	0.0021885280000000003	0.08210514523871096
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0021885280000000003	0.08210514523871096
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0021885280000000003	0.08210514523871096
RITSCHER-SCHINZEL SYNDROME 1	0.0021885280000000003	0.08210514523871096
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0021885280000000003	0.08210514523871096
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0021885280000000003	0.08210514523871096
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0021885280000000003	0.08210514523871096
CRANIOFRONTONASAL SYNDROME; CFNS	0.0021885280000000003	0.08210514523871096
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0021885280000000003	0.08210514523871096
PIERSON SYNDROME	0.0021885280000000003	0.08210514523871096
PSEUDOTRISOMY 13 SYNDROME	0.0021885280000000003	0.08210514523871096
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0021885280000000003	0.08210514523871096
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0021885280000000003	0.08210514523871096
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0021885280000000003	0.08210514523871096
CHIARI MALFORMATION TYPE II	0.0021885280000000003	0.08210514523871096
ACID PHOSPHATASE DEFICIENCY	0.0021885280000000003	0.08210514523871096
GLYCOGEN STORAGE DISEASE IXC	0.0021885280000000003	0.08210514523871096
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0021885280000000003	0.08210514523871096
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0021885280000000003	0.08210514523871096
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0021885280000000003	0.08210514523871096
CRANIOSYNOSTOSIS 6; CRS6	0.0021885280000000003	0.08210514523871096
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0021885280000000003	0.08210514523871096
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0021885280000000003	0.08210514523871096
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0021885280000000003	0.08210514523871096
SPINOCEREBELLAR ATAXIA 1	0.0021885280000000003	0.08210514523871096
MICROPHTHALMIA, SYNDROMIC 3	0.0021885280000000003	0.08210514523871096
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.002070469	0.07767602605826776
HYPEREKPLEXIA 4; HKPX4	0.002070469	0.07767602605826776
CATEL-MANZKE SYNDROME; CATMANS	0.002070469	0.07767602605826776
PERRAULT SYNDROME 5; PRLTS5	0.002070469	0.07767602605826776
CRISPONI SYNDROME	0.002070469	0.07767602605826776
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.002070469	0.07767602605826776
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.002070469	0.07767602605826776
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002070469	0.07767602605826776
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.002070469	0.07767602605826776
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.002070469	0.07767602605826776
LIPOID PROTEINOSIS	0.002070469	0.07767602605826776
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.002070469	0.07767602605826776
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.002070469	0.07767602605826776
RABSON-MENDENHALL SYNDROME	0.002053984	0.07705757232166481
PSEUDOAMINOPTERIN SYNDROME	0.002053984	0.07705757232166481
ALAZAMI-YUAN SYNDROME	0.002053984	0.07705757232166481
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.002053984	0.07705757232166481
MENTAL RETARDATION, X-LINKED 2	0.002053984	0.07705757232166481
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.002053984	0.07705757232166481
MENTAL RETARDATION, X-LINKED 45	0.002053984	0.07705757232166481
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.002053984	0.07705757232166481
SECKEL SYNDROME 5; SCKL5	0.002053984	0.07705757232166481
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002053984	0.07705757232166481
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.002053984	0.07705757232166481
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002053984	0.07705757232166481
POLYVALVULAR HEART DISEASE SYNDROME	0.002053984	0.07705757232166481
MONOSOMY 22	0.002053984	0.07705757232166481
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.002053984	0.07705757232166481
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.002053984	0.07705757232166481
FRONTOMETAPHYSEAL DYSPLASIA	0.002053984	0.07705757232166481
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.002053984	0.07705757232166481
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.002053984	0.07705757232166481
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.002053984	0.07705757232166481
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.002053984	0.07705757232166481
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.002053984	0.07705757232166481
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.002053984	0.07705757232166481
FEINGOLD SYNDROME 1; FGLDS1	0.002053984	0.07705757232166481
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.002053984	0.07705757232166481
FRASER SYNDROME	0.002053984	0.07705757232166481
OTOFACIOCERVICAL SYNDROME	0.002053984	0.07705757232166481
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.002053984	0.07705757232166481
ROBERTS SYNDROME; RBS	0.002053984	0.07705757232166481
MOSAIC TRISOMY 9	0.002053984	0.07705757232166481
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002027891	0.07607866341361626
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.002027891	0.07607866341361626
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002027891	0.07607866341361626
JOUBERT SYNDROME 30; JBTS30	0.002027891	0.07607866341361626
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002027891	0.07607866341361626
ADENYLOSUCCINATE LYASE DEFICIENCY	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.002027891	0.07607866341361626
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002027891	0.07607866341361626
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002027891	0.07607866341361626
HOLOPROSENCEPHALY 1; HPE1	0.002027891	0.07607866341361626
MENTAL RETARDATION, X-LINKED 1	0.002027891	0.07607866341361626
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002027891	0.07607866341361626
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002027891	0.07607866341361626
XQ25 DUPLICATION SYNDROME	0.002027891	0.07607866341361626
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002027891	0.07607866341361626
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002027891	0.07607866341361626
TENORIO SYNDROME; TNORS	0.002027891	0.07607866341361626
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002027891	0.07607866341361626
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002027891	0.07607866341361626
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002027891	0.07607866341361626
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002027891	0.07607866341361626
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002027891	0.07607866341361626
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002027891	0.07607866341361626
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002027891	0.07607866341361626
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.002027891	0.07607866341361626
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002027891	0.07607866341361626
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002027891	0.07607866341361626
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.002027891	0.07607866341361626
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002027891	0.07607866341361626
COFFIN-SIRIS SYNDROME 2; CSS2	0.002027891	0.07607866341361626
COFFIN-SIRIS SYNDROME 3; CSS3	0.002027891	0.07607866341361626
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.002027891	0.07607866341361626
COFFIN-SIRIS SYNDROME 4; CSS4	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002027891	0.07607866341361626
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002027891	0.07607866341361626
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002027891	0.07607866341361626
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.002027891	0.07607866341361626
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002027891	0.07607866341361626
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002027891	0.07607866341361626
AICARDI-GOUTIERES SYNDROME 7	0.002027891	0.07607866341361626
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.002027891	0.07607866341361626
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.002027891	0.07607866341361626
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.002027891	0.07607866341361626
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002027891	0.07607866341361626
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002027891	0.07607866341361626
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.002027891	0.07607866341361626
GRISCELLI SYNDROME TYPE 1	0.002027891	0.07607866341361626
IMMUNODEFICIENCY 49; IMD49	0.002027891	0.07607866341361626
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002027891	0.07607866341361626
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.002027891	0.07607866341361626
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002027891	0.07607866341361626
TIMOTHY SYNDROME; TS	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002027891	0.07607866341361626
SHASHI-PENA SYNDROME; SHAPNS	0.002027891	0.07607866341361626
LISSENCEPHALY 5; LIS5	0.002027891	0.07607866341361626
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002027891	0.07607866341361626
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.002027891	0.07607866341361626
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.002027891	0.07607866341361626
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002027891	0.07607866341361626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002027891	0.07607866341361626
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002027891	0.07607866341361626
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002027891	0.07607866341361626
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002027891	0.07607866341361626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002027891	0.07607866341361626
ADENYLOSUCCINASE DEFICIENCY	0.002027891	0.07607866341361626
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002027891	0.07607866341361626
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001828419	0.06859524189419491
NEPHROGENIC DIABETES INSIPIDUS	0.001828419	0.06859524189419491
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.001828419	0.06859524189419491
CONGENITAL DISORDER OF GLYCOSYLATION	0.001828419	0.06859524189419491
ATAXIA-TELANGIECTASIA	0.001828419	0.06859524189419491
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.06859524189419491
HISTIOCYTOID CARDIOMYOPATHY	0.001828419	0.06859524189419491
HYPER-BETA-ALANINEMIA	0.001828419	0.06859524189419491
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001828419	0.06859524189419491
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.001828419	0.06859524189419491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001828419	0.06859524189419491
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001828419	0.06859524189419491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001828419	0.06859524189419491
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419491
ECTODERMAL DYSPLASIA SYNDROME	0.001828419	0.06859524189419491
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001828419	0.06859524189419491
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001828419	0.06859524189419491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001828419	0.06859524189419491
PROPIONIC ACIDEMIA	0.001828419	0.06859524189419491
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.001828419	0.06859524189419491
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.06859524189419491
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001828419	0.06859524189419491
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001828419	0.06859524189419491
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001828419	0.06859524189419491
GAUCHER DISEASE, TYPE II	0.001828419	0.06859524189419491
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419491
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001828419	0.06859524189419491
SANDHOFF DISEASE	0.001828419	0.06859524189419491
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001828419	0.06859524189419491
MOGS-CDG	0.001828419	0.06859524189419491
COPPER DEFICIENCY, FAMILIAL BENIGN	0.001828419	0.06859524189419491
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001828419	0.06859524189419491
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001828419	0.06859524189419491
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001828419	0.06859524189419491
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001828419	0.06859524189419491
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.001828419	0.06859524189419491
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0018119339999999999	0.06797678815759198
NOONAN SYNDROME 8; NS8	0.0018119339999999999	0.06797678815759198
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0018119339999999999	0.06797678815759198
FACIOCARDIORENAL SYNDROME	0.0018119339999999999	0.06797678815759198
OTOPALATODIGITAL SYNDROME TYPE 2	0.0018119339999999999	0.06797678815759198
CHYLOMICRON RETENTION DISEASE	0.0018119339999999999	0.06797678815759198
JOHNSON NEUROECTODERMAL SYNDROME	0.0018119339999999999	0.06797678815759198
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.0018119339999999999	0.06797678815759198
KAPUR-TORIELLO SYNDROME	0.0018119339999999999	0.06797678815759198
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0018119339999999999	0.06797678815759198
ELLIS VAN CREVELD SYNDROME	0.0018119339999999999	0.06797678815759198
FARBER DISEASE	0.0018119339999999999	0.06797678815759198
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0018119339999999999	0.06797678815759198
HOYERAAL-HREIDARSSON SYNDROME	0.0018119339999999999	0.06797678815759198
PSEUDOPROGERIA SYNDROME	0.0018119339999999999	0.06797678815759198
GALACTOSEMIA	0.0018119339999999999	0.06797678815759198
TOWNES-BROCKS SYNDROME	0.0018119339999999999	0.06797678815759198
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0018119339999999999	0.06797678815759198
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0018119339999999999	0.06797678815759198
MPDU1-CDG	0.001768409	0.06634389771866916
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06634389771866916
TRIPLE A SYNDROME	0.001768409	0.06634389771866916
ALG3-CDG	0.001768409	0.06634389771866916
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.001768409	0.06634389771866916
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001768409	0.06634389771866916
COFS SYNDROME	0.001768409	0.06634389771866916
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06634389771866916
MUSCLE-EYE-BRAIN DISEASE	0.001768409	0.06634389771866916
ONDINE SYNDROME	0.001768409	0.06634389771866916
DPM1-CDG	0.001768409	0.06634389771866916
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001768409	0.06634389771866916
20P12.3 MICRODELETION SYNDROME	0.001768409	0.06634389771866916
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06634389771866916
ALG9-CDG	0.001768409	0.06634389771866916
CENTRONUCLEAR MYOPATHY	0.001768409	0.06634389771866916
CANAVAN DISEASE	0.001768409	0.06634389771866916
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06634389771866916
LEIGH SYNDROME	0.001768409	0.06634389771866916
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06634389771866916
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001768409	0.06634389771866916
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06634389771866916
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06634389771866916
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06634389771866916
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.001768409	0.06634389771866916
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.001768409	0.06634389771866916
PHACE SYNDROME	0.001768409	0.06634389771866916
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001768409	0.06634389771866916
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001768409	0.06634389771866916
CHARGE SYNDROME	0.0017519240000000002	0.06572544398206623
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.0017519240000000002	0.06572544398206623
JUNG SYNDROME	0.0017519240000000002	0.06572544398206623
SMITH-MAGENIS SYNDROME	0.0017519240000000002	0.06572544398206623
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0017519240000000002	0.06572544398206623
9Q SUBTELOMERIC DELETION SYNDROME	0.0017519240000000002	0.06572544398206623
PERMANENT CONGENITAL HYPOTHYROIDISM	0.0017519240000000002	0.06572544398206623
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0017519240000000002	0.06572544398206623
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0017519240000000002	0.06572544398206623
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0017519240000000002	0.06572544398206623
PIEBALDISM	0.0017519240000000002	0.06572544398206623
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.0017519240000000002	0.06572544398206623
HURLER SYNDROME	0.0017519240000000002	0.06572544398206623
ARTERIAL TORTUOSITY SYNDROME	0.0017519240000000002	0.06572544398206623
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0017519240000000002	0.06572544398206623
ALPHA-MANNOSIDOSIS	0.0017519240000000002	0.06572544398206623
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.0017519240000000002	0.06572544398206623
MARINESCO-SJÖGREN SYNDROME	0.0017519240000000002	0.06572544398206623
OROFACIODIGITAL SYNDROME TYPE 14	0.0017519240000000002	0.06572544398206623
PENTASOMY X	0.0017519240000000002	0.06572544398206623
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0017519240000000002	0.06572544398206623
MUCOLIPIDOSIS TYPE IV	0.0017519240000000002	0.06572544398206623
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0017519240000000002	0.06572544398206623
MONOSOMY 13Q14	0.0017519240000000002	0.06572544398206623
COOPER-JABS SYNDROME	0.0017519240000000002	0.06572544398206623
LAURIN-SANDROW SYNDROME	0.0017519240000000002	0.06572544398206623
GOLDENHAR SYNDROME	0.0017519240000000002	0.06572544398206623
FAMILIAL THYROID DYSHORMONOGENESIS	0.0017519240000000002	0.06572544398206623
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
VELOCARDIOFACIAL SYNDROME	0.0017519240000000002	0.06572544398206623
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00152905	0.05736406951487527
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00152905	0.05736406951487527
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00152905	0.05736406951487527
SAY-BARBER-MILLER SYNDROME	0.00152905	0.05736406951487527
NON-DISTAL TRISOMY 10Q	0.00152905	0.05736406951487527
NON-DISTAL TRISOMY 13Q	0.00152905	0.05736406951487527
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00152905	0.05736406951487527
PFEIFFER SYNDROME TYPE 1	0.00152905	0.05736406951487527
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00152905	0.05736406951487527
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00152905	0.05736406951487527
TYPICAL NEMALINE MYOPATHY	0.00152905	0.05736406951487527
ADULT-ONSET NEMALINE MYOPATHY	0.00152905	0.05736406951487527
DISTAL TRISOMY 18Q	0.00152905	0.05736406951487527
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00152905	0.05736406951487527
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00152905	0.05736406951487527
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00152905	0.05736406951487527
SHELDON-HALL SYNDROME	0.00152905	0.05736406951487527
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.00152905	0.05736406951487527
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00152905	0.05736406951487527
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00152905	0.05736406951487527
ULBRIGHT-HODES SYNDROME	0.00152905	0.05736406951487527
OROFACIODIGITAL SYNDROME IV; OFD4	0.00152905	0.05736406951487527
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00152905	0.05736406951487527
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00152905	0.05736406951487527
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00152905	0.05736406951487527
LOEYS-DIETZ SYNDROME 3; LDS3	0.00152905	0.05736406951487527
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00152905	0.05736406951487527
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00152905	0.05736406951487527
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00152905	0.05736406951487527
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00152905	0.05736406951487527
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00152905	0.05736406951487527
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00152905	0.05736406951487527
EMERY-NELSON SYNDROME	0.00152905	0.05736406951487527
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00152905	0.05736406951487527
BRANCHIOOTORENAL SYNDROME 1	0.00152905	0.05736406951487527
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00152905	0.05736406951487527
LANGER MESOMELIC DYSPLASIA	0.00152905	0.05736406951487527
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00152905	0.05736406951487527
HAMAMY SYNDROME; HMMS	0.00152905	0.05736406951487527
RAINE SYNDROME	0.00152905	0.05736406951487527
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00152905	0.05736406951487527
MYOPATHY, DISTAL, 1; MPD1	0.00152905	0.05736406951487527
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00152905	0.05736406951487527
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00152905	0.05736406951487527
PFEIFFER SYNDROME	0.00152905	0.05736406951487527
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00152905	0.05736406951487527
GORDON SYNDROME	0.00152905	0.05736406951487527
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00152905	0.05736406951487527
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00152905	0.05736406951487527
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00152905	0.05736406951487527
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00152905	0.05736406951487527
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00152905	0.05736406951487527
LAING EARLY-ONSET DISTAL MYOPATHY	0.00152905	0.05736406951487527
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00152905	0.05736406951487527
ATELOSTEOGENESIS TYPE III	0.00152905	0.05736406951487527
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00152905	0.05736406951487527
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00152905	0.05736406951487527
FRONTOMETAPHYSEAL DYSPLASIA	0.00152905	0.05736406951487527
NEMALINE MYOPATHY 1; NEM1	0.00152905	0.05736406951487527
MARSHALL SYNDROME	0.00152905	0.05736406951487527
NEU-LAXOVA SYNDROME 2; NLS2	0.00152905	0.05736406951487527
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00152905	0.05736406951487527
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00152905	0.05736406951487527
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00152905	0.05736406951487527
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00152905	0.05736406951487527
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00152905	0.05736406951487527
TRISOMY 8Q	0.00152905	0.05736406951487527
OROFACIODIGITAL SYNDROME IX; OFD9	0.00152905	0.05736406951487527
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00152905	0.05736406951487527
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00152905	0.05736406951487527
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00152905	0.05736406951487527
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00152905	0.05736406951487527
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00152905	0.05736406951487527
HYPOGLOSSIA WITH SITUS INVERSUS	0.00152905	0.05736406951487527
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00152905	0.05736406951487527
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00152905	0.05736406951487527
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00152905	0.05736406951487527
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00152905	0.05736406951487527
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00152905	0.05736406951487527
PSEUDOXANTHOMA ELASTICUM	0.00152905	0.05736406951487527
9P13 MICRODELETION SYNDROME	0.00152905	0.05736406951487527
OCULOCUTANEOUS ALBINISM TYPE 5	0.00152905	0.05736406951487527
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00152905	0.05736406951487527
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00152905	0.05736406951487527
EVEN-PLUS SYNDROME	0.00152905	0.05736406951487527
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00152905	0.05736406951487527
SWEENEY-COX SYNDROME; SWCOS	0.00152905	0.05736406951487527
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00152905	0.05736406951487527
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00152905	0.05736406951487527
LERI-WEILL DYSCHONDROSTEOSIS	0.00152905	0.05736406951487527
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00152905	0.05736406951487527
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00152905	0.05736406951487527
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00152905	0.05736406951487527
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00152905	0.05736406951487527
CZEIZEL-LOSONCI SYNDROME	0.00152905	0.05736406951487527
ACRORENAL-MANDIBULAR SYNDROME	0.00152905	0.05736406951487527
ASCHER SYNDROME	0.00152905	0.05736406951487527
RHIZOMELIC SYNDROME, URBACH TYPE	0.00152905	0.05736406951487527
RIN2 SYNDROME	0.00152905	0.05736406951487527
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00152905	0.05736406951487527
BRANCHIO-OCULO-FACIAL SYNDROME	0.00152905	0.05736406951487527
ACRO-RENAL-MANDIBULAR SYNDROME	0.00152905	0.05736406951487527
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00152905	0.05736406951487527
MANDIBULOACRAL DYSPLASIA	0.00152905	0.05736406951487527
608028 THAI SYMPHALANGISM SYNDROME	0.00152905	0.05736406951487527
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00152905	0.05736406951487527
NOONAN SYNDROME 3; NS3	0.00152905	0.05736406951487527
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00152905	0.05736406951487527
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00152905	0.05736406951487527
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00152905	0.05736406951487527
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001502957	0.056385160606826724
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001502957	0.056385160606826724
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001502957	0.056385160606826724
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.001502957	0.056385160606826724
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001502957	0.056385160606826724
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001502957	0.056385160606826724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.001502957	0.056385160606826724
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001502957	0.056385160606826724
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001502957	0.056385160606826724
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001502957	0.056385160606826724
TAY-SACHS DISEASE; TSD	0.001502957	0.056385160606826724
SULFOCYSTEINURIA	0.001502957	0.056385160606826724
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001502957	0.056385160606826724
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001502957	0.056385160606826724
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001502957	0.056385160606826724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001502957	0.056385160606826724
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001502957	0.056385160606826724
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001502957	0.056385160606826724
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001502957	0.056385160606826724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001502957	0.056385160606826724
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001502957	0.056385160606826724
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001502957	0.056385160606826724
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001502957	0.056385160606826724
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.056385160606826724
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001502957	0.056385160606826724
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001502957	0.056385160606826724
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.001502957	0.056385160606826724
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.001502957	0.056385160606826724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001502957	0.056385160606826724
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.001502957	0.056385160606826724
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001502957	0.056385160606826724
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001502957	0.056385160606826724
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.056385160606826724
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001502957	0.056385160606826724
PSEUDO-TORCH SYNDROME 2	0.001502957	0.056385160606826724
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001502957	0.056385160606826724
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001502957	0.056385160606826724
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001502957	0.056385160606826724
SHUKLA-VERNON SYNDROME; SHUVER	0.001502957	0.056385160606826724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001502957	0.056385160606826724
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001502957	0.056385160606826724
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.056385160606826724
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001502957	0.056385160606826724
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001502957	0.056385160606826724
RING CHROMOSOME 22 SYNDROME	0.001502957	0.056385160606826724
SIALIDOSIS TYPE 2	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001502957	0.056385160606826724
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001502957	0.056385160606826724
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001502957	0.056385160606826724
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.056385160606826724
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001502957	0.056385160606826724
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001502957	0.056385160606826724
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001502957	0.056385160606826724
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.001502957	0.056385160606826724
GLUTAMINE DEFICIENCY, CONGENITAL	0.001502957	0.056385160606826724
ADAMS-OLIVER SYNDROME 2; AOS2	0.001502957	0.056385160606826724
RAPID-ONSET DYSTONIA-PARKINSONISM	0.001502957	0.056385160606826724
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.001502957	0.056385160606826724
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001502957	0.056385160606826724
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001502957	0.056385160606826724
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001502957	0.056385160606826724
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001502957	0.056385160606826724
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.056385160606826724
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.001502957	0.056385160606826724
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.056385160606826724
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.001502957	0.056385160606826724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001502957	0.056385160606826724
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.056385160606826724
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001502957	0.056385160606826724
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.056385160606826724
EPISODIC ATAXIA, TYPE 6	0.001502957	0.056385160606826724
JOUBERT SYNDROME 21	0.001486472	0.05576670687022379
JOUBERT SYNDROME 28	0.001486472	0.05576670687022379
GOLDBERG-SHPRINTZEN SYNDROME	0.001486472	0.05576670687022379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001486472	0.05576670687022379
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.001486472	0.05576670687022379
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001486472	0.05576670687022379
GIANT AXONAL NEUROPATHY	0.001486472	0.05576670687022379
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001486472	0.05576670687022379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001486472	0.05576670687022379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.001486472	0.05576670687022379
JOUBERT SYNDROME 27	0.001486472	0.05576670687022379
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.001486472	0.05576670687022379
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.001486472	0.05576670687022379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001486472	0.05576670687022379
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.001486472	0.05576670687022379
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001486472	0.05576670687022379
JOUBERT SYNDROME 7	0.001486472	0.05576670687022379
JOUBERT SYNDROME 15	0.001486472	0.05576670687022379
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001486472	0.05576670687022379
SIFRIM-HITZ-WEISS SYNDROME	0.001486472	0.05576670687022379
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.001486472	0.05576670687022379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001486472	0.05576670687022379
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.001486472	0.05576670687022379
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001486472	0.05576670687022379
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001486472	0.05576670687022379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.001486472	0.05576670687022379
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001486472	0.05576670687022379
PERIPHERAL HYPOTHYROIDISM	0.001486472	0.05576670687022379
LAMB-SHAFFER SYNDROME	0.001486472	0.05576670687022379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001486472	0.05576670687022379
COFFIN-SIRIS SYNDROME 10; CSS10	0.001486472	0.05576670687022379
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.001486472	0.05576670687022379
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001486472	0.05576670687022379
OPTIC ATROPHY 11; OPA11	0.001486472	0.05576670687022379
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.001486472	0.05576670687022379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001486472	0.05576670687022379
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001486472	0.05576670687022379
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.001486472	0.05576670687022379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001486472	0.05576670687022379
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.001486472	0.05576670687022379
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.001287	0.04828328535080245
MELNICK-NEEDLES SYNDROME	0.001287	0.04828328535080245
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.001287	0.04828328535080245
IMMUNODEFICIENCY 57; IMD57	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.001287	0.04828328535080245
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.001287	0.04828328535080245
MEIER-GORLIN SYNDROME 5; MGORS5	0.001287	0.04828328535080245
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.001287	0.04828328535080245
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.001287	0.04828328535080245
CYSTIC FIBROSIS	0.001287	0.04828328535080245
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.001287	0.04828328535080245
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.001287	0.04828328535080245
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001287	0.04828328535080245
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.001287	0.04828328535080245
ACROOSTEOLYSIS DOMINANT TYPE	0.001287	0.04828328535080245
IMMUNODEFICIENCY 52; IMD52	0.001287	0.04828328535080245
PRUNE BELLY SYNDROME	0.001287	0.04828328535080245
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.001287	0.04828328535080245
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.001287	0.04828328535080245
BARE LYMPHOCYTE SYNDROME, TYPE II	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.001287	0.04828328535080245
FAMILIAL DILATED CARDIOMYOPATHY	0.001287	0.04828328535080245
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.001287	0.04828328535080245
HYPERLIPOPROTEINEMIA, TYPE ID	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 58; IMD58	0.001287	0.04828328535080245
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
SPINOCEREBELLAR ATAXIA TYPE 7	0.001287	0.04828328535080245
DIARRHEA 9; DIAR9	0.001287	0.04828328535080245
CATEL-MANZKE SYNDROME	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
MELORHEOSTOSIS	0.001287	0.04828328535080245
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.001287	0.04828328535080245
IMMUNODEFICIENCY 53; IMD53	0.001287	0.04828328535080245
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.001287	0.04828328535080245
TYROSINEMIA, TYPE I; TYRSN1	0.001287	0.04828328535080245
VALINEMIA	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.001287	0.04828328535080245
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.001287	0.04828328535080245
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001287	0.04828328535080245
MANNOSE-BINDING LECTIN DEFICIENCY	0.001287	0.04828328535080245
PRIMARY PULMONARY HYPOPLASIA	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.001287	0.04828328535080245
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.001287	0.04828328535080245
MULTIPLE OSTEOCHONDROMAS	0.001287	0.04828328535080245
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.001287	0.04828328535080245
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.001287	0.04828328535080245
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.001287	0.04828328535080245
ISOLATED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.001287	0.04828328535080245
APPARENT MINERALOCORTICOID EXCESS	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.001287	0.04828328535080245
ERYTHRODERMA DESQUAMATIVUM	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.001287	0.04828328535080245
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.001287	0.04828328535080245
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
614044 TRYPSINOGEN DEFICIENCY	0.001287	0.04828328535080245
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.001287	0.04828328535080245
FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.001287	0.04828328535080245
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.001287	0.04828328535080245
MEIER-GORLIN SYNDROME 3; MGORS3	0.001287	0.04828328535080245
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.001287	0.04828328535080245
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.001287	0.04828328535080245
BARTH SYNDROME; BTHS	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.001287	0.04828328535080245
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.001287	0.04828328535080245
ATYPICAL WERNER SYNDROME	0.001287	0.04828328535080245
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.001287	0.04828328535080245
MEIER-GORLIN SYNDROME 2; MGORS2	0.001287	0.04828328535080245
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.001287	0.04828328535080245
FREEMAN-SHELDON SYNDROME	0.001287	0.04828328535080245
PROGEROID SYNDROME, PETTY TYPE	0.001287	0.04828328535080245
PSEUDODIASTROPHIC DYSPLASIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.001287	0.04828328535080245
ACTH-DEPENDENT CUSHING SYNDROME	0.001287	0.04828328535080245
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.001287	0.04828328535080245
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.001287	0.04828328535080245
ERYTHRODERMA, LETHAL CONGENITAL	0.001287	0.04828328535080245
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.001287	0.04828328535080245
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.001287	0.04828328535080245
BARBER-SAY SYNDROME	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.001287	0.04828328535080245
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.001287	0.04828328535080245
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.001287	0.04828328535080245
IMMUNODEFICIENCY 46; IMD46	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.001287	0.04828328535080245
BRADDOCK SYNDROME	0.001287	0.04828328535080245
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.001287	0.04828328535080245
IMMUNODEFICIENCY 22; IMD22	0.001287	0.04828328535080245
POPOV-CHANG SYNDROME; POPCHAS	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.001287	0.04828328535080245
HARDIKAR SYNDROME	0.001287	0.04828328535080245
CONGENITAL LETHAL ERYTHRODERMA	0.001287	0.04828328535080245
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.001287	0.04828328535080245
ENTEROKINASE DEFICIENCY	0.001287	0.04828328535080245
OMENN SYNDROME	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.001287	0.04828328535080245
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001287	0.04828328535080245
OROTIC ACIDURIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.001287	0.04828328535080245
RAVINE SYNDROME	0.001287	0.04828328535080245
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
ATRESIA OF SMALL INTESTINE	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.001287	0.04828328535080245
GRAFT VERSUS HOST DISEASE	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001287	0.04828328535080245
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY	0.001287	0.04828328535080245
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA TYPE 1	0.001287	0.04828328535080245
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.001287	0.04828328535080245
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.001287	0.04828328535080245
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.001287	0.04828328535080245
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.001287	0.04828328535080245
MUCOPOLYSACCHARIDOSIS TYPE 6	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.001287	0.04828328535080245
CASPASE 8 DEFICIENCY	0.001287	0.04828328535080245
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.001287	0.04828328535080245
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.001287	0.04828328535080245
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.001287	0.04828328535080245
NEPHROPATHIC INFANTILE CYSTINOSIS	0.001287	0.04828328535080245
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.001287	0.04828328535080245
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.001287	0.04828328535080245
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.001287	0.04828328535080245
ISOTRETINOIN SYNDROME	0.00122699	0.04603194117527669
KENNEDY DISEASE	0.00122699	0.04603194117527669
FETAL METHYLMERCURY SYNDROME	0.00122699	0.04603194117527669
NON-DISTAL MONOSOMY 10Q	0.00122699	0.04603194117527669
TOLUENE EMBRYOPATHY	0.00122699	0.04603194117527669
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04603194117527669
KEARNS-SAYRE SYNDROME	0.00122699	0.04603194117527669
IMAGE SYNDROME	0.00122699	0.04603194117527669
8Q12 MICRODUPLICATION SYNDROME	0.00122699	0.04603194117527669
CENTRAL CORE DISEASE	0.00122699	0.04603194117527669
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04603194117527669
WAARDENBURG-SHAH SYNDROME	0.00122699	0.04603194117527669
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04603194117527669
STÜVE-WIEDEMANN SYNDROME	0.00122699	0.04603194117527669
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.04603194117527669
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527669
OPSISMODYSPLASIA	0.00122699	0.04603194117527669
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.04603194117527669
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00122699	0.04603194117527669
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.04603194117527669
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.04603194117527669
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04603194117527669
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.04603194117527669
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527669
ALG12-CDG	0.00122699	0.04603194117527669
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527669
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04603194117527669
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00122699	0.04603194117527669
TETRASOMY X	0.00122699	0.04603194117527669
ALG6-CDG	0.00122699	0.04603194117527669
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04603194117527669
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.04603194117527669
ANTISYNTHETASE SYNDROME	0.00122699	0.04603194117527669
3Q13 MICRODELETION SYNDROME	0.00122699	0.04603194117527669
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00122699	0.04603194117527669
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04603194117527669
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00122699	0.04603194117527669
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00122699	0.04603194117527669
14Q22Q23 MICRODELETION SYNDROME	0.00122699	0.04603194117527669
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00122699	0.04603194117527669
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.04603194117527669
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00122699	0.04603194117527669
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04603194117527669
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527669
B4GALT1-CDG	0.00122699	0.04603194117527669
COLE-CARPENTER SYNDROME	0.00122699	0.04603194117527669
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00122699	0.04603194117527669
THAKKER-DONNAI SYNDROME	0.00122699	0.04603194117527669
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.04603194117527669
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04603194117527669
KYPHOMELIC DYSPLASIA	0.00122699	0.04603194117527669
INTESTINAL BOTULISM	0.00122699	0.04603194117527669
INFANT BOTULISM	0.00122699	0.04603194117527669
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00122699	0.04603194117527669
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00122699	0.04603194117527669
THYROID HEMIAGENESIS	0.00122699	0.04603194117527669
DIASTROPHIC DWARFISM	0.00122699	0.04603194117527669
ABETALIPOPROTEINEMIA	0.00122699	0.04603194117527669
COG7-CDG	0.00122699	0.04603194117527669
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00122699	0.04603194117527669
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04603194117527669
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00122699	0.04603194117527669
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.04603194117527669
SPONASTRIME DYSPLASIA	0.00122699	0.04603194117527669
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.04603194117527669
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.04603194117527669
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04603194117527669
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00122699	0.04603194117527669
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.04603194117527669
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.04603194117527669
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04603194117527669
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.04603194117527669
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04603194117527669
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04603194117527669
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00122699	0.04603194117527669
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00122699	0.04603194117527669
CODAS SYNDROME	0.00122699	0.04603194117527669
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04603194117527669
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00122699	0.04603194117527669
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00122699	0.04603194117527669
CRIGLER-NAJJAR SYNDROME TYPE 1	0.001066353	0.04000545935018201
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001066353	0.04000545935018201
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.001066353	0.04000545935018201
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001066353	0.04000545935018201
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.001066353	0.04000545935018201
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001066353	0.04000545935018201
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.001066353	0.04000545935018201
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001066353	0.04000545935018201
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.04000545935018201
ACROMELIC FRONTONASAL DYSPLASIA	0.001066353	0.04000545935018201
SJOGREN-LARSSON SYNDROME; SLS	0.001066353	0.04000545935018201
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001066353	0.04000545935018201
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001066353	0.04000545935018201
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001066353	0.04000545935018201
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001066353	0.04000545935018201
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001066353	0.04000545935018201
PHENYLKETONURIA	0.001066353	0.04000545935018201
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001066353	0.04000545935018201
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001066353	0.04000545935018201
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001066353	0.04000545935018201
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.001066353	0.04000545935018201
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001066353	0.04000545935018201
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001066353	0.04000545935018201
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001066353	0.04000545935018201
SCHIZENCEPHALY	0.001066353	0.04000545935018201
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.001066353	0.04000545935018201
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001066353	0.04000545935018201
GALACTOSIALIDOSIS	0.001066353	0.04000545935018201
EPILEPSY-TELANGIECTASIA SYNDROME	0.001066353	0.04000545935018201
WOLFRAM SYNDROME	0.001066353	0.04000545935018201
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001066353	0.04000545935018201
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001066353	0.04000545935018201
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.001066353	0.04000545935018201
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.001066353	0.04000545935018201
ANGELMAN SYNDROME (TYPE 1)	0.001066353	0.04000545935018201
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001066353	0.04000545935018201
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.001066353	0.04000545935018201
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001066353	0.04000545935018201
AUTISM	0.001066353	0.04000545935018201
ACQUIRED PARTIAL LIPODYSTROPHY	0.001066353	0.04000545935018201
DERMOTRICHIC SYNDROME	0.001066353	0.04000545935018201
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001066353	0.04000545935018201
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001066353	0.04000545935018201
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.001066353	0.04000545935018201
DONNAI-BARROW SYNDROME	0.001066353	0.04000545935018201
GLUTATHIONE SYNTHETASE DEFICIENCY	0.001066353	0.04000545935018201
HENNEKAM SYNDROME	0.001066353	0.04000545935018201
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001066353	0.04000545935018201
611961 STEVENSON-CAREY SYNDROME	0.001066353	0.04000545935018201
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001066353	0.04000545935018201
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001066353	0.04000545935018201
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.001066353	0.04000545935018201
COFFIN-SIRIS SYNDROME 5	0.001066353	0.04000545935018201
POTOCKI-SHAFFER SYNDROME	0.001066353	0.04000545935018201
ATYPICAL JUVENILE PARKINSONISM	0.001066353	0.04000545935018201
CYSTATHIONINURIA	0.001066353	0.04000545935018201
ANGELMAN SYNDROME (TYPE 2)	0.001066353	0.04000545935018201
LISSENCEPHALY 8; LIS8	0.001066353	0.04000545935018201
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.001066353	0.04000545935018201
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 100	0.001066353	0.04000545935018201
ICHTHYOSIS AND MALE HYPOGONADISM	0.001066353	0.04000545935018201
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.001066353	0.04000545935018201
WAISMAN SYNDROME; WSMN	0.001066353	0.04000545935018201
PORENCEPHALY	0.001066353	0.04000545935018201
CEDNIK SYNDROME	0.001066353	0.04000545935018201
LISSENCEPHALY 1; LIS1	0.001066353	0.04000545935018201
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.001066353	0.04000545935018201
SMITH-FINEMAN-MYERS SYNDROME	0.001066353	0.04000545935018201
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001066353	0.04000545935018201
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001066353	0.04000545935018201
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.001066353	0.04000545935018201
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001066353	0.04000545935018201
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.001066353	0.04000545935018201
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.001066353	0.04000545935018201
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.001066353	0.04000545935018201
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001066353	0.04000545935018201
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001066353	0.04000545935018201
224250 DYSMYELINATION WITH JAUNDICE	0.001066353	0.04000545935018201
NETHERTON SYNDROME	0.001066353	0.04000545935018201
311450 PALLISTER W SYNDROME;;W SYNDROME	0.001066353	0.04000545935018201
LEUKOCYTE ADHESION DEFICIENCY	0.001066353	0.04000545935018201
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001066353	0.04000545935018201
STURGE-WEBER SYNDROME	0.001066353	0.04000545935018201
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.001066353	0.04000545935018201
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.001066353	0.04000545935018201
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001066353	0.04000545935018201
INCONTINENTIA PIGMENTI; IP	0.001066353	0.04000545935018201
HYPERPROLINEMIA, TYPE II	0.001066353	0.04000545935018201
17Q11.2 MICRODUPLICATION SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.001066353	0.04000545935018201
PRIMARY CUTIS VERTICIS GYRATA	0.001066353	0.04000545935018201
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.001066353	0.04000545935018201
MENTAL RETARDATION, FRA12A TYPE	0.001066353	0.04000545935018201
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.001066353	0.04000545935018201
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001066353	0.04000545935018201
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.001066353	0.04000545935018201
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001066353	0.04000545935018201
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.001066353	0.04000545935018201
MOYAMOYA DISEASE	0.001066353	0.04000545935018201
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001066353	0.04000545935018201
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.001066353	0.04000545935018201
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001066353	0.04000545935018201
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.001066353	0.04000545935018201
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001066353	0.04000545935018201
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.001066353	0.04000545935018201
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.001066353	0.04000545935018201
L1 SYNDROME	0.001066353	0.04000545935018201
MULTIPLE SULFATASE DEFICIENCY	0.001066353	0.04000545935018201
CEREBROTENDINOUS XANTHOMATOSIS	0.001066353	0.04000545935018201
XP21 MICRODELETION SYNDROME	0.001066353	0.04000545935018201
MICROPHTHALMIA, LENZ TYPE	0.001066353	0.04000545935018201
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.001066353	0.04000545935018201
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.001066353	0.04000545935018201
OCULODENTODIGITAL DYSPLASIA	0.001066353	0.04000545935018201
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001066353	0.04000545935018201
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.001066353	0.04000545935018201
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.001066353	0.04000545935018201
KBG SYNDROME	0.001066353	0.04000545935018201
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001066353	0.04000545935018201
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001066353	0.04000545935018201
TYROSINEMIA TYPE 2	0.001066353	0.04000545935018201
ASPARTYLGLUCOSAMINURIA	0.001066353	0.04000545935018201
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001066353	0.04000545935018201
WYBURN-MASON SYNDROME	0.001066353	0.04000545935018201
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001066353	0.04000545935018201
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.001066353	0.04000545935018201
BETA-MANNOSIDOSIS	0.001066353	0.04000545935018201
AYME-GRIPP SYNDROME; AYGRP	0.001066353	0.04000545935018201
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.04000545935018201
17Q12 MICRODELETION SYNDROME	0.001066353	0.04000545935018201
17Q12 MICRODUPLICATION SYNDROME	0.001066353	0.04000545935018201
EPILEPSY-TELANGIECTASIA	0.001066353	0.04000545935018201
GURRIERI SYNDROME	0.001066353	0.04000545935018201
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001066353	0.04000545935018201
FOUNTAIN SYNDROME	0.001066353	0.04000545935018201
OCULODENTODIGITAL DYSPLASIA; ODDD	0.001066353	0.04000545935018201
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001066353	0.04000545935018201
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001066353	0.04000545935018201
SUPRABULBAR PARESIS, CONGENITAL	0.001066353	0.04000545935018201
SRD5A3-CDG	0.001066353	0.04000545935018201
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.001066353	0.04000545935018201
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 82	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.001066353	0.04000545935018201
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.001066353	0.04000545935018201
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.001066353	0.04000545935018201
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001066353	0.04000545935018201
RECOMBINANT 8 SYNDROME	0.001066353	0.04000545935018201
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001066353	0.04000545935018201
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 96; MRX96	0.001066353	0.04000545935018201
STURGE-WEBER SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 88	0.001066353	0.04000545935018201
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001066353	0.04000545935018201
HEREDITARY HYPEREKPLEXIA	0.001066353	0.04000545935018201
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001066353	0.04000545935018201
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.001066353	0.04000545935018201
ZLOTOGORA-OGUR SYNDROME	0.001066353	0.04000545935018201
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001066353	0.04000545935018201
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001066353	0.04000545935018201
TETRASOMY 18P	0.001066353	0.04000545935018201
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.001066353	0.04000545935018201
PAPILLORENAL SYNDROME	0.001066353	0.04000545935018201
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001066353	0.04000545935018201
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 72	0.001066353	0.04000545935018201
CONGENITAL HYDROCEPHALUS	0.001066353	0.04000545935018201
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001066353	0.04000545935018201
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001066353	0.04000545935018201
CROUZON SYNDROME	0.001066353	0.04000545935018201
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.001066353	0.04000545935018201
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.001066353	0.04000545935018201
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.001066353	0.04000545935018201
COCKAYNE SYNDROME A; CSA	0.001066353	0.04000545935018201
CROME SYNDROME	0.001066353	0.04000545935018201
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001066353	0.04000545935018201
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001066353	0.04000545935018201
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001066353	0.04000545935018201
ATYPICAL RETT SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.001066353	0.04000545935018201
RUVALCABA SYNDROME	0.001066353	0.04000545935018201
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001066353	0.04000545935018201
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.001066353	0.04000545935018201
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001066353	0.04000545935018201
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001066353	0.04000545935018201
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001066353	0.04000545935018201
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001066353	0.04000545935018201
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.04000545935018201
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001066353	0.04000545935018201
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001066353	0.04000545935018201
KIFAFA SEIZURE DISORDER	0.001066353	0.04000545935018201
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001066353	0.04000545935018201
BARAITSER-WINTER SYNDROME 2; BRWS2	0.001066353	0.04000545935018201
GENITOPATELLAR SYNDROME	0.001066353	0.04000545935018201
IMMUNODEFICIENCY 47	0.001066353	0.04000545935018201
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.001066353	0.04000545935018201
SANJAD-SAKATI SYNDROME	0.001066353	0.04000545935018201
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.001066353	0.04000545935018201
MENTAL RETARDATION, X-LINKED 103	0.001066353	0.04000545935018201
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001066353	0.04000545935018201
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001066353	0.04000545935018201
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001066353	0.04000545935018201
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.036073204063434255
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.036073204063434255
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.036073204063434255
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.036073204063434255
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0009615380000000001	0.036073204063434255
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.036073204063434255
ETHANOLAMINOSIS	0.0009615380000000001	0.036073204063434255
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.036073204063434255
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0009615380000000001	0.036073204063434255
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.036073204063434255
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.036073204063434255
SUSAC SYNDROME	0.0009615380000000001	0.036073204063434255
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.036073204063434255
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	0.036073204063434255
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.036073204063434255
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.036073204063434255
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.036073204063434255
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	0.036073204063434255
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.036073204063434255
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.036073204063434255
RIGID SPINE SYNDROME	0.0009615380000000001	0.036073204063434255
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	0.036073204063434255
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.036073204063434255
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.036073204063434255
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.036073204063434255
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.036073204063434255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0009615380000000001	0.036073204063434255
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.036073204063434255
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.036073204063434255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0009615380000000001	0.036073204063434255
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.036073204063434255
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.036073204063434255
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.036073204063434255
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.036073204063434255
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.036073204063434255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.036073204063434255
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	0.036073204063434255
CHITAYAT SYNDROME	0.0009615380000000001	0.036073204063434255
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.036073204063434255
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.036073204063434255
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.036073204063434255
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.036073204063434255
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0009615380000000001	0.036073204063434255
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.036073204063434255
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.036073204063434255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	0.036073204063434255
AL-RAQAD SYNDROME; ARS	0.0009615380000000001	0.036073204063434255
DIAPHANOSPONDYLODYSOSTOSIS	0.0009615380000000001	0.036073204063434255
SPINOCEREBELLAR ATAXIA TYPE 29	0.0009615380000000001	0.036073204063434255
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.036073204063434255
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.0009615380000000001	0.036073204063434255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.036073204063434255
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0009615380000000001	0.036073204063434255
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.036073204063434255
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0009615380000000001	0.036073204063434255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.036073204063434255
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0009615380000000001	0.036073204063434255
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.036073204063434255
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	0.036073204063434255
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.036073204063434255
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.036073204063434255
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.036073204063434255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.036073204063434255
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.036073204063434255
SYDENHAM CHOREA	0.0009615380000000001	0.036073204063434255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.036073204063434255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.036073204063434255
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	0.036073204063434255
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.036073204063434255
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0009615380000000001	0.036073204063434255
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.036073204063434255
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	0.036073204063434255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.036073204063434255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0009615380000000001	0.036073204063434255
YOU-HOOVER-FONG SYNDROME; YHFS	0.0009615380000000001	0.036073204063434255
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	0.036073204063434255
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.036073204063434255
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.036073204063434255
JOUBERT SYNDROME 26	0.0009615380000000001	0.036073204063434255
JOUBERT SYNDROME 4	0.0009615380000000001	0.036073204063434255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.036073204063434255
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.036073204063434255
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.036073204063434255
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.036073204063434255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0009615380000000001	0.036073204063434255
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.036073204063434255
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.036073204063434255
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.036073204063434255
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.036073204063434255
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	0.036073204063434255
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.036073204063434255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0009615380000000001	0.036073204063434255
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.036073204063434255
PEROXISOME BIOGENESIS DISORDER 6B	0.0009615380000000001	0.036073204063434255
JOUBERT SYNDROME 25	0.0009615380000000001	0.036073204063434255
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.036073204063434255
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	0.036073204063434255
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.036073204063434255
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.036073204063434255
JOUBERT SYNDROME 24	0.0009615380000000001	0.036073204063434255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	0.036073204063434255
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.036073204063434255
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.020311956543392472
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020311956543392472
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.020311956543392472
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392472
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392472
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392472
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392472
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392472
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.020311956543392472
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392472
HYDRANENCEPHALY	0.000541419	0.020311956543392472
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392472
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020311956543392472
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392472
CADASIL	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392472
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392472
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392472
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392472
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392472
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392472
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
OPTIC PATHWAY GLIOMA	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392472
KBG SYNDROME	0.000541419	0.020311956543392472
DEND SYNDROME	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.020311956543392472
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392472
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392472
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392472
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392472
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA	0.000541419	0.020311956543392472
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392472
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392472
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
HARTNUP DISORDER	0.000541419	0.020311956543392472
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392472
PHACE ASSOCIATION	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392472
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.020311956543392472
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020311956543392472
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
KNOBLOCH SYNDROME	0.000541419	0.020311956543392472
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392472
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392472
MERCURY POISONING	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000541419	0.020311956543392472
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392472
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392472
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
PERRAULT SYNDROME 3	0.000541419	0.020311956543392472
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392472
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392472
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
GLIOBLASTOMA	0.000541419	0.020311956543392472
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
CHÉDIAK-HIGASHI SYNDROME	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392472
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392472
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
PROLACTINOMA	0.000541419	0.020311956543392472
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392472
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
HHHH SYNDROME	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
ALG1-CDG	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392472
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392472
FABRY DISEASE	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392472
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392472
WHIM SYNDROME	0.000541419	0.020311956543392472
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392472
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392472
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020311956543392472
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.020311956543392472
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392472
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000541419	0.020311956543392472
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392472
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020311956543392472
THUMB DEFORMITY AND ALOPECIA	0.000524934	0.019693502806789536
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000524934	0.019693502806789536
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.000524934	0.019693502806789536
X-LINKED INTELLECTUAL DISABILITY-RETINITIS PIGMENTOSA SYNDROME	0.000524934	0.019693502806789536
DISTAL MONOSOMY 10P	0.000524934	0.019693502806789536
TELECANTHUS	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000524934	0.019693502806789536
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.000524934	0.019693502806789536
CEREBROCOSTOMANDIBULAR SYNDROME	0.000524934	0.019693502806789536
LELIS SYNDROME	0.000524934	0.019693502806789536
CURRY-JONES SYNDROME	0.000524934	0.019693502806789536
DESBUQUOIS SYNDROME	0.000524934	0.019693502806789536
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000524934	0.019693502806789536
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000524934	0.019693502806789536
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.000524934	0.019693502806789536
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.000524934	0.019693502806789536
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000524934	0.019693502806789536
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000524934	0.019693502806789536
DYSSPONDYLOENCHONDROMATOSIS	0.000524934	0.019693502806789536
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
SPONDYLO-OCULAR SYNDROME	0.000524934	0.019693502806789536
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000524934	0.019693502806789536
CEREBROFACIOTHORACIC DYSPLASIA	0.000524934	0.019693502806789536
CRANIODIAPHYSEAL DYSPLASIA	0.000524934	0.019693502806789536
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000524934	0.019693502806789536
ANE SYNDROME	0.000524934	0.019693502806789536
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.000524934	0.019693502806789536
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.000524934	0.019693502806789536
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.019693502806789536
OTOMANDIBULAR SYNDROME	0.000524934	0.019693502806789536
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.000524934	0.019693502806789536
FEINGOLD SYNDROME 2; FGLDS2	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000524934	0.019693502806789536
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.000524934	0.019693502806789536
RUVALCABA SYNDROME	0.000524934	0.019693502806789536
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.000524934	0.019693502806789536
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.000524934	0.019693502806789536
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000524934	0.019693502806789536
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000524934	0.019693502806789536
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000524934	0.019693502806789536
SOTOS SYNDROME 3	0.000524934	0.019693502806789536
TOWNES-BROCKS SYNDROME 1; TBS1	0.000524934	0.019693502806789536
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.000524934	0.019693502806789536
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.000524934	0.019693502806789536
BASAL CELL NEVUS SYNDROME	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000524934	0.019693502806789536
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.019693502806789536
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000524934	0.019693502806789536
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000524934	0.019693502806789536
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000524934	0.019693502806789536
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000524934	0.019693502806789536
RAHMAN SYNDROME	0.000524934	0.019693502806789536
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000524934	0.019693502806789536
CEREBELLOFACIODENTAL SYNDROME	0.000524934	0.019693502806789536
MECKEL SYNDROME 13; MKS13	0.000524934	0.019693502806789536
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000524934	0.019693502806789536
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.000524934	0.019693502806789536
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000524934	0.019693502806789536
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000524934	0.019693502806789536
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000524934	0.019693502806789536
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000524934	0.019693502806789536
8P23.1 DUPLICATION SYNDROME	0.000524934	0.019693502806789536
NF1-MICRODELETION SYNDROME	0.000524934	0.019693502806789536
CRI DU CHAT SYNDROME (5P DELETION)	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000524934	0.019693502806789536
WILLIAMS-BEUREN SYNDROME (WBS)	0.000524934	0.019693502806789536
22Q11 DUPLICATION SYNDROME	0.000524934	0.019693502806789536
WAGR 11P13 DELETION SYNDROME	0.000524934	0.019693502806789536
8P23.1 DELETION SYNDROME	0.000524934	0.019693502806789536
CHROMOSOME 15Q14 DELETION SYNDROME	0.000524934	0.019693502806789536
CAT-EYE SYNDROME (TYPE I)	0.000524934	0.019693502806789536
7Q11.23 DUPLICATION SYNDROME	0.000524934	0.019693502806789536
LIG4 SYNDROME	0.000524934	0.019693502806789536
2Q37 MONOSOMY	0.000524934	0.019693502806789536
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000524934	0.019693502806789536
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000524934	0.019693502806789536
MYOTONIA PERMANENS	0.000524934	0.019693502806789536
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000524934	0.019693502806789536
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000524934	0.019693502806789536
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.019693502806789536
ATR-16 SYNDROME	0.000524934	0.019693502806789536
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.019693502806789536
16P11.2-P12.2 MICRODELETION SYNDROME	0.000524934	0.019693502806789536
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA TYPE 2	0.000524934	0.019693502806789536
2P15-16.1 MICRODELETION SYNDROME	0.000524934	0.019693502806789536
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000524934	0.019693502806789536
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000524934	0.019693502806789536
FRONTONASAL DYSPLASIA 1; FND1	0.000524934	0.019693502806789536
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000524934	0.019693502806789536
MEGALENCEPHALY	0.000524934	0.019693502806789536
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.000524934	0.019693502806789536
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000524934	0.019693502806789536
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000524934	0.019693502806789536
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000524934	0.019693502806789536
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.000524934	0.019693502806789536
WAARDENBURG SYNDROME TYPE 3	0.000524934	0.019693502806789536
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000524934	0.019693502806789536
HEMIFACIAL MICROSOMIA	0.000524934	0.019693502806789536
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.000524934	0.019693502806789536
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000524934	0.019693502806789536
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000524934	0.019693502806789536
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000524934	0.019693502806789536
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000524934	0.019693502806789536
BAMFORTH-LAZARUS SYNDROME	0.000524934	0.019693502806789536
BJÖRNSTAD SYNDROME	0.000524934	0.019693502806789536
BARTSOCAS-PAPAS SYNDROME	0.000524934	0.019693502806789536
APERT SYNDROME	0.000524934	0.019693502806789536
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000524934	0.019693502806789536
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.019693502806789536
OROFACIODIGITAL SYNDROME V; OFD5	0.000524934	0.019693502806789536
FEINGOLD SYNDROME	0.000524934	0.019693502806789536
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000524934	0.019693502806789536
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000524934	0.019693502806789536
FRAXE INTELLECTUAL DISABILITY	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000524934	0.019693502806789536
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000524934	0.019693502806789536
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.000524934	0.019693502806789536
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000524934	0.019693502806789536
ACRODYSOSTOSIS	0.000524934	0.019693502806789536
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000524934	0.019693502806789536
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
HOLOPROSENCEPHALY 3; HPE3	0.000524934	0.019693502806789536
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000524934	0.019693502806789536
HYPOCHONDROPLASIA	0.000524934	0.019693502806789536
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000524934	0.019693502806789536
NEPHRONOPHTHISIS 18; NPHP18	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000524934	0.019693502806789536
FIBULAR HEMIMELIA	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000524934	0.019693502806789536
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.000524934	0.019693502806789536
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000524934	0.019693502806789536
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000524934	0.019693502806789536
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000524934	0.019693502806789536
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000524934	0.019693502806789536
MICROPHTHALMIA, SYNDROMIC 12	0.000524934	0.019693502806789536
LARYNGEAL ABDUCTOR PARALYSIS	0.000524934	0.019693502806789536
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000524934	0.019693502806789536
STICKLER SYNDROME TYPE 1	0.000524934	0.019693502806789536
SECKEL SYNDROME 8; SCKL8	0.000524934	0.019693502806789536
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000524934	0.019693502806789536
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.000524934	0.019693502806789536
UNVERRICHT-LUNDBORG DISEASE	0.000524934	0.019693502806789536
LYSINE MALABSORPTION SYNDROME	0.000524934	0.019693502806789536
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000524934	0.019693502806789536
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000524934	0.019693502806789536
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000524934	0.019693502806789536
245800 LAURENCE-MOON SYNDROME	0.000524934	0.019693502806789536
LAMBERT SYNDROME	0.000524934	0.019693502806789536
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.000524934	0.019693502806789536
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000524934	0.019693502806789536
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000524934	0.019693502806789536
MICROPHTHALMIA, SYNDROMIC 4	0.000524934	0.019693502806789536
RICHARDS-RUNDLE SYNDROME; RRNS	0.000524934	0.019693502806789536
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.000524934	0.019693502806789536
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000524934	0.019693502806789536
MASA SYNDROME	0.000524934	0.019693502806789536
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000524934	0.019693502806789536
KID SYNDROME	0.000524934	0.019693502806789536
3MC SYNDROME 3	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000524934	0.019693502806789536
CHROMOSOME XP11.3 DELETION SYNDROME	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 63	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 81	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 46	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 84	0.000524934	0.019693502806789536
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000524934	0.019693502806789536
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 92	0.000524934	0.019693502806789536
BRUNNER SYNDROME; BRNRS	0.000524934	0.019693502806789536
MCDONOUGH SYNDROME	0.000524934	0.019693502806789536
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000524934	0.019693502806789536
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.000524934	0.019693502806789536
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 95	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000524934	0.019693502806789536
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000524934	0.019693502806789536
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.000524934	0.019693502806789536
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.000524934	0.019693502806789536
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000524934	0.019693502806789536
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000524934	0.019693502806789536
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000524934	0.019693502806789536
N SYNDROME	0.000524934	0.019693502806789536
COWCHOCK SYNDROME; COWCK	0.000524934	0.019693502806789536
OPTIC ATROPHY 2	0.000524934	0.019693502806789536
PROTEUS-LIKE SYNDROME	0.000524934	0.019693502806789536
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.000524934	0.019693502806789536
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.000524934	0.019693502806789536
HYDROXYPROLINEMIA	0.000524934	0.019693502806789536
SCARF SYNDROME	0.000524934	0.019693502806789536
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000524934	0.019693502806789536
3MC SYNDROME	0.000524934	0.019693502806789536
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.000524934	0.019693502806789536
HOMOCARNOSINOSIS	0.000524934	0.019693502806789536
VAN DEN BOSCH SYNDROME	0.000524934	0.019693502806789536
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.000524934	0.019693502806789536
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000524934	0.019693502806789536
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000524934	0.019693502806789536
IMINOGLYCINURIA	0.000524934	0.019693502806789536
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000524934	0.019693502806789536
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.000524934	0.019693502806789536
FOCAL DERMAL HYPOPLASIA; FDH	0.000524934	0.019693502806789536
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000524934	0.019693502806789536
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.000524934	0.019693502806789536
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.000524934	0.019693502806789536
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.000524934	0.019693502806789536
PTEN HAMARTOMA TUMOR SYNDROME	0.000524934	0.019693502806789536
WOODHOUSE-SAKATI SYNDROME	0.000524934	0.019693502806789536
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.000524934	0.019693502806789536
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000524934	0.019693502806789536
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000524934	0.019693502806789536
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 53	0.000524934	0.019693502806789536
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000524934	0.019693502806789536
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000524934	0.019693502806789536
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.000524934	0.019693502806789536
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.000524934	0.019693502806789536
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000524934	0.019693502806789536
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000524934	0.019693502806789536
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000524934	0.019693502806789536
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000524934	0.019693502806789536
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000524934	0.019693502806789536
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000524934	0.019693502806789536
ALDH18A1-RELATED DE BARSY SYNDROME	0.000524934	0.019693502806789536
HYPOCHONDROPLASIA	0.000524934	0.019693502806789536
X-LINKED ADRENOLEUKODYSTROPHY	0.000524934	0.019693502806789536
COENZYME Q10 DEFICIENCY	0.000524934	0.019693502806789536
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.000524934	0.019693502806789536
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000524934	0.019693502806789536
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000524934	0.019693502806789536
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000524934	0.019693502806789536
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000524934	0.019693502806789536
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.000524934	0.019693502806789536
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.000524934	0.019693502806789536
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000524934	0.019693502806789536
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000524934	0.019693502806789536
3MC SYNDROME 2	0.000524934	0.019693502806789536
GORLIN SYNDROME	0.000524934	0.019693502806789536
OROFACIODIGITAL SYNDROME III	0.000524934	0.019693502806789536
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000524934	0.019693502806789536
OLIVER SYNDROME	0.000524934	0.019693502806789536
OCULORENOCEREBELLAR SYNDROME	0.000524934	0.019693502806789536
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.000524934	0.019693502806789536
RODRIGUES BLINDNESS	0.000524934	0.019693502806789536
SACCHAROPINURIA	0.000524934	0.019693502806789536
OCULOPALATOCEREBRAL SYNDROME	0.000524934	0.019693502806789536
SONODA SYNDROME	0.000524934	0.019693502806789536
PENDRED SYNDROME	0.000524934	0.019693502806789536
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA 16, X-LINKED	0.000524934	0.019693502806789536
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000524934	0.019693502806789536
VAN DEN BOSCH SYNDROME	0.000524934	0.019693502806789536
VACTERL WITH HYDROCEPHALUS	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 23	0.000524934	0.019693502806789536
NIJMEGEN BREAKAGE SYNDROME	0.000524934	0.019693502806789536
JAWAD SYNDROME	0.000524934	0.019693502806789536
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.000524934	0.019693502806789536
MICROCEPHALY-CARDIOMYOPATHY	0.000524934	0.019693502806789536
MENTAL RETARDATION, X-LINKED 20	0.000524934	0.019693502806789536
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.000524934	0.019693502806789536
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000524934	0.019693502806789536
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000524934	0.019693502806789536
WEISMANN-NETTER SYNDROME	0.000524934	0.019693502806789536
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000524934	0.019693502806789536
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.019693502806789536
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000524934	0.019693502806789536
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000524934	0.019693502806789536
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000524934	0.019693502806789536
DE SANCTIS-CACCHIONE SYNDROME	0.000524934	0.019693502806789536
MMEP SYNDROME	0.000524934	0.019693502806789536
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.000524934	0.019693502806789536
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.000524934	0.019693502806789536
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000524934	0.019693502806789536
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.000524934	0.019693502806789536
CHANARIN-DORFMAN SYNDROME	0.000524934	0.019693502806789536
TRYPTOPHANURIA WITH DWARFISM	0.000524934	0.019693502806789536
T-SUBSTANCE ANOMALY	0.000524934	0.019693502806789536
TYROSINE TRANSAMINASE DEFICIENCY	0.000524934	0.019693502806789536
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.000524934	0.019693502806789536
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000524934	0.019693502806789536
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.000524934	0.019693502806789536
ISOLATED BRACHYCEPHALY	0.000524934	0.019693502806789536
ISOLATED PLAGIOCEPHALY	0.000524934	0.019693502806789536
PROPIONIC ACIDEMIA	0.000524934	0.019693502806789536
MUCOLIPIDOSIS III ALPHA/BETA	0.000524934	0.019693502806789536
MORQUIO SYNDROME C	0.000524934	0.019693502806789536
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.000524934	0.019693502806789536
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000524934	0.019693502806789536
LEBER OPTIC ATROPHY AND DYSTONIA	0.000524934	0.019693502806789536
CONGENITAL VARICELLA SYNDROME	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000524934	0.019693502806789536
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000524934	0.019693502806789536
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000524934	0.019693502806789536
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000524934	0.019693502806789536
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.000524934	0.019693502806789536
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000524934	0.019693502806789536
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.000524934	0.019693502806789536
CAHMR SYNDROME	0.000524934	0.019693502806789536
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000524934	0.019693502806789536
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.000524934	0.019693502806789536
DYSTONIA 16	0.000524934	0.019693502806789536
IRIDA SYNDROME	0.000524934	0.019693502806789536
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000524934	0.019693502806789536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000524934	0.019693502806789536
BIEMOND SYNDROME II	0.000524934	0.019693502806789536
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000524934	0.019693502806789536
HYDROXYKYNURENINURIA	0.000524934	0.019693502806789536
GEMIGNANI SYNDROME	0.000524934	0.019693502806789536
CEPHALIN LIPIDOSIS	0.000524934	0.019693502806789536
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000524934	0.019693502806789536
HYPERTRICHOSIS CUBITI	0.000524934	0.019693502806789536
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.000524934	0.019693502806789536
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000524934	0.019693502806789536
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000524934	0.019693502806789536
USHER SYNDROME TYPE 1	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.000524934	0.019693502806789536
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000524934	0.019693502806789536
ARGININOSUCCINIC ACIDURIA	0.000524934	0.019693502806789536
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000524934	0.019693502806789536
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000524934	0.019693502806789536
ICF SYNDROME	0.000524934	0.019693502806789536
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.000524934	0.019693502806789536
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.000524934	0.019693502806789536
CHARGE SYNDROME	0.000524934	0.019693502806789536
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000524934	0.019693502806789536
PROLIDASE DEFICIENCY	0.000524934	0.019693502806789536
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000524934	0.019693502806789536
BEHR SYNDROME	0.000524934	0.019693502806789536
FLOATING-HARBOR SYNDROME	0.000524934	0.019693502806789536
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000524934	0.019693502806789536
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000524934	0.019693502806789536
DYSOSTEOSCLEROSIS	0.000524934	0.019693502806789536
FRONTONASAL DYSPLASIA 2; FND2	0.000524934	0.019693502806789536
GILLESPIE SYNDROME; GLSP	0.000524934	0.019693502806789536
MEDNIK SYNDROME	0.000524934	0.019693502806789536
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000524934	0.019693502806789536
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000524934	0.019693502806789536
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000524934	0.019693502806789536
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000524934	0.019693502806789536
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000524934	0.019693502806789536
TRISOMY 12P	0.000524934	0.019693502806789536
ALPHA-METHYLACETOACETIC ACIDURIA	0.000524934	0.019693502806789536
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000524934	0.019693502806789536
CHROMOSOME 13Q14 DELETION SYNDROME	0.000524934	0.019693502806789536
AGENESIS OF CEREBRAL WHITE MATTER	0.000524934	0.019693502806789536
DERMATOLEUKODYSTROPHY	0.000524934	0.019693502806789536
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000524934	0.019693502806789536
207790 ARACHNOID CYSTS, INTRACRANIAL	0.000524934	0.019693502806789536
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000524934	0.019693502806789536
PHENOBARBITAL EMBRYOPATHY	0.000524934	0.019693502806789536
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.000524934	0.019693502806789536
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.000524934	0.019693502806789536
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000524934	0.019693502806789536
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.000524934	0.019693502806789536
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000524934	0.019693502806789536
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.000524934	0.019693502806789536
FETAL IODINE SYNDROME	0.000524934	0.019693502806789536
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.000524934	0.019693502806789536
EEC SYNDROME	0.000524934	0.019693502806789536
OROFACIODIGITAL SYNDROME XI; OFD11	0.000524934	0.019693502806789536
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.000524934	0.019693502806789536
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.000524934	0.019693502806789536
LOWRY-WOOD SYNDROME	0.000524934	0.019693502806789536
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.000524934	0.019693502806789536
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.000524934	0.019693502806789536
JUBERG-HAYWARD SYNDROME	0.000524934	0.019693502806789536
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.000524934	0.019693502806789536
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000524934	0.019693502806789536
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.000524934	0.019693502806789536
OSTEOPETROSIS AND RELATED DISORDERS	0.000524934	0.019693502806789536
FORMIMINOTRANSFERASE DEFICIENCY	0.000524934	0.019693502806789536
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000524934	0.019693502806789536
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.000524934	0.019693502806789536
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000524934	0.019693502806789536
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000524934	0.019693502806789536
FETAL IODINE DEFICIENCY DISORDER	0.000524934	0.019693502806789536
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000524934	0.019693502806789536
MONILETHRIX	0.000524934	0.019693502806789536
OCULOFACIOCARDIODENTAL SYNDROME	0.000524934	0.019693502806789536
MUCOPOLYSACCHARIDOSIS TYPE 1	0.000524934	0.019693502806789536
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000524934	0.019693502806789536
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000524934	0.019693502806789536
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000524934	0.019693502806789536
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000524934	0.019693502806789536
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.000524934	0.019693502806789536
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.000524934	0.019693502806789536
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000524934	0.019693502806789536
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.000524934	0.019693502806789536
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.000524934	0.019693502806789536
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.000524934	0.019693502806789536
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000524934	0.019693502806789536
LOWRY-MACLEAN SYNDROME	0.000524934	0.019693502806789536
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000524934	0.019693502806789536
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.000524934	0.019693502806789536
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000524934	0.019693502806789536
PFEIFFER-PALM-TELLER SYNDROME	0.000524934	0.019693502806789536
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.000524934	0.019693502806789536
GERODERMA OSTEODYSPLASTICUM; GO	0.000524934	0.019693502806789536
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000524934	0.019693502806789536
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000524934	0.019693502806789536
CONE-ROD DYSTROPHY 1; CORD1	0.000524934	0.019693502806789536
GLUTATHIONURIA	0.000524934	0.019693502806789536
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA-GLAUCOMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
RHOMBENCEPHALOSYNAPSIS	0.000524934	0.019693502806789536
16P13.11 MICRODUPLICATION SYNDROME	0.000524934	0.019693502806789536
TRISOMY 9P	0.000524934	0.019693502806789536
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000524934	0.019693502806789536
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.000524934	0.019693502806789536
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000524934	0.019693502806789536
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.000524934	0.019693502806789536
ACROGERIA	0.000524934	0.019693502806789536
DEAFNESS AND MYOPIA; DFNMYP	0.000524934	0.019693502806789536
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000524934	0.019693502806789536
FRONTONASAL DYSPLASIA	0.000524934	0.019693502806789536
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789536
MASA SYNDROME	0.000524934	0.019693502806789536
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000524934	0.019693502806789536
CYSTEINE PEPTIDURIA	0.000524934	0.019693502806789536
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000524934	0.019693502806789536
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789536
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000524934	0.019693502806789536
PENDRED SYNDROME	0.000524934	0.019693502806789536
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000524934	0.019693502806789536
DERMATOLEUKODYSTROPHY	0.000524934	0.019693502806789536
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000524934	0.019693502806789536
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000524934	0.019693502806789536
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.000524934	0.019693502806789536
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000524934	0.019693502806789536
N SYNDROME	0.000524934	0.019693502806789536
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.000524934	0.019693502806789536
MIETENS SYNDROME	0.000524934	0.019693502806789536
ENCEPHALOMALACIA, MULTILOCULAR	0.000524934	0.019693502806789536
ELLIS-VAN CREVELD SYNDROME	0.000524934	0.019693502806789536
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.000524934	0.019693502806789536
DYSAUTONOMIA-LIKE DISORDER	0.000524934	0.019693502806789536
DIBASIC AMINO ACIDURIA I	0.000524934	0.019693502806789536
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000524934	0.019693502806789536
CREE MENTAL RETARDATION SYNDROME	0.000524934	0.019693502806789536
HURLER SYNDROME	0.000524934	0.019693502806789536
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.000524934	0.019693502806789536
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.000524934	0.019693502806789536
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000524934	0.019693502806789536
DICARBOXYLICAMINO ACIDURIA	0.000524934	0.019693502806789536
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000524934	0.019693502806789536
